var title_f42_6_43104="Upper GI pyloric stenosis";
var content_f42_6_43104=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyloric stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 334px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upper GI of pyloric stenosis. Note the characteristic \"apple core\" or \"string\" sign caused by the narrowed lumen of the pylorus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Mary L Brandt, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43104=[""].join("\n");
var outline_f42_6_43104=null;
var title_f42_6_43105="Papulonecrotic tuberculid on extremities";
var content_f42_6_43105=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74606%7EDERM%2F55062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74606%7EDERM%2F55062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Papulonecrotic tuberculid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 256px; height: 372px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A symmetrical eruption of erythematous to violaceous papules is present on the legs of this patient with papulonecrotic tuberculid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. M Ramam, New Delhi.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Papulonecrotic tuberculid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 245px; height: 218px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A purulent ulcer is present on the penis in this patient with papulonecrotic tuberculid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. M Ramam, New Delhi.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43105=[""].join("\n");
var outline_f42_6_43105=null;
var title_f42_6_43106="Isoelectric focusing of hemoglobins";
var content_f42_6_43106=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F52896&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F52896&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 606px\">",
"   <div class=\"ttl\">",
"    Isoelectric focusing for separation of hemoglobins",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 586px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Isoelectric focusing gel showing separation pattern of various hemoglobins. C is a control mix of Hbs A, F, S, and C. Note the differences in mobility of Hb C and E (lanes 5 and 6), and Hb S and D (lanes 1 and 2) using this separation method.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43106=[""].join("\n");
var outline_f42_6_43106=null;
var title_f42_6_43107="Latissimus flap breast reconstruction";
var content_f42_6_43107=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F67952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F67952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Latissimus flap breast reconstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 526px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAIOAg0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiqer6nZ6Pp0t9qc629pFjfI2cDJCjp6kgfjWD/wsLwx/0E//ACXl/wDiaAOqorB0fxfoWsagtjp2oLLdsjSLEY3UlVxkjcBnGR+db1ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRWfres6foVkLvVrlba3LrGHYE5Y9AAATmsX/AIWF4Y/6Cf8A5Ly//E0AdVRWHonivRNbvXtNLv1nuVjMpj2Mh2AgFvmA4yQPxrcoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDlfif/wAihJ/1+2P/AKVw14P+0D8SNV0z4mxQ6DrFxa23hmCG5ubSGSRUvpnlRmicL8pURYPzcfeHU19DeNdJudb8Oz2NjLDFcmWGaNpgSmY5Ukwcc4OzH41yUHg/WYF10R6b4VxrpY6lua5b7TuBUhsnphiMDAGaANWe+t9T8a+DL+ykElrdabeTxOP4kb7Myn8iK7SuD8L+FNV03VdEa4XSbbS9ItJ7W3t7IysQJDH3kJ4Hl/rXeUAFNLAEgdhk0y5uI7aEyTNtUfmT6Cs6G7LAswwZG3Eeg7Cs5zUdC4QctTWHSiqn21R2p8d0rnFNVI9wdOXYsUUUE4BNWQFFMiJZAxKkEZGBisnW9eg04eWgE1x/cBwF+p/pUymoq8iowcnaJs0EgDJIA9685vdYv70nzLqREP8ABCfLA/Ln8zVOO3WR90kasfVhk/nXK8Yvso644N295npb3dsn37iFfq4FQjU7V22xSGU+qKSP++un61yFpEqYwqj6CtASMo4NH1lvoL6sl1OrRtyg+tLWZpd3uXY/4Vp10wmpK5yzi4uwUUUVZIUUUUAFFFFABRRRQAUUUUAcr4//AOZc/wCw1bf+zV83eK9V8XSah8S7/Tr3xU0ej6swiu7bWvLtrGIPkg27PmQbc8KMV9N+M9JvtWsrH+ypbaO7s72K7T7SGKNszwdvPevPNQ+E39o6pdajfeH/AAnPd3UxnnZ5bsrK5Ocsu7aee2MUAdRol/HqnjLw1qEE5uYrvw3JOkxTYZFaS2YNt7ZznHau7rkNB0TWo/E0Gp6udJigtrB7GGCwVwAGeNv4uAAI8AD1rr6ACkyOPeoLyYQxgZ+dztX/AB/DrSxzIzMc4A4FS5JOxSi7XJ6KZ5qf3hTwQRkU00xWCiimu4UgYJJ6ACmIdRRWNqniC0sXaJM3E44KIeFP+0eg+nJ9qmUlFXkyoxcnaKNmiuLm8VX0hH2eG2i9m3Sfrlf5VJBqupy8tcKvssY/rmsfrUOht9Wn1OwpGZV+8wH1Nc/FJcTY865lYegIT/0ECtGy2Rt8qAZ796uNVS2IlScdy+CD0paB0orUyCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqtqF7DYWrT3BIQcADksT0AHrSbtqxpNuyLJIAJJwKxrvxDZxEpbN9pkH9w/KPq3T8s1ymqX1zqkha7YrDnK26n5R9f7x+v4YquhCCuKeL6QO6ng+szbmu5byYPOwOPuqOi/SnST7AMGsuGbuelQ3F1l+DXM6jerOlU7aI1BeNn71TQ3bjnNYkUm6ryHCCkpMbgjcj1kouH/AJVWutdcn93n8qzDzUbR5NaOrO1rkKjC97Es+tXxj8mCby48nAVfmAPbPp6Ywaz0tJJmzIST15q/DAM5xVsIFAqG3P4mUlGHwoqRWSIOlSeQB0FWKSlZBdjYgAanbGKq78GnmTIqkyWieGfYevNdRbP5kCP6iuLZua6nRX32KA9uK6cNL3rHLiY+7cv0UUV2nGFFFFABRRRQAUUUUAFFFFABRRVHVtUt9MhDTkl2zsjUZZyPT/E8Um0ldjSbdkXqoahqcFmCuRJN2jU8/j6Vx1/rGoX7ESSfZ4T0hhJ/8ebqf0HtUMLiNQBgAdhXJPFraJ2Qwb3mba3Es85nmbL9B6Aegp/20pxmswT7YyaqNc7m61yuo9zpVJbG8L8561ftNSVeHPFcxAxZqsnJqo1ZJ3QpUYtWZ1bahCqbs5rPk1qJZlc8oMqwHXnvj6/zrn3QmmeUTVvEzZmsLBF/VNenuA0VqphjPBb+I/4ViR2TuemBWpDbjuKsqoUVlJyqO8mbRUaatFFK309UGTyauRx7TxU69KGwKpJIhybLVuoxVuI4as+GTFWo5BW8Gc80asLZGKkqlaSfPirtdcXdHLJWYUUUVRIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVxXiu7+0aqIFOY7YYx23kZJ/IgfnXaOyojOxwqjJPoK8x81p3aZ/vysZG9ixz/WuXFztFR7nXg4Xk5diyoyKrSghqtLwtVpeXNecz0kMZyq4FQZyakl61GtSUWbbqK1EACis61HIrRHQVcSJBmgfMaa1ERw1MktoNooeRV6mkDUj4I5AqifUcrqwyrAj1BqOWQAVj6jZypJ9o0+Ro5h1XPDf596i07UJ7sus0QDIcMQcY/Co5tbG/sLx54u6/FGmXJNNkm2Dk8mqc+oQRM67tzKpZgOwFYFhqD3glvpm+QkpCmeAAeT+fH4UN21EqbauzpTdc4zXaeHM/2epPevLobxpZ0jjVnd22qqjJJ9AK9Y0i3e2sIY5QBJtGVHb2rpwd5SuceMtGKRdooor0TzQooooAKKKKACiiigAooooAbLIsUTySMFRAWYnsB1rzu5uWv7yW6lyGk+6p/gXsv+e+a6rxhcGLSfKU4Nw4jP05J/QY/GuPh5auHFzu1E9DB09HNjnXauR1qFWO6rUv3DVTsa4mdqFmmJGB0qFCdwprHJp8YywqR2NSyHGass23pUFvwtEhzWuyI6kqvmnryaqo3NWojxSTE9CwrYGKdnioTyKp3z3UMW+1IcjkowzmquKMeZ2uaSvimSTr0zWHba5DONk37mYcFT0/OrO/cNwOR60ufsOdCUHaSsX/ALQF5zSDUdrYrB1XUDbmKCHDXExwoPYepqCS6C4UvkjqfWh1HEPY3V2drpV0ZrpADxXS1wnhG48y7+UF2A4A/wA8V3KhsfMefboK78NLmjc87Ex5ZWHUUUV0nMFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAZniWbydCvDnBdPLB9Cx2/1rhIhlxXW+NZANOhjzy8oOPUAH+uK5S2+/XnYt3nY9PBxtTbJ3OBVRmy9Wbg8Gqan5q5WdSGT8VGtS3PQVEOtR1KL1kctitEVl2DgucVqCtI7ESEYVF0NSt0qI9aZKAykGkacmmOOaZildlWQ5nJNcr4zeWxWC/tmYHeElC/xDr/TH5V0xYVzfjqQf2MFP8UmP/HWqZK6OjCyUaqvt19DltT1bda3AtmzJcSBI/fd/wDrFb+kWM1zJa6bYJ5soUKo6AADliew715ppMU8+qRIL25AtwzZ2x8N0/u9sivfvhv4UuLXSF1GTVr+O6vF3DakHEf8PWM9ev5elaUqftpJdCswqfVly9Tp/DPhy20OHef314w+eYjp7KOw/nXNwfFbSZrzV7QaR4gW40mHz75Hstv2dTG0i7iW43Kpxmu6soJLeIpNdz3TZzvmCAj2+RVH6Vw58B3J174j3/22HZ4ps7e2hTacwGO3eIlvXJbPHpXrRioK0T5uUnN80ja8N+O/DXiHSvt+n6xY7EtY7u4ie4jElqjqGHmgMdhAPOTgEGrFr4x8M3emf2jbeIdIksPOFv8AaFvI/L809E3ZxuPYdTXl2r/BCW/08WkWpWloD4ZtdEdooD888M6S+aw4yrbNp74NXtT+FWo65PqF5q1zpUc1/qenXc1pbxM1uIrUEFfm+8zhiDkYwAOcVRJ6Avjfwq2o2+nr4k0Zr25CGGAXsZeQOAV2jPO4EY9c8VYXxV4fbVrjS11vTDqVsjSTWouk8yJVGWLLnIAHJz0rzjxN8K9W1jxO10mq20ekRXtnd2VopkjS2WErujEKERsTt4dgSOgA606D4WanH4Y8ReGGvtNOl6nJdTpqAgb7YjTHIDDOGxnBOfmXjAoA9K0DxDo3iGGaXQdVsdSihbZI1pOsoRvQ7ScVqV5do3wwe5v7u78VSwAS2drYpbaPNNariDfiRnVlYk7yNvQAAc16RptlDpun21la+YILeNY4/MkaRtoGBlmJLH3JJoAs0UUUAFFFFAHIeNZd19axDpHGzn33EAf+gn86xbccZq34nnM2uXAzlYgsY/LJ/VjVeAfu68ms+ao2exQjy00hs5wpqt1FPuDzimLyKxZsisx+apYT84qJvvmnx8EVKGbEX3KQ0QnMYpTxWpmRHg0onKmkeoZfWp2KtcuC5FMebI4qoAacTii7FyoxfFNu4g+32ny3UHzcdHA7H/PtVGHxIl7aRSr8ilSWRexHBH51u6o2LFyPVf5ivJorgWy30EZwqTEqPQYP/wATU7SPTw8FWotS3jt6M6jT76e91O5vJMYRfJjx0yeT+gWuh0HRb3Xrgi2wsKHEk7fdX29z7fyrnvCenzalJY6Za/K8vzSSdcA8sfwFe96XYW+mWENpaJtijGB6k9yfc1vQoe2lzS2PMx2J9k7Q3I9F0q20iyW3tV93dvvOfU1foor1UklZHiNuTuwooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOR8aybry1i7IjMfxI/8AiTWPaJwTV/xk2NbUH/n3TH/fT1RtyVjryqzvUZ69BWpIjuzgGqkfWprp8nFQxdawZugu/uA1BnirN2P3WapNwtS9xosWMgWbFbaHKg1zCOVfNbdhcCSPGeRVQYpIumo2FSZFNfGK0MyB+lVZpdvAqxM4ANZjOWlx2qGy0Tq2etcb8R7oraW1tEQZpHJA9AFIJPsM10WpajFp8G5/nlbhIx1Y/wBB7155q0731zI9y2Wk++R0A7KPb/69JnXhaTlNMj8BWI1DW/swywllihJ6HDMSx/L+VfU8aLGioihVUAADoBXzT8NGNvr6XPAC3URb2Gef0zX0xXdgkrM87OG3WCvm8/EzxBf+J/Cesy39mLCQ61L/AGJZs6SBbe3k2JcneQ7EoCPkGDyM9vpCuU07XPBM2r3w0/UfDzanaGSe6MUsPmxYGJHcjkYHDE9O9dx5B5NcfGPxLp2i3dzMfD+pXEnh1NegNpFIEtWaVEMMo8wluH4YFTkHitDxr8SPGfhK8sBra6Hb2T263M93aWkt0kZeQqiOvmo6LgffCtk8AcGu1n8YfDnS57axGo+HUTV5GQmF4TE7BN+ZSDgZBXBbqWXHUVs3GqeDrvxA1tc3ugz61p6FzHJJE09sq8k8/MoHU9MdaAPNpPinrP8AwsiDSIPsd1otzqdzpZcW3kvE8asflbz2ZyCOSYlX0Ndj8BtQvNU+EXhu91O6nvLyaBjJPPIXdz5jDJY8ngCtbTdV8F3+pI+mX/h251C5YyK1vNC8srKgJYbTkkKwOewb0NbWiXGm3Wl282hy2c2muD5MlmytERk52leMZz0oAvUUUUAFFFFABRRUV05itppB1VC35CgDzi4k8+7ml/56SM4+hJNWVXbFVK3GNi+gxV6RxsxXi3vqe5aysULg/PSp0qKU5c1NF0qSio3EjUqtgimzcTNUZODUXGblqwaMYqYis3TZuSDWkK2WqM2rMYy5qF1q1UTjihoEyq5CrUBkyadcN8xFV6gsi1lyumyN2Uqx+gYE141qDNHqWqlfuhcj8SP/AK9e1XEYntnibkMpU141qyPbzX8bj502I3Ho5FPzPRwEtJR7ntnwmto/7Vu5RjMduqr9GPJ/QV6jXgnw/wBfOjWtpqE4+QKIJRn76ZGD9enXv9a9VvfHnhezJE2t2ZI6iJvN/wDQc13YSpFQ5b6o8HG0Kjq6K501FeUa/wDFdUYpo8Mar2muc5PuEBGPxP4Vyk3j7WbqT5takUH+GJFXH4gVrLFQXmVSymvNXdl6n0FRXhumeONatnUxaqt3jrDdoCG/4EMEV6b4Y8XWWt7IHH2W/Iybdznd7o3Rh+vtVU68J6IyxGX1qC5nqvI6WiiitjhCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5Lxvanzba6XoQYm+vUf+zViRnEYrtfEkIm0O7yMmNDKv1Xn+mPxrgHlwmAa83FR5Z37nqYSXNTt2I5my5ojb5qg3EtT0PzCuO+p1lmb5rc+1UTylaC/NEw9qogYOKGCK3erFlMYpMdqjdMGm8g5pLQrc6JX3KCKR24rLguiqgE0XV/HGhLuFHvWnMRyu5LdS9hWNe6itsrLGBJOe2eF+tVr3UZJSVgDKv94jk/T0qgsQVSXPPWkdFOj1kUL52d2lmffM3GT/IDsKw7px5bY5J4FbN6iyE7lAQc5bmsudRndt4GePak9dD0KTUfeNPwbD/ot43rIB+Q/wDr19H2MpnsreZuskaufxGa+fvCcXl6S5I+/Kx/IAf0r3zRedGsD/07x/8AoIrtwT96R4Ga6yTLleJR/CHXZ9ZGo6prsN1cC01G0MrPM3mC4UrGRGTsiC55VAAcdT29tor0DyDy8fDOTT9O8C/2LHpCXvh7H2gSQbI7tjbmF3JUZ3Z+YZBz3NYWn/Bm6s9QufMvbe7g86+ntrma4uBJCblHUjyg3l5y4y/8QHTNe20UAeFeOvhjdWPww8KaV4bhVfEmnTw2322xtwM+ZGYZ5JOh2lCSSeflAr2bQNKtdC0Ow0qwTZaWUCW8Q77VAAz78VfooAKKKKACiiigApsiCSNkb7rAg/SnUUAeXwxvDO0cn34yUb6g4NT3DYQ1peKoEt9YLoMecgkP16H+Q/OsO6mzxXjVFyNxPbpy54qRFmp4W6VUByKnhNZJmhHdDE59xUD9atXo+dT7VXYcZpPcBschikDDp3rbt5xIgNYbDIp1vO0R5PFOMrA1c6AmoZZNoqrHeKw61FcTg9DmruSojJn5qHcc0jPuOTQoy1Q2UWoz8uT3rgvG2kBNSW6Rf3dyDFJ9eoP6YrvVGFqG9tYru3aOZQy9foR0NWXSqOnLmR5F4ynWy/s3SEP7oL9pkLc7iDhQfx3H8qoNdeTFvjVC2MhmOfyFdP8AELTEi+z6nyUjzbXHfarHcjY9Mll/KuRitbGYEwzD3+YL+lRS2PVw0oyhfqd7b+GbG4to5mluCXUEncOv5Vah8KQdbe7uEYf3sMPywKpeF9UjezFlI5EsKgEg/eXoGH8j+FdTZpcKpaOZZB6Ov9RSUns9zgnOpBtORg3mkXdlGXkgW6tgOZIgQV9yvP6ZplswYI9vITtIdSpwyHsR/iK9C02QtEokQKfrmuQ8YaR/ZtyuoWS4tpG/eIv/ACzY/wAQ9AT1rXzNKGKcnyVD0LwH4rk1Nxpup4N6ibo5hwJ1Ht2Yd/XrXbV4h4Hle58UaUsTKrmQs3HYKSfzAr2+vTw83OGp4eZ0IUa1odVcKKKK3PPCiiigAooooAKKKKACiiigAooooAKKKKACiiigBk8azQyRP911Kn6EV5NGW8lA/wB8ABvr3r1yvLtWi+z6vfQ/3Z2I+jHcP0YVw41aJndgXq0UjwaVT8wpG60g6ivNPSL8BqpKNrn61PCeRTLmNnExj6qCx+lXa+iEiCeWKKPdK6ovuazZdUh3YgjkmPsMD9aqyv57nPT1zmnxRx+YglYpDx8wPJOeM46ChpI6PZKCvIekt7eD9yiRoc/NnPPpn/61WF0rktJM7Mccj+VaiqqKFUAAdAKZMzKvy4+posZczei0KS6dbqQQpyDu+8ev51WurW0iCrhi+CqqGPf8f1NWZHnkOIivPVtvFRR24hJLMXkbq5qSlFLWTM6801pIwY8k8fKcZHv6Guduotp2jlf6da6+6nWJGAYbh16HbnODj8P89a524DTS4x8zYUf5+lOJtSnLrsbejQ+VotqD1Zd5/Hn+te1aF/yBNP8A+veP/wBBFeTOghtkjHRFCj8K9a0QY0WwHpbxj/x0V24L4meRmDuk/Mu0UUV6J5gUUUUAFFFFABRRRQAUUUUAFFFFAHJePI8Pp83b95H+JwR/6Ca5GTmu78cRb9EEn/PGZH/M7P8A2auDPINeVjFap6nq4N3p+g0HjmpoTUNPiPUVyo6mWLobolNVl5FWn5g+lVUOGNN7ghjDFQySRIT5kirgZOTirhXIpm0ngGlYCokkJOFnjJztwGHX0pWmhX700fQn7w6DrVoxEjkZ+tCxFfugD6CnYLlZX3OVVXJBxnaQOmepoUztjaqR5xndlj15HH+NWShFOiTmiwXHW6MkWHcu2c5IxUr8Rt9KKZP/AKpqvYRk3MD3IWOEE3DHy4wO5bgD6E4ru4/hx4XksoI77RbGa4WJUkmSPyy7Actlcck1ieCbdLjxJFvwfIiaYD34Uf8AoRP4V6ZXZg6MbObWrOHF15RkoxdjyjxJ8GtKkjNz4Yll02/j+aNWkZ4yfQk5YfXJHsa4iLV9R8N6h/Z3iazaymIyGYZjceoIzx7jI9ea+jqy/EOhab4h09rLV7VLiAnIzkMjf3lYcg+4rSthI1NVox0cwkvdre8vxPN9J1eymVWE6BG5ySCPzHFbVzHb6hYTQFkkilQqdpz1FeeeLvhXq3ht3v8Aw3PPfWYJZo0GJox/ujh/qBn271zmiXjXjbHvJVbPzb1ViP0rglCrT0Z6lOhCuuelI774ZWpi8cLDOR59sknJ/i4x/Js/Q17VXiHg+CPSPFemXAmMqyy7GcgDdvXYOnuVr2+vQwj9w8/N4yVWLfYKKKK6jygooooAKKKKACiiigAooooAKKKKACiiigAooooAK4DxpCsWvFl486JXPuQSv8gK7+uS+IEH7mxuwPuOYm9gwzn81A/GufFR5qbOjCy5aiOPYUAU40leQeuSRnpUuTibH8UZFQLU0fMig9CMVcd0JnMImM7ucdu3/wBercIJHPTt7UpgaOTLj5jyB6CpolyQBzSZ6Dd0MQz2w/ctujAOIz/n/PpT3vjj95ascYxg5+vapSQBxz79vwqJyMc9KRh7NNjHv2Lfu4cqGxySOPXpVWSaeT7xA4IIXgHP6g/Q1O/PQYFROdvbH9KLFKnFGfcBhtDMT6Z/LNGlwiXUogBkL85/CkuXycj6fStXQbYxW7zMMNJ0+gp2sOb5Yli/bERr2Gxj8qyt4z1SNV/IV5BMnmzwx/33C/ma9mrtwK+JnjY96RXqFFVdV1Gz0nTp7/U7mK1s4F3yzSttVB6k1PDLHPDHLC4eKRQysDwQeQa9A84fRVObU7GHUEsJbuBb54mnW3LjzGjUgMwXqQCQM+9Jo2qWetaZBqGmzedaTgmOTaV3AEjoQCOQe1AF2iory4is7Sa5uH2QQo0kjYJwoGScDnoKbYXcGoWNteWj+ZbXEazRPgjcjDIODyOCOtAE9FFFABRRRQAUUUUAUtbtjeaReQKMu8TBf97HH64ry+Ng6K46MMivXa8qvYRb393bgYEUrKB6DPH6EVwY6O0jvwMt4lbFOTg0HrQOteej0C0DmJh7VUbhqsRHtULimwRJH8wwanSMAVXiODVtWyKaExNtGw0+jNUSRlAaj27asGonoGMqOY5QjtUhqCc4jakxmr8NgZdbv5eyQhPzbP8ASvRa4P4WR/Lqkv8AedF/IH/Gu8r1MKrUkeVi3+9YUUUV0HMFeb/Eb4c22rLNq2hx/ZtaXMjCPhbj1BHQN79+/qPSKKmcFNWZrRrToy54OzPmbSNVlkhaKUtHdwNuXjGHU5HHY5GCK+mR0GeDXIXHgDR5vGC+ISZ1uNwkeBWHlSOBgMRjOeAeDyfxz19Y0KTp3uduYYyGJ5OVbbhRRRXQeaFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWZ4ltDfaFeQoMybN6D1ZfmH6gVp0UpLmVmOL5XdHkUbB41dTkMMg0d6s39uLPUbu1C7VilYKPRTyv6EVWbrXhSXK7M92L5ldDlNTLw8Z96gj61ZA+5n+9TiDKWsR7AkowOcH3qrC29c9F7+/+fSulv7BLmyKlQWA+WuUj/cSFJGyQSOO5rWpGzOjDz5427Fh249v51Hju3X09KYZQWyT9AKBJ3PSsjfYcRxnGAKpXb4GKnnuNqe/ase/vreB1FxcQxO33RI4XcfbNNIXqWbO3a8u1iBwo5Y+grqAgVAqjAAwB7VkaXf6RZ2+06nYmVuXP2hPy61bOt6Vn/kJ2P8A4EJ/jTaZyVKik9CeMf8AE0sh/wBN0/8AQhXr9eHprel/2tY/8TKyx9ojyfPX+8PevW/+Ek0P/oM6b/4FJ/jXbglZM8zHO7iYnxe0a/8AEHw08Q6TpEH2i/u7Yxwxb1Tc2RxliAPxNcJ4rtPGHiLwdoulyeCp7ZbW4ijuBJewSybBEy+ZGqTqp54IduM5CnGR6N4v8Z6V4a8Hah4kklF7ZWgAxaOrmR2YIqAg4yWZR7ZrzrT/AIravZa/4lttf0iVbpdR0/TdM0mOSMss1xCX2tKPlx8pbcc46V3HCYXgzwB4l0/WPAmp+JNHvr28tNPuLK6kW/RntpPtJaB3PmAMgjP8O7sCOlZWpeAvHh8N+EIm06+vtSstPaCe0nuUe2ErTsxZ5FuUdGCY+dA/GBwRXpUfxdSaKzgtPDepXWsTahd6XLp8UsW+K4t03uu8sFZcEHdnp+VVD8YItRufFWm2dhJY3OkW14xea4h89XhjLFhbscsuRweQe+BQBzCeDfGg8c+JLqLTbmaC8j1Erd3VwqNEXidYEgdZzvQkjAkjTYPcVT8R/DjxrqOkyyR29/8A2pa6BpUNiY9UEe29iZfPPEgUsF3fM3B7Emvd/BeoSat4P0LUpnaSW8sILhnZQpYvGrEkDgHnoOK2aAPCdX8FeJ9FfUG8OWN9cafa+KLHVbW1/tENJcW6RATgNI5PL54cjOKyPFHhDxzqWjxytpmp/aG1rUr8aeLmGeFklK+Qk37+P5R82GVjswfl5FfRtFAGb4ahubbw5pUF/FHDdxWsSTRxyNIqOEAYBmJZgDnkkk960qKKACiiigArz7xnbfZ/EHmgYW6iD/Vl+U/psr0Gua8eWvm6XFdKPntpQT/ut8p/UqfwrDEw5qb8jfDT5ai8ziT0pM0p6VHmvHPYLMZ5FQMxMhHbNSxdRUU42zNQwRMoqeJarxtk81aXpxVITJQB60pUUzmjJqyQbgVATk1M3NQNwaTGgbpVa6P7pqst0qpdn9y1TIaOr+Fq/wDEpvn9bkj8kX/GuzrkPhiP+JDc+903/oKV19evh/4cTyMT/FkFFFFbGAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHnnjAbfEc5/vRRn+Y/pWK/QVv+NVH/CRAjvbR/8AoT1hTcAV41dfvGezQ/hxCAZarpXaI/XcKrWa5cVdmO14h/tVmjVm5BFvVQPSsvVtJiupBsiHy/wjjdW5bn9yoA5xzUhiwML1PWu+UFJHHCo4O6PN77R7qJyIlL+rE9/T6CsqSUxvtcEY/WvU3sgQ3HBrF1XQo71MMdh6bwOT/n/PrWEqL6HoUsYnpM8+km3MWzWloNt5jm7kHyj5Ywf1NJf+Fr2JpTHKhjUgAng447fjWvBGsMKRJwiAKKwknHc2q1YuNosm3Um7mmmkz2qLnMVUcLr2mlun2mIn/vsV7PXhOtO8UiSxnDowZT6EdK9u066S+sLa6i+5PGsg9sjNd+BfxI4MfH4WVvEOi6f4i0W70nWbZbrT7pNk0LEgMM5HI5BBAII5BFczF8LPCMdjeWo06Zhdyw3Esz3s7zebCMRyLIXLKygnBUirHxc0zVtZ+G+u6f4dSR9WuIAtuscoiYtuU8MSAOAe4ry1/hjr9prGpT6fBqXlW+tabd6Zu1ZmAiwn2tsNKckkNndyccZr0Dzz1vSPAnh3R20x7DT/AC5dOmmuLeRppHfzZlKyu7FiXZgSCWz+gqofht4YfULq9nsri4muIZ4D9ovZ5VjSYESrGrORHuBOdmPbFee6ZoPjiHxHHaTaVe/YLfxRd6p/aAv4tklrJHII0Clt3BZeCMDjjrjltJ8BfECHw9rdrBaXweUQtJNdXiwXl6BNulh3pcSIcpx5p2E9MYJoA+grW60bw/LovhmCVLaR7cxWFqSzFooVUEBjn7q7epz9a2q8MvfBmu3V/oN14Y0K78PxWtjq8MYu75JXtZpoUWFsiRiAXBOFJ24ycdKv/A7wz4h0LV7ubWbTU7KKSxjimhnkiaF7hW/1ibZpGZiCcuQueOM0AeyUUUUAFFFFABRRRQAVR14BtD1AEZH2eT/0E1eqtqieZpt2n96Fx/46aUtmOO6PLR0FRmpIfmiVvUA0w/frwrHvIsQjkVFe/wCvOPxq3bJnFV76NhPkDqKHsC3IwOAatRPwM1XVSEFPTg0loJlsMKXNQqMj0pwBA61oSPPSqznLU6RjUdJsaFZsCql2cwtVhulVrkZhf6VLZSOz+GBB8PTYP/Ly+f8Avla6+vO/hLe5Op2LHkMs6j1z8p/kv516JXr4Z3pI8fFK1WQUUUVuYBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVT1e8Fhp09wcbkX5Qe7HgD88Um7K7Gld2RwniG4+067eOeiN5S/ReD+u786zG5NHPcknuT1J9aci14s5c0mz24R5YpE1quMmpXY+fFn1pIuBinAbrhD2GKSGzpLZ8KMdas+YoHJx9ayUnb+EYpSSTya7HVXQ5PZ33NJriMDAOTULSLg46+tU6Q1DqMpQSK2pjzI2ROhrCkjZCa6JlBqpcwBuR1rCa5tTaDtoY4NIRjmrEsBTnFQkVk1Y1WplarH5iGvQPhfem48OG2c5e0kMYz/AHT8w/mR+FcRfLmM1u/CubZquoW+f9ZEsmP904/9mrfCS5aq8zDFx5qL8j0qiiivYPHCiiigAooooAKKKKACiiigAooooAKz9fnFtot5ITg+UVH1bgfqRWhXJeOrwYt7JTznzX+nRR/M/gKzrT5INmlGHPNI5QYVAB0Apirk04c1LGnPNeMe0W4FAQE1TnRjOxJNXV5AxURU7jn1ptCRCy4UU+GPPWnuucVLCvFNITY0rjtTDVopxTTFVWJuVmUEc1AwwaveXUEsdS0UmV2HFVpx+7YVcZTUEiZBqGirlbwTcf2f4xtieEuMwMf97p/48BXsdeF3TNb3CzJ96Jw6/UHIr3ONg6K6nKsAQa9DAy91xODHx95S7i0UUV3HAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXGeNr7zLqKyRhti+d8f3iOB+AP/j1dbe3CWlpNcSfdjUsR6+1eZSNJc3DzSnMkjFmPua5MXUtHlXU68JT5pcz6CRRbuaeFxU6LhcUyQYNecemIp4qWAZkyag7VPAOhNCEzQj5qXbxUUNT1ojFgAKdtBpvenBqoCN09KrSHmrjsMVUl5NJjRVkUEc1Smix0q855xUbqCKzauWtDHu0zE1WPh1II/FqqTjzIXQfof8A2Wi7ThqzvDk32TxbpkmcZnEf/fWV/wDZqVN8tRPzHUXNTkvI9qooor3DwwooooAKKKKACiiigAooooAKKKKAGyOscbO7BUUEsT0AFeZ6hctf301ycjzGyoPYdAPyxXWeMr0xWSWqHDzn5v8AcHX8zgfTNcnbxZOSK4MXO75Eehg4WTmxqw4GTUirirBXI+lMC1x2Oy4o4HuabjinEcipI0yeapIlsiEeatQw4qeKEY6c1OI6tRM3Mh8sEU0xelWglLsquUnmM+SPFVnjOa1Xiqu8WO1JxGpGc0fFQSR8VqGPiq0seM1DiaKRy+qx4Zq9b8NzfaPD+nSnktbpn6hQD+teY6vFlc4rvPh7N5vhe3UnmJ3jP/fRI/QitsG7TaMMYr00zpKKKK9I80KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb8bXAWzhtQTumfcR6qv/ANcr+VcxBCQMmtbxFL5+uSj+GFVjH/oR/wDQsfhUKINteXXfPUZ6lBclNFTGDzUM3Wrki4BIqtIuawaOhO5Ac7OOpOBVpBjA9KgQAy+yfzq0uD0oQMniOKlDUyJC1WBEMcVaM2REk0AmphHmniKnYVysc1E4NXjFxUTx8UWBMzmXvTD0q3ImKqy4WoZadyldDrXMaiz29yk0f342Dr9QciummOc1z+sJzmspdzaHY9wtpkuLeKaI5jkUOp9QRkVJWD4EuftXhLTmJ5SMxf8AfBK/0rer3YS5opngzjyycewUUUVRIUUUUAFFFFABRRRQAUUVBfT/AGaynn6mNCwHqccChu2oJX0OJ16c3urzFeUjPlL+HX9c1GkZVafaRYUZOT3Jq2YxjivKfvNyZ6yfIlFFTb8pqMLzVtkwcUzaFyT2qbFXIFQmUjHAq3DHzSwx4XnqeTVmKOrjEzlIcicVMsdSRRcZqdY61UTFyK4jp3l1ZEdO2VfKRzFFo6hkirSZKgkjpOJSkZbx4qtMnWtSVKpTJ1rKUTWMjA1SPMR4re+GUo+x39vn5klEmP8AeGP/AGWs2/jzG1HgKXyfEUsX8M0J/MEEfpmlRfLVRVb3qTPRqKKK9M8sKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKDQB59K/m3VxL2eVmH0JOP0qdT8tVbONmhjJ64GavLEdvSvI1ep7DstCvL/q6qnpWhPEQg4qg6HFRJFRZDB/qy3dmJqeLJYAVDEP3K1eso8sCaSRTehchQhRgVOi+tOQU/bzWyRg2IBS4pQKMH0pk3G0hUEVIEb0pRE1OwrlGaLisy4jIJzXRGAkdKqz2ZI6VMoMuM0jmJUPPFZGpwMyZrrprMg9Ko3VplTxWLps2jURtfC9j/AGBNE3/LO4YD6EKf5k12Fcp4BURwXsQ4w6t+YI/pXV16uH/ho8rEfxJBRRRWxiFFFFABRRRQAUUUUAFZXiZ9ullB/wAtHVf1z/StWsjxNzZwqO8o/kazq/AzSl8aMCAYqfuKSKI1OIjmuBI72yrIPmprjO1fU1PJGc9Kb5Z8xaLBckQVat0yc1CiHOK0IEwtaRRnJj1XFSAUoHFLitkjFsTFFOwaXaaqwhmM0x1qbaaNhosFzPmSqM6da23hz2qtJbZzxWcoMuMzmrxCVPFZ+ghrfxNYydBvKn/gQI/rXVS2eQeKoiwMd7BKBykit+RBrH2bUkzb2icWjsqKKK9E84KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOZtNOKIqkdBirq2WB0rWEag8CnbR6VgqCRu67Zhz2WV6VRksPaupKKeoppgjPUUpYdMccQ0cV9hYAjHQ1etrQjHFdGbOEnO39acLaMdFrNYWxo8Vcykt6lW29q0xEg7UuxfStVQRk6zM4W1OFrWhtFG0VSpIl1WUhbCni3FW8CjFNU0T7RlbyBTHtwauYoxT9mg52Y01lntVKbTyQeK6XaKaY1PUVDoplqs0YXhq3NtdXQI4dV/Qn/GugqOOFI3LKME8VJVwjyqxE5c0rhRRRVkBRRRQAUUUUAFFFFABVLVYPPhjHo+f0NXaCAetJq6sOLs7mTHZ4HSpRa+1aOB6UVCpIt1WZbWme1Naz6HFa2BSbR6UeyQe1ZmJa4PSrCQ4q3tFGBQqaQnUbIBHThHU2KKrlFzMi2U7ZT6KdhXGbKXZTqKLBcbsppjBqSiiwXITCDUb2yntVqijlQczCiiimIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAormh4qkeScW2gatcRxTSQeajWwVijlGIDTA4yp6gUv8Awk11/wBCzrP/AH8tP/j9TzLuVyS7HSUVzf8Awk11/wBCzrP/AH8tP/j9H/CTXX/Qs6z/AN/LT/4/RzR7hyS7HSUVzf8Awk11/wBCzrP/AH8tP/j9H/CTXX/Qs6z/AN/LT/4/RzR7hyS7HSUVzf8Awk11/wBCzrP/AH8tP/j9H/CTXX/Qs6z/AN/LT/4/RzR7hyS7HSUVzf8Awk9z/wBCzrP/AH8tP/j9H/CT3P8A0LOs/wDfy0/+P0cy7hyS7HSUVl+HtZi1u1nljt7i2aCdreSKfbuV1xn7rMD1HQ1qVRIUUUUAFFFFABRRRQAUUUUAFFFFABTJpFijLN+A9TTLu5htIGnupViiXqzHH+fpXOx6uNRviyArCvEYPU+5Hv8A571nOooeppTpuevQ6OGbzP4cVLUVuAIxUtVFu2pErX0CiiiqEFFFFABRXni/EK+/sC31yfQrez0q4UPHcXmrQQLg9MlsAH2p8XxAu5dNi1SPRbe40pp4oGurPVYbhVMkioD8vXBccUAegUUUUAFFFFABRRRQAUUVmeKLiW08Natc27mOeG0mkjcdVYISD+dAGnRXkPh/4jNa/BTRNavNWsLjXpoIVb7SWYvK7hcFIgWyc8cAZxkgc1zN18UvGGqnQksItM0y7j8SyaLepIzeVOREHUHKkopyc4+YFRjqcAH0JRXhs3xI1vR7PXpbLT2v2j8RXdpNNNNJOlpDFFGxdY0G8pluighepPNXX+LmoDW9AjNlp8eiahHZ51M+fJFLLPglEKpmMgH5RKFJ4ztHNAHstFeCaP8AErxBFHZ6fo9nb3t3e3WrnzNUvJCI1tWBABVScEE4XHHHNSwfGfXE068ur/Q9OTPhlfEdmsNy75XzFjKSZUYOWzx0Hc0Ae7UV5BrPxX1JL7xJaaBpFtqsmm/2eIDDMWL/AGhHZyVXJfZs+6nzH8DW9ofxCF18LdT8WzpBdPp8dw8sVossYLRAkpiVQynjByCBzyaAPQaK+dtP+KXiC01fXdW1P7DcKdJ06W1sba6ZrWGS4l2qzsR8pG8biPTjrXRn4qeIBdSaPFo+lXWuw62mkM0d062sm+B5VdX2kgjZhhg4oA9moryT/hZGsw+OYNA1nTrLTreVxapNmaT7TL5W5/KlVSgIbI2uQcDJweK674S6nLrPw38PajcPM8tzarIzTSmVyTnqx6/WgDraKK8p1H4pX2maVZanqdl4Z06xvnkW1N7rk0bybGwcqtowB6HGT160AerUV5jF8RNXufDF54g07TvCupaXaKXmex8QyysuBkrj7IMNg5wSK9OoAKKKKACiiigAooooAKKKKACiiigDkdA/49Lr/r/vP/SmWtKs/wAPLm0uv+v+8/8ASmWtTAFcUt2d0XohmDRx3NQy3Me94omV51HKA/d9M+lZ2n2twZbldSbzUD5iwcKVIBwR35yOfQVLZaL631oXdBPGXU4ZQ2SD9Kjn1SzhmgieUB5m2oDxk4J/kDTbSxhtLieWEbRM24qOBnAH8gKfLBFJcxzyLl487T6ZpXY7IvDBAIwRS4rC1S2luHiWxlNvlwZGXjcBzj8f5ZrStZypWG4AWTHBzkNj0/wouS42RbwKQqKXPGe1NLAfSmSZ/gHhNe/7Cs3/AKCldTXLeATlNeP/AFFZv/QUrqa7Y7I45bsKKKKokKKKKACiiigAooooAKxdf8QW+kgRqvn3jDKwqcYHqx7D9T2HWm+KdZOlWqpBg3c2RHnkKB1Y/TI49T9a8/IeaR5JGLyO25mbqx9a5MRiPZ+7Hc68Phvae9LYmvry71O4Et7MZGB+RFGET/dX+pyfetPRQY5AzVTtoO5FXA2zG2uBNt8zPQaSXKjsbe9UKATVkXAPINcbFdsOpqcakUHBrrjXOOWHuzrPtCgdaEl3sMVxz6s24YNbmlyyTFUX7xG52/uj/E//AF60hW5nYznQ5Fdm7RQBgADpRXWch8w6mdOstS+FGp+N4BL4Li0p4980Rlt4rsg7TKoBHI24yOoz2JHosl94S1H4eapceA4rVNNbWrQTNawGGKScT225lGADxtGQMEg+9dNbfD+0tbFLK21vX4rONdiQLe/Iq+gBXpT38BWkscMVzrOu3FtHJHKIJLzMZKOHXI29MqOKAOwooooAKKKKACiiigAqO6WF7aZLpY2t2QiQSAFSuOQc8Yx1zUlZ/iKyk1Lw/qdjAyLLdWssCFyQoZkIGcduaAOXj8OfDeKC6WLSPCMcMqJHOEtrZQysQyK2B0JVSAepAI6VfufDXguPS7nTbjRvD0enRypPPbNbQrEkhG1XZcYDEYAJ5I4ryK4+Ac76YsEdt4dWf/hFV0otsIB1ASBvtGfL/u5G/wC/zjGK0vGHwv8AFmpx6/Z6bcaK1rrdnpcc8t1NKskclowJCgIchsZycfTvQB6VeeH/AATqVy+l3mleHbm4ErXTWklvCz+YwG6QpjO4gLk45AFZuqP4Ds9X0jUDpmjXWpSXsOmW1zbW8MskEpVvLBYcoAEIHpjiuJl+E+vTeMdevLa407TdM1L+0GkcSC5md7iN0R03Qq8JG4FgJGBxgACrmifDfW4bTw5BNpXhXS20jULCeSbTnk33iQJKrM+Y1+YmQFQc9Xy3SgD0e00zwuNRNvZ2Wi/b7bzXMcUUXmxeb/rDgDK7+N397vmuQ8U+KfAfhjWrjRrnRYJrq10eT7QlpYRMILEBnMLdMIdpPljjoSB1rC+Hvwq1bw141tNRvzYXkNpcXcyagt06zyrOG4eLy8FskZJkI44Ga1fGPwyudb8U+LtWtk0pW1bw+dMtnlBEkdwQ6mRiEOAVYLkEnAxjFAHQWegfD+e0j02LRfDaLexxSmxa2gV5AFJjLJjJIDHHpk461u6Wvh+1t10PSxpUUCq6Cwt/LChckOPLHbJOePrXkWtfCvxVqPjDTb559Daysr7TrqKUMYpkSBVEiELDmQnacMz9ABgds/4f/D3WL3xxJrNxp9lplpp3ifUb77W8bpe3SsSqoAUA8og53bjnsKAPaLLwb4ZsLa4t7Lw7o9vBcx+TPHFZRqsseSdrAD5hkng+tTaf4Y0HTbW2ttP0XTba3tZvtEEcVsirFLgjzFAHDYJG4c4Nakc8UkssUcsbSxECRFYEpkZGR2yKkoAxk8LaAmtvrKaJpi6u+d16LVBM2Rg5fGenHXpWjYWVrp1nDaafbQWtpCuyOGCMIiD0VRwB9KnZgqlmOAOTVK3v1kcg+tS5JOzKUW1dF6vm7xT5ltZ/CbVG02/v7GwvryW6W0tWuCq7sDKqDX0iCCOK5KL4faHCpS3l163i3FhFBr9/Gikkk4VZgAMk8AVRJ45Bpt3eTfE7xZZ6HeaB4c1DSlggtbuD7O9zKoGZvK/hHUA992eua+kK5G4+HmhXMLw3Uuv3EDjDxTeIL+RHHoymYgj2NddQAUUUUAFFFFABRRRQAUUUUAFFFFAHIaA+LW6H/T/ef+lMtTaxqkWm26yS7iXO1cKTz74HA461T0Jv9Hux/wBRC8/9KZKfcXFvJqsVq0yeasbP5WeeSMHH4H868+T1Z6EErK5Ys4YA32sANcSoA0nQsOoz9OcemakubhLeB5pThEUsxxngUikKvHQVzfiu6M8sOnj/AFcoJl91HUfjkfhmocrI1UOZhbeKTfwiazs7h4SNwc4UEewJB/T86s2OsJd5EbEMOGRhhh+FWtHijjg27QoYFSa5/U7byJi0fyzJkxt6+x9jUNvc1jFP3TqElBAPeq+pWUuqRCMXLwbecocE+2eo/DBqlYXgniVh3ANaEM53DBwad+5LjY0NOlBsYxyCo2kE5II4I/OnPJk1g6bDLa6jdB7qaVZP3gV8YGSc4wBWkHOeafMZuGo/4eHMGun/AKis3/oKV1lcl8Ov+PfXP+wrN/6CldbXpQ+FHmz+JhRRRVEhRRRQAUUUUAFFFZPiq8NnoV06HEjjykI6gscZH0yT+FKUlFNscYuTSRw2tX39qavPcKcwg+XF/uDofxOT+NMgTLCq8KhUAAwOmBV21HGa8VtyfM+p7iiopJdCz91eKiL80PIM4qJmpisSb6gkkzwKa7Vm6hqCWy4QeZKeijt7mk2NI07UmS8SNMGQ84PQD1Nei6VCkFoqoc9y3cnua89sLM2pFwrF5zy/+0PT/Cus028yg2t8p5rpw8lF6nLiYua0Oi3Cml1AJzwOTWZLcEDlqYJSEAJ+9yfpXZ7Y4vYs1ojmMMerc0+spdR8hRvUsg9Oo/xq/b3UNwoMUitnt3q4zjLREShKOrJqKKKsgKKKKACiiigAorkPiD45g8FDSjdaRqmoLqV0tlCbJYjiZjhEbe68tzjqODnHFT3fxA8J2N99h1HxDpdlfq2x7a4ukR422hirDPBwRQB1FFcxJ4/8JRaTb6pJ4j0pNOuWdYbhrlQkjJ94A55I9OtV0+IGiyeIFsIriJ7E6O+t/wBpLKptxAsgQ8+2c56cGgDr6K5q28eeFLrSptTg8RaW1hBKsMs/2hQkbt91WJPyk9s1k6p8WfBenxaTO+u2c1pqVxJbRXMMyNGjIu5i5yMAZUd+XX1oA7uiiobq6htIjJcSKi+/f6etJu2rGk3oiaisCTXnlyLSEKvZ5T/7KP8AGqMt1qMxy19JGD/DDGqj9QT+tYvEwW2pvHCze+ha8TxNptzF4itR81qnl3qD/lta5y31ZDl17/fUffqxL4jtHiV9P/0wMMq6HEZHY7u4PqM1z1xZvM26WeaYg5HnOXwfbPT8KwdHSTQdS/sl1JsJt0ti46R92h/DO5f9nIxhOcJYqT0irG8cLFfE7nWXeo3VwP3rAL/dQYFV4pmVgc0wvk88UuK53Nt3bOhQSVkjf0+8LcE1qJMpxk81ytlLscc1q3MhWIMD711U6zSOWpRTehsF1A5NJ5qf3hWC16XUAGpoZPkzV/WL7Gf1drc0J9QtoHCzSBQf4iOB9T2q0jK6hkYMpGQQcg1y162ZsnmqscklsxeyleAk5Kqcofqp4/rULFWfvIt4W691naUVzcHiKZABc2yyerRNg/gp/wDiqvwa/p8pCvMYG9JhtH/fXT9a3jWhLZmEqFSO6NWikVgyhlIIPII70tamQUUUUAFFFFAHA6M2I73/ALCF5/6UyU5bxW1xoUR2BgVmfGFGGbj3PI6VV0yTC3w/6iF5/wClMlQa0Lf7P5l1O1tb4KTSrJsKK2OQ3bkLzXlyfvNHqwXuo0bvVoIZNihpGWVYpQBgx7vuk57E4Gen5VxF/JqkWuR3WpbBG0flFV/gbPJ+hwK7PTEiNukqt5kvlrG0pBHmY5BI/E/nWXrtr9ohbIzUSemhtTVnqXNMv42jKswU46GqOuXcbSKd2QgOa5ae5udOhd2jaeNeflOHA9PemxSz6rFzbTW8Tfe80je3qMDoP51Dd0aqCUrm54ckcxR5z2/lXRq21sjtWTpFv5SDjFahOBQiJ6sreTNPraTfapERI/8AVKF2kZ78Z/I9q2c1gaaJ/t085n3wN8qoVHbuD6ZJrXEnFVczki98Nzm11s/9RSb/ANBSuurj/hmc2OtH/qKTf+gpXYV60PhR5E/iYUUUVRIUUUUAFFFFABXLfECUCxtIu7TbvwCkf+zCuprjviF9/TvpL/7JWGJdqTN8Mr1UcvFyKupwgFVIEzgCrqpxXlI9dmfqU/2cI2cEGnJcpLEJEOVP6VS8UQsbZZE6A81xK69LZSskZ3RNwy+lM3hR543W5115evJIYoTj1NTQ2aLEgK/MXDMTyTjmqvh5YrqBbmJxICeT3B9DW8sZY8DmkkZSXK7GhaHKAVdtS0bdDtJqhBlFHrWnbSBhg1tA55li4lPy46VI0m7kdMVGcdxTJG4wK1uY2Hu2VI61WZAQSv4g0FyKjaXJ44NQ2i4plqz1a4s2AYtNB3QnLD6E/wAj+ldTBNHPCksTbo3GQa4iRg/IGD3rV8L3JjuZLUn5JAZFHow6/n1/A1vQrO/LIwxFFcvPE6aiiiu04QooooA4T4qeD9X8XroK6TqllYJpeoR6n/pFq0xkliOYxw64XlsjqeMEY5w9R+E8t/faldTalbebea9Z6yT9mPyiBQDH97+LB57Z716vRQB4hc/DjxBoniDQ38PT2czNreqam1xcWpaC1W4hIVHQOpPPAIPUg4xxV3Q/g7d6Dp8cGk+I3t7iPw/PpCXKwYdZZbnzzKBnAXJICjkDvmvYqKAPFtK+DV9BDqxv9cguJ9RvtNvZG8uaT/j1OWUtLI7tv9S3HpjAGg/wt1G0u7i/0bVrKK+/4SSXX4FntWaJRJCYjEyq4JPOcgj6V6zQTgZPSgDmfF2p32hNFqVtm7tQvlzWAUbz382MgZLDPKnqMYwww2LbXP8AbSxX3nLcRzKHjdTldp6Y9qn1K7/tDUnkB/dr8qfQd/xrN+w3GjXb6jpcTTWkzb72yQZOe80Q/vd2Qfe6j5vvedUqe2lZbHp0qfsY8z3Z0lvbKqgmpjGOwp2n3EF/Zw3VnKk1vKodJEOQwNOuZI4ELysFUetHJYXO5PQz7htuQBWJrdkNSszEshhnRhLBOoyYZB91h6+46EEg8E1rGb7SSyIVj7Fu9QkAGsZXvobWtozN0LUTqNiWnjEN5C5huYQc+XKMZA9Qchge6sD3rQDrWJrYfSr5NaTJswnlX6+kYyVmHuhJz/ssTztAreWIMoIwQehFDQJ9GLH94EGtHzDLDt64FZpgI6HFSQMycE5pp2CSuC7hNt9TWkPki96pkhucc+tSeYdvNNOxLVyCdJXYsFzVcJKeCtXPO46UxnJ6dalpFJsatsCMNUiWsSDhAT71GjkNljmrCvuHFCsJ3K0Jls2Y2UjQ5OSo5Q/8B6fiMGt3SdWW7fyJ1EVzjIA5V/cH+n86yim7kdaqXEJIBUkMpyCOoI6GtYVZU35GU6Uam+52tFVdMuftdlHKcB8YcDsw61ar0U01dHnNNOzCiiimI8y0483/AP2Ebz/0pkqa5t4rqPy50Dp12noah0/rf/8AYRvP/SmSrdeRP4mexT+FFSfUBpUKrcZkRmCRsuMkk4AP+PT1xVoq0ibmUAHnFBCkgsAcdKo6hDOLV/7OkMcpB2qeUz9Ow+lTctCyWML8hcGhLJF9KSEXUMaqypLgcsGwT+GP61DHPevdyqYEWIKCpLHrk57fSloWX02RnbkZrNvTPdTx/Y5CIQcSejj0Hf8AEUXGmtdXNvNcSljE27aBhehGMfj3rSRAo4ouII1CKAowOgAp6k0lLnApCZqfDHnT9Z/7Ck3/AKCldjXGfC//AJB2s/8AYUm/9BSuzr2KfwI8ap8TCiiirICiiigAooooAK5H4gr+6sH9HZfzAP8ASuurlfHwza2Q/wCmp/8AQTWOI/hs3w38VHMWy4j3etWAcCkiA8sAVHM23Ary+h6xBfBZoXjk+4wxXl3iLTHtLguvPPPHBr0+4yUAHc1R1XRRf2TbcecBxnow9Kk6KFX2ctdjgPDN1cWl1vtJSpJ+aI9GHuK9M03UY5lHmoYXPryPzrj7bQVHDBo5B0ccEH3rWsnbzRbzhlmA+91Vx7H+hpp23N8RGFT3onXAg9CDVmBsCsa0iESl3kEaj1OBVxdQskUZuFPuMkfpVKSW550o9jU87JxmniQEc1mw3FrcHEFxE7eiuCfyqb50PqKtSM3EsON3TpUTrU0bBhTmQEU2riTsVVGan0ximqWkg7SYx9QV/rTGj2nIpsDBL2LccBiCPqOf8/SlHRpjlqmjuqKKK9Y8gKKKKACiiigAooooAKy/EdybfTXVDh5T5Y/Hr+lalcv4nlMl9FCPuoufxP8A+oVjiJ8tNm+Hhz1Fcx7OE5zW1AdoAFU4EwBirGcCvOhoelN3M24hm0K5n1LSonmtJiXvLCMZJY9Zoh/f/vIPvdR833pre7tNdZbu0lWayA+WRTkSfSp7i4McEjIfmCkj64rjLWC60OxjvtMjea3mzLfWacszHkyxj+96r/F1Hzfe1dRPQmFJwi5r0Ovup1XhcDHQCq8JLtzWfb3MN5BFcW0yywyqHR1OQwPer8BWNcuwFZc12Vy2Rb2AqQwBBGCD3rD0Jzpd62gzDEcaGWwfs8AONn1jyq+6lD1zjVN5Ao++GP8As81l69G2oWiNaIUvbZ/OtZWOAsgBHP8AskEqfZjVJolxk9Uje/lTWXPIrD0zW5NS09LqGIITlXic/NE4OGRvcEEfhV221SN5PLl/duex70mUovc0U4oJzxSE5HFR9KQhxFJ0p65NPWPNCQ72K5OAc06CTDYNOljxVZ8jkdaT0Fuaa4zUohDdaoRSEquTzWzYr5hWtYLm0Mqnuq5JpEZgeaIggN+8H8j/AErTqKUbWjYdjj8Dx/PFS16EI8q5Tz5y5nzBRRRVkHlajVrO51CI+HNWmBvrqRJIhEVdXndlYZkBwQw6in/adV/6FjW/++Yf/jleo0VzvDQbudCxM0rHl32nVf8AoWNb/wC+Yf8A45TfP1b/AKFjW/8AvmH/AOOV6nRS+qwH9bmeWfaNW/6FjW/++Yf/AI5R5+rf9CxrX/fMP/xyvU6KPqsA+tzPK/P1b/oWNb/75h/+OUefq3/Qsa3/AN8w/wDxyvVKKPqlMf1uoeWCfVf+hY1v/vmH/wCOUhn1b/oV9a/75h/+OV6pRR9UgL63UOR+Glpe2ukX7ahZTWUlxfyzJFNt3bCFAJ2kjse9ddRRXQlZWOdu7uFFFFMQUUUUAFFFFABXLePD+5sR/wBNG/lXU1ynj44isPeRv5VjiP4bN8P/ABUcykuFqORixJNMzikLjpXk3PYLEa5Iz6VaHC1WjkAAzUrsWXgU0SyK8RXGQBu7n1qlMRBD8oXcxwC3Qd8n6AE1bkzu29qp6pbmeBIi2wOWXOPVWH9aio3GLaKizibzxkZJZE0NVLD/AJfLlcvJ/uKeFHpn8qyItY1sOWGp3Z7f604H4dP0xWXokQ+0QQTLtkiZo3UjoVVjg/iK9Tm0mxn3GS2iDt951GCfxHX/APVRGjDtc9CUqdFpON7nKW3iPXEbbMbe+ixzHcRhT+a4FdBo3i2KNtlyracT0SVi8LfRv4f0H1qpd6K1mhePfPCp6Y/eJ7jHX8P1qIxQyRAT7XjYcSAcf8CH9aToRTvHR+RXs6NaN4notpdLIFPCkjcBnII9QRwRWipBWvIreTUNDkX7G/mWqOH8l+QvrtPbI4/HpmvSNC1a11S38y1k3Y4ZDwyH0Iram5WtI83EYaVLXoaTHNQzx74yBw3UH0PY1MetBGRVHOdTpV6t/ZpMo2t910/usOo/z7VbrkdGuvsWo/OcQXBCP6B/4W/p+XpXXV6VGpzxv1PNrU+SVugUUUVqZBRRRQAUUUUAFcdfnztauT2DbfyGP6V2NcvBCJJ5pT/G7N+ZrlxSukjrwjs2xFG1ap6jdLaw7j1PArUliAFZOs6dJd237pgGXnB71yOLO2m4t6nN3eozS58uQqPasRtSulAUTMCpII9MVfu45LVtkyFGA71gzN+/ZuzdfrWXU9KCVrIrSyX2n3cl7Yl5LeVt91ap3J6yRj+96r/F9evT6LdJe28dzBIskMi7lcHORWdYR723H7o6Vq6TpMNnd3E9uzotx8zwgjy9/dwOxPfHB64zk1oldakTXLpE2Y+QOTUoyPQinxIMdKkKDFBztlKC2t4Li5ngTbLcFWlIJ+YgYBI6ZwAM9wB6Cs/WY1dQxUHBz9DWpMuDkHkVmahIDGSePX2qZF01dmzpNyZ7SJic5UZx61fA5rD8OEfZFA6Bjj8631GaEc81Zj41qdRxTY1qZV4rRIxkyGRc1WkjrQZeKqSjGaUkOLMu5kaKaAA8MxU/ln+lddoy/uAx64rkb3DL/tKQw/Dmux0dg1kjL0IrTDazM8V8BdZQwwa5bS9a8RapYQ3tlouk/Zphuj83VJFfbnjIFuQD7ZNdVXP+AP8AkTdJ/wCuI/ma9E84Ptfir/oDaJ/4N5f/AJGo+1+Kv+gNon/g3l/+Rq6CigDn/tfir/oDaJ/4N5f/AJGo+1+Kv+gNon/g3l/+Rq6CigDn/tfir/oDaJ/4N5f/AJGo+1+Kv+gNon/g3l/+Rq6CigDn/tfir/oDaJ/4N5f/AJGo+1+Kv+gNon/g3l/+Rq6CigDn/tfir/oDaJ/4N5f/AJGo+1+Kv+gNon/g3l/+Rq6CigDn/tfir/oDaJ/4N5f/AJGo+1+Kv+gNon/g3l/+Rq6CigDn/tfir/oDaJ/4N5f/AJGo+1+Kv+gNon/g3l/+Rq6CigDO8O6kdX0Oy1BoRA1xGHMYfeFPcZwM/XArRrn/AAB/yJuk/wDXEfzNdBQAUUUUAFFFFABXMfECIto8M4XIhnUsfQMCv82WunqG9to7y0mtpxuimQxsPYjFRUjzxcS6cuSSkeSOx6UDOaRUdFCynMi5Rv8AeBwf1FOUV4mx7ly1EcirsOClZ8XSr9sMLjsauJMthFXdKKdfQK9o6n8x2qZIgGzU0ybozt71drrUhy1PHfGFg+na9ZaiEVba4lWO4ZOBuPG72yCfxHvXWvqEhgsobUB767+WNewOPmJ9hz+tR+K9NN1az2rnakgI5GcHsR9DzWB8N75m8RmK+G25toTAOc87sMR9Tt/M1lH3NEdbfPC/Y9Bt/DcZRTf3l1cTY5KSmNQfYLj0rO1Hw79giMlm7SQAkssjZIyfXuP5fy6gSHNQ6vMF0i7J5JjZVHqxGAPxJArWyMKdacJXTOUjgTycEfJ6HqtZdxb3GnXX2rTpPIuF4DYyrD0I7j/IrUtZTLEsh/1gHzj19xU7RrKmzgg/d/woPXumtdjb8M65HrVqxKeTdxHbNFnO09iPUHsa2l615VcTTaJq8N7b5yh+ZR/y0TPzL9e4969PtZ47q2iuIGDxSqHRh3BGQaaZ5WJoeyldbMmlhWRCpGQRg1u6DevcQtDO2Z4cAk9WU9D/ADH4e9Y69KdbS/ZtRtp+i7vLf/dbj+e0/hW9KfJI4K0OeNjq6KKK9A84KKKKACiiigBJG2IzHoBmsm1tClugPUAZrRumxEQOrHaP8/TNLGPlFY1EpM0hJxRmzRErjFVwhAwa2XjB6VWuIQEJ9KxlTN4Vb6HD+K44zZzFwMqpKn0NebicFpMnBBNd94xuP9FmTuSB+oryXWJ2sdUlRs7JOa4W/ePaw2qsdtp7BAAPu/yroLMk4Kgke1cDouqb1j55OBXp3h2xhe2iuZk3hhuQEcIDjjH4ZzWg6s+RXZJEeMmps8VautMtWXekYjcAAMnynA6D6VkmVlLoxy6Ha2BgZo2OWMudi3bYFc7qEu0upPUZrQvbkL9a57VJ85Of4TSlsdVKNmdT4XA/s1CB95if1rfgPzVi+HIXh0m3WQ5faCTjFacb4kNLY5J6yZpp1FTg8VUicHFT7q1TOdoeap3TYNTySAKTmsTUbplVmUjipm7IunG7GX2QBIpxg103hGUSaayA/wCrfbj0GMj9DXF2t01zaSb+vY+orpfApP8Apg7bYz+Pzf4Cnhn+8QYqP7p+R1dc/wCAP+RN0n/riP5mugrn/AH/ACJuk/8AXEfzNeoeSdBVS4voYJFSVgrMdoz61ZlJCEgE49K8y+Jt3J/wj0lxG3z5/durdRgsCD9FcVE5cqNaNP2klFnotlM0jTRyHLxtx7qeQf5j8KtVxPgfxCmuaBZaisge6gURXijrnA3HH5MPyrtVIYAqQQehFZ0KvtI+aCtTdOTixaKKK3MgooooAKKKazqmNzBcnAycZPpQA6iiigAooooA5/wB/wAibpP/AFxH8zXQVz/gD/kTdJ/64j+ZroKACiiigAooooAKKKKAPK9Zh8jVr+P+7cuf++vn/wDZqqDpW54zhEeu3BXrJHHMfryn/sorCWvFrLlm0e3SfNTTJYjzWjAcisxOGFaNuMLmpiUy2DgVNHllqsAT1qzB6VojNmJ4ih/cFh2ryLX1l0vxTFeW0hiMoEm7GRx8rgjuMY/OvbtWjElrIpHUV5F44iZrSKdeDbyjJ/2Twf121ElqdeFlrZ9TvtO1m7mtI2jihuOB83mbT0yM8HP9aLuV3IuNTuY4oFIVUztRS2AMk9SdwH41wnhu9ntCHjYmAgZULkpzzj1Gecds8dwe6jubW9tyk6xtFICpVsMjjuB2PBPHXjpRFr4ZBWouk9ipcuY7iaULgI+CPbaM/rn8qnjlTAwflPIrAFhPaC5j0m4ECxu/+iTDfC2D0H8ScYxg7R/dNVLDxFDFtstRt5ra+ZtkUZ+ZZD2COOGPtw3HQVp6HdB2ilLQ19ejNzjAO4j05z6103w8mkm0ExSgg20zRLn04b9N2Pwqrpuj3d+RLqBNrF/zyQgufqeg/Culs4ItPiSKFdkC8AZz+f8AjQlrc5MXXhOHJHcvAYqC+5t5BnGVIz6VKZAB1qrLFJfzJaQnDSnBbGdq92/D+eKrfRHmruztbaQTW8Uoxh1Dce4qSobK3S0tIbePJSJAgz7Cpq9Rbanlu19AooopiCiiigBrIGIJ5x0pdoHSlopWQDTxVW6f5SParh5qpdxnYxHpWdRWRpTtc808VRNNcbV+6rqzfTcB/MivP/G2jyXA3xHawwwOP0/GvUdXti1tqNyekZhjHvmRSf8A0EfnWJPAlwm1xmvIqLllc9yhPT0PIdHujbTbX7Hn2PevavBuuRTWSQFgHQcZOdw/x5xiuE1/wjI7NcWChZepXs3/ANeubjnvdMl2sHiYH7rCrjI6ZwjXjZbn0BPdosTFmWNFGSScACuWub+Jp53TA3tnpgnAAyfyrzmHX7hzmWRmPqwyf88Vox6tvXk5Pqavcyhh3Td2bt5eBm6/jmsuOU3uqW9soPztzgZ4HrVUzSTsEhyzt0VRmuy8IaEbUNeXQ/fuMAH+EVL10LnNQV+p0luNkaoOijFMkYxyKT91uPoamPysPekuUEkRU96DhuJHOV4NWVu+K59blopTDOfm/hP94f41bSYMODU8zRbgmaM1wWBFYN6txI7RquVbvmrjSe9QXFykK5z81S3cuEbbDGRbW2CA5Y9a67wTCVtLibs7hB77R1/NiPwrgLi6beB1mf7i+g9T7V6Z4SQx+HbJTnO0kk9eWJrpwcbzuc2Olanbua9c/wCAP+RN0n/riP5mugrn/AH/ACJuk/8AXEfzNemeSdBXgfxP1K5065XSmw1pBfGcgjkqMOoz6bWx+Fe+V51488Iwa7rjzXN0ttbiFGJxkmQ7lB+mAPyrGum46HZgqkIVL1Njxrwj4uHgPxekVyWawu5hZTDPAbOEf+Yr6V0y6RRGiMGtpeYXB6f7H+H5V8efEbR2tdc1Ww1ECaa22NGT90jAO8e5O7mu++EPxC+w2w0/Wpnl0kv5cU8jFjFjHDHrgHI3dsc+tedzuhPmjt1PTxeGeIiqsNdD6aorN0++DGOOSQSJKMwzDpIPTPr/AD/OtKvUhNTXNE8GUXF2ZwXx1S0k+FPiJLyKSV2tXFsscbu32jafKwFBOd2Oeg715daan4itvDWhaf4J1C90nTrfwlPqMgTT1cvfRN8yHzUJBZ9/HfqOxr3e01dr7XJ7SxiElnaApc3RPyibjESf3iBkseg4HJzt16sR843fjfx3pXh3Xrq+1Wcu2jaXqUE76fGotZZ5UWWJRtwwAYjDZP41Yt9U8Qa9f6eLu5vdY0ay8Y2P9n6jPYi3eWPyZDLlVRflRyBux3/L3nWdKsdb02Ww1W3S5s5SpeJ84JVgy9PQqD+FXaAPnXw/4+8Z3viy9RZdRFhLa6kfs13bIXtZYQTF92BApPGF3y5HU5rJ1nU/iBqfhHVbDUNV1K8F94Rh1n5LCOJ4rjzgrwqUQdVBJH3vTFfUFFAGN4NuVu/DNhOmpT6oroSLyeEQvLyeSgVQMdPujpWzRRQBz/gD/kTdJ/64j+ZroK5/wB/yJuk/9cR/M10FABRRRQAUUUUAFFFFAHF+P4Nt7p1wB8siyW7H1OAy/wDoL1ySmvQfHNv5vh2aYD5rVluB7BT83/jpavPm4kYe+RXl4uNp37nq4OV6duw8da1LQjyx61lCr1q4C4Nc8ToaL5IFOgf58VXLCnxNtYGrTJsWLtPMiIHpXnWuWqtJcQSg7JAVP416O7ZXiuZ1vTfOLMOGPIomrjpOzPOfDBMN3LaT43p8h/z7jBrqRaosvmhpEBB3bGK7h7/jmsu/0i4Sdbq1Cm4TgqTgOvp9avQJfXW2FEEKkfMz/MR7AD+f86nR7nrxrwlG8mMjE91dtb2EYLcBj0VM+v8AgK6vTtItbO1kiljS4eZdszSIDvHpg9vanaLpsdhbqka9OpPJJ7kn1rVWItziqSOCviHU0WxlWul3WnZPh65VIhz9guiWhPsjctF+G5R2Wrq65ASlpqkcmm3k3yJHP9yRumEkHysT2Gd2OqirYXYwI4qW4WC7s5ILqKOaGRdrxyKGVh6EHrWl+5xuNtjWi0GaaKORL1NjqGGYSTgj/erZ0vTYtPjbYWeV/vyN1Pt7D2rn/C+l3ljY2kmlahIbIZR7K7JlVQrFf3bn506dCWXsAvWpvF3jbTfDF9p9hcQX99qd+Ha3srC3M0rqgyzYGAAM9zXoU6cFaSR5tSpN3jJnUUVyNj4/0i51qLTJo7yxmfSjq7vfRCBYYRL5RWTcQVcN1BGMd6vW3i7Spb7UraeeO0SykiiNxcTxLHM0ib12EOT09QCe2RzWpidBRVSx1Oy1Gw+26bd297akHbLbSrIjY6gMDj9aybDxjolxpmmXl1f22nHUUD28F7cxJI+TjAAchj/uk0AdDRXK6b4+8P3kOqzXN7FpkOm6nLpMsmoSxwq80YBbYS3Iw3HQ9eK1bzxJodkkb3us6bbpJGJkaW6RAyE4DjJ5UnjPSgDVormfGPjfQvCWnm51S9iaXCMlrFKhnlV3CBkQsNwy2SfQGumoAKRgCCD3paKAOY8YW62vhS9KdTLHIf8Av4v9AK5G3UMAfau68bR+Z4V1If3Y9/8A3yQf6VwOnvuiQjpivLxkbTXoerg23TfqXeKq3unW17GVniVvqKvBQRS7fSsbG97HG3HgeyllJjQpn+6SP5GpbXwJaowZi7D3c/412ka4qdeKFEt1p2tczNN0e2sU2xRKv0FaikKuBTGakT73NUtDJtvceeTmmMD0J4qSmnk0yUyle2S3MRVuvY1hSR3dsxUfOo6Bua6ckqPaoniWTqKho1jKxzDXsqjBtz/32f8ACoWmvJmxFEkQ/vfeP5mujls8HKnioTbY5JrNq3Q0UrmZp1mYpd7ks5OSTzk16p4dB/sKwJ6tCjfmM/1rz2TEUbt/dBNelaZF5Gm2kJ/5ZxIv5ACu3A3u2cOPekSzXP8AgD/kTdJ/64j+ZroK5/wB/wAibpP/AFxH8zXonmHQVzXjBABCZHMcE6mB5F6o2QUP/oX510tYnjG3FxoU3HKENk9gflJ/AEmoqK8WXT+NHzl8brSOfxEqTIHnS2RHOBndt9vwrU0n4Zpd+GdPvNLuhDfvbozRsn7p+OnHQ+9c34rWR5fOnZpJG5LMc52nGPrwa9r+Fjrd+DNKIPKReUfqpI/pXNh4xnKSkj2sXOph6NOVN2aPP/Cev6j4HvX0jX7aU6bIctAx3eUCeXjPdfUD8OeD6p/wkLay0WkaLdh0mCebqaMcQRMMhQf+ezDp6Ahj/CrZ3xK0P+17W3023tWe/l3PDdbTstQuN0jHv1ACdWJ7AFh5z4Q1a5+HepzaDrSPLpcrlnbvknmZT6E8kdu3vE6csK+eGsf6/r+teZuOOV0rT6+fp5n0Rp9nb6fZQ2llCsNtCoSONeigVYrL0e+EyRxtKs25N8U68iVfXjv0+vUdwNSu2E1OPNE8yUXF2YVheOvE9n4N8KX+v6lFcTWlkqtIluAXO51UYBIHVh3rdrmfiX4V/wCE28D6p4d+2fYftyov2jyvN2bXV/u5Gfu46jrVCLmveKNH8P2Fvea1eLZwXBxGXVmLHG7GFBPSsCb4p+Fk8Q6Vo8V959xqlsLm0miAMUgZtqruz95ieOMcHJFZ2u+BfE+uWmlwah4ttWjspi7wwafNBDcoU2hZVS5DNtPzDDAZ6g1W8O/Cu78P3PhOew12B20Wwl06YTWJIuIpJA7FcSjY3YE7h3welAG1pvxQ8Ny6HpN/ql/babLqMTTRW7zLKwQOU3Epkbcj73TtmtC88eeHYb6/0+DU7a41SzjlZ7VHwd0aF2TcflDAA5BPHevOpPgdcx6ToNpp/iVLK70qzFmupwWksd1t855W2lZwu07gNrq2MEg84rWHwmul8W6rq1vr6WVrqH2w3FpaW8qJctOjKrTK0xQsm4HKou4jJxQBt2PxN8G2el6WL7VNO0eS6tobiOzeVf3aSfd5X5ce44rW07x94V1KETWGu2VxEbxNPDRvkGd/uJ9W7HofWuF/4UqP7D1DTjrwP2vQ7TRvM+xfc8ht3m48znd/dzx6mr3iD4VXGoa5rGr2GuR2t3eatYavCsll5iQvaxlQrASAuGznPy46c9aAOsvvH3hawhkkutatUCXctiVyWbz4/wDWIFAySuRnA4zXQafeW+o2Nve2UyT2txGssUqHIdGGQR7EGvHbz4K3Vzp8qSa9ZvqEup3uqfbRYzRSQS3OzPlGO4UrjYeCWDZGQNuT6x4c0+bSdA07T7q+l1C4tbdIZLub787KoBduTyevU/U0AaNFFFABRRRQBHcQpcQSQyrujkUow9QRg15C0TwDypTmSEmFz6sh2k/pXsVeaeK7Q2niC8UDEdwFuU9MkbWH5jP/AAKuPGRvFSO3BTtJx7mSpq1bgtxVRetW7c4YV5yPRZdRcDmplFRrUgIxWhDJAcLVe4+fgins4qF5BQCKptEY/MKs29rFGMogBPeolcu4FaMaZUAUIbY1E5FWkUAURx45PWnAEGrM2xkiAiqzDBq7UE68UmNHTeFgRo0ee7yH/wAfNcX8XfAd34zudOeDT9BvY7VHx/aEtxBLE5Iw0csBBxxyp4OBXdeHxjRrXHdN35nNee/EjXvEGl/FPwHp+lajY2mm6gl558d0DslaNEPzEEdAflxjnOcivUp6QR5NR3m35nM6p8FNcv8A+ypbjxFHdXWn6JFZCS43MtzcR3QnUTLg74cDbgnPAODitjV/hbqOr+IdR1C9m0xre+1zTNUltm3Ovl20WyWM5XB3HOM8EdcVQvPHHibU/DUerXdtp9rph16HT4DZ3U8c7lb3yWLgYAUqPu7iD34OA61+JfjHUNdS0sNP8Pi2udbvtEt2meYOrwKzLI+MjGFOQOp7irIO4+G/g6bwlp3iOzd7XydQ1i7v7aO3BCwwy42JjAwQB0HHpXnA+DXiCCHw4LG90q3vNPsILGa+EkjFkSQuy+SyMki88Z2HJ5J4qO1+MninVNC0670vTNFjuZNCvdXuRcGUqDbTtGyptOfmCZAPTPXjm3F8ZdctdI1281TSNOZoNIsdXsktZHIVLlgoWUtjO0sCSMDAP1oAvX3wv8QsmpR2t/pj2t/4gvdUmt5S6b4Z41VB5iruVlKkkKQGzgmqVl8FLwaJDZajPpV1LB4VuNDiZ0ZxHcvKzpMuV4Cg9R83pUi/FXxKv2XT7m00K1vrvUUtYdQuJttqITC0m50WVmVvkKgFsNnIrqv2f9TvtY+GdneapeyX1091dgzySmTcBO4GGJJwAAB7YoA4i/8Agxr7i8igu9DuEvrDS7eSe7SQzWz2iorCEgcI+zJJweenevfaKKACiiigCnrMH2nSL6AcmWB0/NSK8r0aQG0iPqor2A145bxfZmeDvE7J+RxXn45axZ6OAekkbEbVKrc9KpQyfKM1OJB2rjTO1xLiOB1pxkB4BqiXJNWLYZOTVJ3JasThSalROKUCpVHFWkZtjCtJsqWkpiIGXiq5OGxV5hVW4jz0pNFJiDBqGcAUiyhThutMmfeeOlQ9jSO5WZBKwiPRyE/PivUa830+PzNStF9Z0P5MDXpFdmBWjZw496xQVz/gD/kTdJ/64j+ZroK5/wAAf8ibpP8A1xH8zXccB0FRXUCXNtLBKMxyoUYexGKlooDY+bfFPhfVXt72/Fm5t4bidXPoNx5A9M55rpP2ftQEml3mnu2Wtpt6g/3W/wDrg13F20j6i0KjEMc8kFxGWwCjnKnGOeH/AJV5H8Irj+zviFe2eflmikA9yrAj9M1x0/cqrz0PZlUeIw01L7Nmj6JliEsYGcEdD6VxPjvwhDr2mPHKiJcxgtbzLnKN/ge4ruIG3xgjvRNGJIyDXZ5M8iMnBqUXqjwb4ZeJLrStUXw5q7GGNZCkBY828w/hB7qRkj8q93sbj7RDlgFkU7XUdAfb2PWvEvjD4dUSDU0Uqy/JMy8Hb2b6qcfhWr4A8Q+Itb0ZHDW9gbM/Z7u5l/fTSL1DrGPlGAc7iW6sNtcEU8NV5fss9DEKOIpqvFa9fX/gnrd5d29jbSXN7PFb28Y3PLK4RVHqSeBXEfFHxncaF8Mr/wAReHlWSRWjSOW4hcJGrSqhlKkAlQCSD0PB5FdHp3hvT7W6S9mEmoaivIvL1vNkGeuz+GMH0QKPaq/xA8Wad4J8KXuuauJHtoAAI4xlpGPAUZ45967zzTxC18catpEfia5sfEdlqcd14i0/T5Nd8sNa2sMluu+cIGKAAjH3tuTk1q6f4/8AGGs6n4e0bSdU0vffalqtguqtZ+ZDdxW0auk6IrAc5YcNtJX04rutA+J+lahb3j6pbNpUFrZ213K8siyptnd0RRszk5QdP7wrWb4h+EIdGt9SbXbGPT5pWto5CxAMijJjxjIYD+EjPSgDyO++JGuXWt+MNI1K8tHtxZaobOGw8qWPy4YmwZJEk82J+OdyjngY4rr9d8Uap4f/AGe9D1zSHij1E2OmBWmUyqPNMKtkMcnhj1OfevStC1TTtc0yDVNGuYLuyuV3R3EJyHAOOvsQRjsRV+gDwG38e+NbLWoI7/VNNu7W38XxeG5400/ymnSUA+Zu3naVzwAPqTS+F/i7qeo/2Day3+ltqrtq/wDaNu4CeSLdHaHzAOUHyjJ7gGvfaQKATgAZOTjvQB826d8XvE48MapJd3lm+pRXVjBPdLBDNZ6fHO7hphJDKwdQAOGII4JznAta14w1TTPFcmqabrdt4oks/C99PHLaLtgmdLhQGKIxUlRnJB5welfRCoqghVUA9QBQoCgBQAB0AoA8t+C3i/WfEt1q8Or3+mahbQxwTW81rPA8q7w25ZFhdgoyuRnB65zXqdIqqoIVQuTngY5paACiiigArifiFn7dpnoYp/5x121cb8QlBm0s98yr+GFP9BWGJ/hM3wv8VHIhT1qxCCME0gAC08V5KPYZY84AdKY9x2quzGmU7k2JzNmm7iajUZqVFouMmtxhge9att92s2L79aEB7VcSJFmlHNIKcBVmYYqK4X5KmpsgyhpsDofDjb9Gt/bcv5MR/SpdS0nTtU8n+07C0vPIfzIvtEKyeW395dwOD7iqPhN82M8X/POYgD2IB/mTW3XpUneCPMqq02il/ZWnfZVtvsFp9nWXzhF5K7BJu3b8Yxu3c5655oi0jTYnV4tPtEdJmuFZYVBErDDOOPvEE5PU5q7RVmZmw6Do8MYSHStPjQRPAFW2QARucunT7rEkkdCakj0fTIw4j06zQPALZtsCjdEBgRnjlQP4elXqKAMWPwn4cjsWso9A0hbNpBK0C2cYjLjoxXbjI9etaVjZWun24t7C2gtYFJIjhjCKCTknA45JJqxRQAUUUUAFFFFABXkuoDbrepLjAF1J/wChGvWq8mvyH1zVG9LqQfka4cd8KO/AfEyROlSRioYz2qwPu156PRY4dau2o4qkgyav2/yrWkTORaUU8Ui9KUVoZC0mKdjjNNNMBKY65FPxTW5pAZt1Hg5FQA1pTplaz5EIaspo2g7lrR+NZsj28z+hr0GvObF/Lv7R/SZM/TcM16NXdgn7jXmcGOXvp+QVz/gD/kTdJ/64j+ZroK5/wB/yJuk/9cR/M12nCdBRRRQB5p8QtRutB1Ke5s9p8xFkbcP7w2H8vLQ/jXkPgmf7P8QtMZiSznyyfUmMg17b8UtPfUYrOC3RmuJAygKM5G6Mn9Mn868Ekin0LxPpzXcbwzwzKzK4wR8+P5Vxz92qn5nuYTlnh5RW7TPqbTJN0AFXhWLokmU61tCu17nhnN+M9PS702UMu4EHI9RXhOg6tdeGPEX2F7j7Pp88q2tzLkAquCUcE5C5yFJPQEn3H0jqUYktXBGeK+dPG4bTfEUd2mAYispBHUxuCB+Vc2Mhz0W+qPQy9803Se0l/wAMe1/DQ7fD00RvJ73y7ydVmllEmU3kptIAyu0rg9+vep/iT4W/4TTwRqvh77Z9i+3IqfaPK8zZh1bO3Iz93HUdataNIDfkrjbPaxyceoJBP5EflW3V0J89NSOKorSPOfFvw5vdZ1HW77TPEUumT6lBZQHy4W4WB3ZlLLIrFXD4OCpGOpzXJXXwu17Q38Ox+H7u1upk8RzavNcPbMIbVXg2YMbTF3AIH8eefbn3OitSDmPht4TXwV4SttGF2b2RJJZpbgxiMO8jl2IQE7Rk4AyeldPRRQBT0fUItV0y3vrdXWKdd6iQAMB74Jq5XP8AgD/kTdJ/64j+ZroKACiiigAooooAKKKKACuA8Z3P2nxAsSnKWkOw/wC++GI/IJ+dd7I6xxs7kKigkk9gK8uuC013PMQQ00jSEHqMngfgMD8K5MZK0OXudmDhefN2IsE9KkVCR0qykQAGRT9oArzrHpXM1lINJg1oSIrCoTGB2osBCi+tTDgUYopDHIcNWhCc4rMq/aHI5q4siRoL92nU1TwKXNaGQ2SRYly5x+FPblaryxtJOhBwgHX19qsHhaYFzws+2+u4z0ZFYfgTn+Yrpa5Xw42NaI9YH/8AQkrqq7sO/cPPxK/eBRRRW5gFFFFABRRRQAUUUUAFFFFADJpFhhklkOERSzH0AryO0LSCSaThpXaQ/ic13/jW78jSDApxJcny/wDgP8X6cfjXCkbUwK83GyvJR7Hp4GNouXcVBluPWra9KqQ9RVpT2rjidrZJEOavQVTiHPFXLcc1rEykWx0pRSClzVmZIvSmHrSFwKM0xWEI5oIpc8UUhkbDIqrcpjkVcNVbhhjFTIqL1KEm5clDhuoPoa9Gsrhbq0hnT7siBgPTI6V524rqfBtyXtJrZv8Ali25f91sn+efzFbYOVpOPcxxsOaCl2Ohrn/AH/Im6T/1xH8zXQVz/gD/AJE3Sf8AriP5mvSPMOgooooAx/EmY7eOZXMbcxB842lxhef94KPxrwv41RyS2mlXbKwuvLaKTcAGyDxnHuK918WwpN4a1ES52xwtMMdcp84/VRXzt441q417U71ZY0QWVsyDb/EVkX5vxyTXJiNz1Mti+dSXR6/l+p7X4HvBd6VZTZ/1sKP+aiuxHQV5d8LLkN4X0w5+4hiOf9liP6V6fEcoK7G7pM82ceWTj2C45hb6V85fF0iPVYQR1aT/ANAP9cV9E3bhIHJ9K+YfjDdPd+I0t7Y5k8mRgPcnA/rWdZ2pSOvL1fERPf8AwaTLp+iztnc2mrnP/ADXU15t4B0Zzrsd1Bd6nb2thZx2z28pZRcTHJZnV8nKjb8y4Bz3CivSaywqtSRz1nebCiiiugyCiiigDn/AH/Im6T/1xH8zXQVz/gD/AJE3Sf8AriP5mugoAKKKKACiiigAooooAyPEc+yz8nP+s+9/u+n4/wCNcgse5y5FbGqSPf3jFP8AV52r9BT4rFVUA151ZupPQ9KjalDzMYg1C7EGuiayQjpVOewHUVi4M2VVMxsmkNXJLUr2qBoyKzcWaKSZDijFPIIppqRjDVy0qqRUts+1sGqi7MHqjWXoKKRDlRS1qZCg4pHbiig0wJ9A/wCQyh/2GX+R/pXW1x2kPs1q19GYqf8Avk12NduF+A4MUvfCiiiug5gooooAKKKKACiiigAoopsjBI2c9FBJoA4bxbIbjWCM5SFQij36k/0/CsaaMbRmr90TLcSSMclmJqnPnNeNUfNJyPaprliokMajNSimxKSaeRg1mak1vwatxthhVSLtVtBnFWiJF1TkUtRIcCpAciruZ2K91CJcZOMVJDuC7WO4jvSyU2M80ATUtNBpSaYhkjYBqhIcnJqzcOMYBqrgk1EmaRQw8kCup8Lx7EkYjBasC2t2ZwcV2Gl23kQDPU10YWD5rnNiprl5S9XP+AP+RN0n/riP5mugrn/AH/Im6T/1xH8zXonmnQUUUUAR3MK3FvLDIMpIpRh7EYNfLkenXb3khlikZZVa2kfZwHaPI593x+NfU9cRI4UtYx7BatJcRuu37rh2YHOeD0NYVoptM7MLXdJSSW5wfwhuGPh2RG4MN06/mA39TXrFnqCeUA5wQK8q+HKCSDxDFbD50v8AzAvorIMfyNdPOl1GpaeRIIVGWdm4ArpppOCRlin++k++v3m7reqq8ZiRwq4LO/8AdUdTXhvguz/4TP4mXN2VLWFswfJ6bEPyj8WyfcA1P418UHXSugeFVluBO2yWdBzL/sr7ep6V2nhfwvrnhbSktNGtbPUmlUPqUPmmGZSf4Y5DlD8vG0he53DOK4cXU9pajTOuhB4am6s9JPRenc9Q0FB9lkuAB/pEhkH+6MKv/jqg/jWnXN6b4v0ia+i0y6MulamwASxv4/Jdj6Rn7kuPWNmHvS+JPGug+HNRgsNUuphfTRNOltbWk1zJ5anBcrEjELnjJwK6oR5IqK6HnSd3c6OisHRPFui61Ncx6feBzbwW91IXRowI51LRHLAdQDx1HfFXbPWbO6W5YO8K288lu5uI2iyyfeK7gNy/7Q4PrVCNGimxuksavGyujAFWU5BHqDTqAOf8Af8AIm6T/wBcR/M10Fc/4A/5E3Sf+uI/ma6CgAooooAKKKKACq2ouUtHC/eb5R+NWaguULtGP4QST+VKWw47mJFCIz09qlqa4j2Oahrhatodyd9QpCoNLRQBA8IYdKqzWQPIrRoIqXFMpSaMCW0YHpVZ4CD0ro5Iwe1UpoxnkVlKFjWMzFKGk2c5rSeEHpVZ12nFZuJopDreQgAGrQOaojrVyEFgKtEsfQelTJAzVYisyxAxxVqLZLkkZ9oCt2kmPusG/Wu2HIrBuLMRBSBjIxWxZvvtYm77RmuvDpxumcWIkpWkiaiiiuk5gooooAKKKKACiiigAqpqrFbCbb1I2/nVuoriPzVC9s8/lSkrqw4uzucPDatNIevFEtgc9K7CPT4487QBmmyWOegFcf1eyO36yrnILYle1RTWpHOK6t7MgcrVZ7TJ5FZugaRrnMKhQ1YjateTTwe1QPp7D7tZeyaNVWT3KytUgIxSNaSLTRBIKXK0PmTEkNRq2DU4tnPWpFtD6U+Vi5kiFZPakZmbgCriWnrU6WwHaqVNsl1EjNjtS5yatxWaKAXIGSFGe5NWLhHSFjGMYBJPsP61DA8zLMHIZYxGUJHO4lf5gqfxNaRppMylUbL2m2fmXLMOIYjt/wB9sZ/IZ/P6VugYqlovzaZA/eQeYSe+45/rV2u2nFRWhxVJOT1Cuf8AAH/Im6T/ANcR/M10Fc/4A/5E3Sf+uI/masg6CiiigArzL4n6qvhsX8ltBvuL+DenOMSAFC/vgFc/UV6bXn3xh8Pza1pdhJZgtcwytHtxkFHHOfoVU1lWTcNDpwnK6qU9j5n1TxPqWh6m9zpuo3FlM9vChSMBvObylxkEHILccV3dl4T8b+KYY5tYungsHUSCS9lAG0852KeePXFb/gvw1d6J4z0drmBhG8LQZYcZAJ/9lFexaRBFdX17NOvmSQTiOMPyEGxWyB0zknnrXCnUnL2Sdj0sTXjSlzRSem9texyXgHwHBoMfmWu6S6dcPfzJg49I07D3P/j1eiWltFaQiKBcLnJJ5LHuSe5qaiu2lQjS23PJq1p1XeTKmq6bY6tZSWeqWkF5ayfeinjDqfwNeTfFP4dajqt7YSeFdN8q5tLEWtpqsOuTWlzbHcx2v8j+ZGMqeob7w44NeyUVsZHg138KvFkviW31u91Gy1eS2OmSTWlwxSLUXgjdJHkwvyspfch5BOcitCX4VXuoa/YS6xb6bd6SniPUtUuLeVt4eCdMRjaVwW3AEjt6mvaaKAOO+D/hy/8ACXw40bQ9XeJ72zWRXMTl1wZHZQCQDwpArsaKKAOf8Af8ibpP/XEfzNdBXP8AgD/kTdJ/64j+ZroKACiiigAooooAKKKKAIJ4d46VSe1cHgVqUVnKmpFxqOJjmBx2ppjYdRWzgelIY1PaodFGirMxcEdqStdrdG7Uw2iGpdFlKsjLqKWPcDWo1j6GomspB0IqHSl2LVWPcw3jKmqlwuTXSNp7t1xUf9jbmyzVk6EnsjVV4rdmFBbbsE1pW9t0wOa1otMjTqc1bjhSMfKorWGHfUxniF0KVtZd3q8kaoOBT6K6YwUdjmlNy3K18m6MexpNO/1LL/dYj+tTzjdGRUVopUy+5B/QUW9647+7YsUUUVZAUUUUAFFFFABRRRQAUUUUAFFFFABTGjVhyKfRQF7FZ7b05qJoiOoq9RUOCLU2Zbwg9qi8kDtWuUU9qaYVPaodItVTL8oelL5YHatL7OlKIEHal7IftTMEfPAqWO2dj0wK0VRR0ApapUl1JdV9CnPYrLbNFuwWIycdgQTT5LSOSUsygA7TgcZKsCP5CrNFacqM+ZhRRRTEFc/4A/5E3Sf+uI/ma6CuYsfC1zYWsdrZeJ9bhtoxiOMR2jBRnpkwEn8SaAOnorn/AOwdR/6GzW/+/Vl/8j0f2DqP/Q2a3/36sv8A5HoA6CggHqM1z/8AYOo/9DZrf/fqy/8Akej+wdR/6GzW/wDv1Zf/ACPQBq3til09sxO0wSeYMDr8pGP1pbKzW1kunVixnk8w5HT5VXH/AI7WT/YOo/8AQ2a3/wB+rL/5Ho/sHUf+hs1v/v1Zf/I9TyR5ubqPmdrHQUVz/wDYOo/9DZrf/fqy/wDkej+wdR/6GzW/+/Vl/wDI9UI6Ciuf/sHUf+hs1v8A79WX/wAj0f2DqP8A0Nmt/wDfqy/+R6AOgorn/wCwdR/6GzW/+/Vl/wDI9H9g6j/0Nmt/9+rL/wCR6AOgorn/AOwdR/6GzW/+/Vl/8j0f2DqP/Q2a3/36sv8A5HoAPAH/ACJuk/8AXEfzNdBVHQ9Nj0fSLTT4JZZo7eMRiSXG9sdztAGfoBV6gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooACMjFIoxS0UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The latissimus dorsi flap is a reliable option for autologous tissue reconstruction. The flap is tunneled through the axilla, leaving its vascular pedicle, the thoracodorsal artery and vein, intact. Because the LD is not a bulky flap, it usually is used in combination with a saline or silicone implant to provide sufficient breast volume and projection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43107=[""].join("\n");
var outline_f42_6_43107=null;
var title_f42_6_43108="High cholesterol treatment options";
var content_f42_6_43108=[" <h1 id=\"patTopicTitle\">",
"  Patient information: High cholesterol treatment options (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?42/6/43108/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43108/contributors\" id=\"au5541\">",
"       Robert S Rosenson, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?42/6/43108/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43108/contributors\" id=\"se212\">",
"       Mason W Freeman, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?42/6/43108/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43108/contributors\" id=\"de6672\">",
"       David M Rind, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?42/6/43108?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     High cholesterol and lipid levels can significantly increase a person's risk of developing chest pain, heart attack, and stroke. Fortunately, a number of effective treatment options are available.",
"    </p>",
"    <p>",
"     Lipid levels can almost always be lowered with a combination of diet, weight loss, exercise, and medications. As lipid levels fall, so does the risk of developing coronary heart disease (CHD), as well as the risk of suffering a heart attack. It is not too late if CHD is already present; lipid-lowering treatment can be lifesaving.",
"    </p>",
"    <p>",
"     An explanation of what cholesterol and lipids are, how they affect health, and when levels should be measured is available in a separate topic. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?6/4/6212?source=see_link\">",
"      \"Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)\"",
"     </a>",
"     .) This topic will review when treatment is recommended, the available treatment options, and the risks, benefits, and effectiveness of each treatment.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHO NEEDS TREATMENT FOR HIGH CHOLESTEROL?",
"     </span>",
"    </p>",
"    <p>",
"     The decision to start lipid-lowering treatment is made on a case-by-case basis. Clinicians consider current lipid levels, the presence or absence of CHD, and other risk factors for CHD.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      People with CHD",
"     </span>",
"     &nbsp;&mdash;&nbsp;Several large trials have demonstrated that aggressive lipid lowering is beneficial in people with CHD. Independent of the following goals, many clinicians recommend treating all patients with CHD with a statin.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A target LDL cholesterol level below 70 to 80",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       (1.81 to 2.07",
"       <span class=\"nowrap\">",
"        mmol/L)",
"       </span>",
"       is recommended for people who have CHD",
"       <strong>",
"        and",
"       </strong>",
"       have multiple major risk factors (eg, people with diabetes or who smoke).",
"      </li>",
"      <li>",
"       People who have a heart attack (myocardial infarction or MI) are started on cholesterol-lowering medication while",
"       <strong>",
"        in",
"       </strong>",
"       the hospital and are advised to make lifestyle changes, regardless of their LDL level. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=see_link\">",
"        \"Patient information: Heart attack recovery (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       A target LDL cholesterol level less than 100",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       (2.59",
"       <span class=\"nowrap\">",
"        mmol/L)",
"       </span>",
"       is recommended for people who have CHD but do not have many additional risk factors. Lifestyle changes as well as medications may be recommended when LDL cholesterol levels are greater than 100",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       (2.59",
"       <span class=\"nowrap\">",
"        mmol/L).",
"       </span>",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     These general guidelines may be modified by other individual factors.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      People without CHD",
"     </span>",
"     &nbsp;&mdash;&nbsp;People without a history of CHD also appear to benefit from lipid lowering therapy, although the treatments are not as aggressive as in patients with CHD. Guidelines from the United States National Cholesterol Education Program make the following recommendations:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A target LDL cholesterol less than 130",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       (3.36",
"       <span class=\"nowrap\">",
"        mmol/L)",
"       </span>",
"       is recommended for people with two or more risk factors for CHD and a 10-year risk of CHD between 10 and 20 percent. The 10-year risk can be calculated for women (",
"       <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/19/15679?source=see_link\">",
"        calculator 1",
"       </a>",
"       ) and for men (",
"       <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/14/15599?source=see_link\">",
"        calculator 2",
"       </a>",
"       ). Lifestyle changes",
"       <strong>",
"        AND",
"       </strong>",
"       medication are generally recommended when the LDL cholesterol is above 130",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       (3.36",
"       <span class=\"nowrap\">",
"        mmol/L).",
"       </span>",
"      </li>",
"      <li>",
"       A target LDL cholesterol less than 130",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       (3.36",
"       <span class=\"nowrap\">",
"        mmol/L)",
"       </span>",
"       is recommended for patients with two or more risk factors for CHD and a 10-year risk of CHD less than 10 percent. The 10-year risk can be calculated for women (",
"       <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/19/15679?source=see_link\">",
"        calculator 1",
"       </a>",
"       ) and for men (",
"       <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/14/15599?source=see_link\">",
"        calculator 2",
"       </a>",
"       ). Lifestyle changes are generally recommended when the LDL cholesterol is above 130",
"       <span class=\"nowrap\">",
"        mg/dL,",
"       </span>",
"       although medication is not generally recommended until levels are above 160",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       (4.14",
"       <span class=\"nowrap\">",
"        mmol/L).",
"       </span>",
"      </li>",
"      <li>",
"       A target LDL cholesterol less than 160",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       (4.14",
"       <span class=\"nowrap\">",
"        mmol/L)",
"       </span>",
"       is recommended for patients with zero to one risk factor for CHD. Lifestyle changes are generally recommended when the LDL cholesterol level is above 160",
"       <span class=\"nowrap\">",
"        mg/dL,",
"       </span>",
"       although medication is not generally recommended until levels are above 190",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       (4.91",
"       <span class=\"nowrap\">",
"        mmol/L).",
"       </span>",
"      </li>",
"      <li>",
"       Additionally, in some patients the guidelines suggest using the level of non-HDL cholesterol (calculated by subtracting HDL cholesterol from total cholesterol) as a target.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Other experts make alternative recommendations, including global risk-based approaches to therapy. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/32/14856?source=see_link\">",
"      \"Treatment of lipids (including hypercholesterolemia) in primary prevention\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Other special groups",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h3\">",
"      Hypertriglyceridemia",
"     </span>",
"     &nbsp;&mdash;&nbsp;High triglycerides have not generally been thought to pose the same risk of CHD as LDL cholesterol. However, healthcare providers often recommend treatment for people with elevated triglyceride levels if they:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Have very high levels (&gt;500-1000",
"       <span class=\"nowrap\">",
"        mg/dL",
"       </span>",
"       or 5.65-11.3",
"       <span class=\"nowrap\">",
"        mmol/L)",
"       </span>",
"      </li>",
"      <li>",
"       Also have high LDL cholesterol or low HDL cholesterol levels",
"      </li>",
"      <li>",
"       Have a strong family history of CHD",
"      </li>",
"      <li>",
"       Have other risk factors for CHD",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Diabetes mellitus",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with diabetes (type 1 or 2) are at high risk of heart disease. Thus, an LDL level below 100",
"     <span class=\"nowrap\">",
"      mg/dL",
"     </span>",
"     (2.59",
"     <span class=\"nowrap\">",
"      mmol/L)",
"     </span>",
"     is recommended in many people with diabetes. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/22/9572?source=see_link\">",
"      \"Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h3\">",
"      Elderly",
"     </span>",
"     &nbsp;&mdash;&nbsp;The decision to treat high cholesterol levels in an elderly person depends upon the individual's chronologic age (age in years) and physiologic age (health, fitness). A person with a limited life span and underlying illness is probably not a good candidate for drug therapy. On the other hand, an otherwise healthy elderly person should not be denied drug therapy simply on the basis of age alone. In general, the treatment goals discussed above are followed for elderly people.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      HIGH CHOLESTEROL TREATMENT OPTIONS",
"     </span>",
"    </p>",
"    <p>",
"     Lipid levels can be lowered with lifestyle changes, medications, or a combination of these approaches. In certain cases, a clinician will recommend a trial of lifestyle changes before recommending a medication.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Lifestyle changes",
"     </span>",
"     &nbsp;&mdash;&nbsp;All patients with high LDL cholesterol should try to make some changes in their day-to-day habits, by reducing total and saturated fat in the diet, losing weight (if overweight or obese), performing aerobic exercise, and eating a diet rich in fruits and vegetables. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/42/7844?source=see_link\">",
"      \"Patient information: Exercise (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/62/28642?source=see_link\">",
"      \"Patient information: Diet and health (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The benefits of such lifestyle modifications may be evident within 6 to 12 months. However, the success of lipid lowering with lifestyle modification varies widely, and clinicians may elect to begin drug therapy before this time period is over.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are many medications available to help lower elevated levels of LDL cholesterol and triglycerides, but only a few for increasing HDL cholesterol. Each category of medication targets a specific lipid and varies in how it works, how effective it is, and how much it costs. Your healthcare provider will recommend a medication or combination of medications based on blood lipid levels and other individual factors.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Statins",
"     </span>",
"     &nbsp;&mdash;&nbsp;Statins are the most powerful drugs for lowering LDL cholesterol and are the most effective drug for prevention of coronary heart disease, heart attack, stroke, and death. Statins include lovastatin, pravastatin, simvastatin, fluvastatin, atorvastatin, and rosuvastatin&nbsp;(",
"     <a class=\"graphic graphic_table graphicRef70312 \" href=\"mobipreview.htm?42/50/43819\">",
"      table 1",
"     </a>",
"     ). These medications decrease the body's synthesis of cholesterol and can reduce LDL levels by as much as 20 to 60 percent. In addition, statins can lower triglycerides and slightly raise HDL cholesterol levels.",
"    </p>",
"    <p>",
"     It is important to closely follow the dosing instructions for when to take statins; some are more effective when taken before bedtime while others should be taken with a meal.",
"    </p>",
"    <p>",
"     In addition, some foods, such as grapefruit or grapefruit juice, can increase the risk of side effects of statins. Most manufacturers recommend that people who take lovastatin, simvastatin, or atorvastatin consume no more than one-half of a grapefruit or 8 ounces of grapefruit juice per day.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Ezetimibe",
"     </span>",
"     &nbsp;&mdash;&nbsp;Ezetimibe (Zetia&reg;) impairs the body's ability to absorb cholesterol from food as well as cholesterol that the body produces internally. It lowers LDL levels when used alone. It has relatively few side effects when used alone.",
"    </p>",
"    <p>",
"     However, there are no studies that demonstrate better outcomes in patients who take ezetimibe, either alone or in combination with other cholesterol-lowering medications. Further study is needed before ezetimibe is recommended as a first-line treatment.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Bile acid sequestrants",
"     </span>",
"     &nbsp;&mdash;&nbsp;The bile acid sequestrants include cholestyramine, colestipol, and colesevelam&nbsp;(",
"     <a class=\"graphic graphic_table graphicRef70312 \" href=\"mobipreview.htm?42/50/43819\">",
"      table 1",
"     </a>",
"     ). These medications bind (combine with) bile acids in the intestine, reducing the amount of cholesterol absorbed from foods.",
"    </p>",
"    <p>",
"     Bile acid sequestrants may be recommended to treat mild to moderately elevated LDL cholesterol levels. However, side effects can be bothersome, and may include nausea, bloating, cramping, and liver injury. Taking psyllium (a fiber supplement, such as Metamucil&reg;) can sometimes reduce the dose required and the side effects.",
"    </p>",
"    <p>",
"     Bile acid sequestrants can interact with some medications, including as digoxin (Lanoxin&reg;) and warfarin (Coumadin&reg;), and with the absorption of fat-soluble vitamins (including vitamins A, D, K, and E). Taking these medications at different times of day can solve these problems in some cases.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Nicotinic acid (Niacin)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Nicotinic acid is a vitamin that is available in immediate-release, sustained-release, and extended-release formulations (",
"     <a class=\"graphic graphic_table graphicRef70312 \" href=\"mobipreview.htm?42/50/43819\">",
"      table 1",
"     </a>",
"     ). Nicotinic acid may be recommended for people with elevated cholesterol levels and some types of familial hyperlipidemia.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Side effects &mdash; Nicotinic acid has several possible side effects, including flushing (when the face or body turns red and becomes warm), itching, nausea, and numbness and tingling. This medication can also injure the liver; patients who use it require regular monitoring of liver function.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Taking nicotinic acid with food and taking aspirin (325 to 650 mg) 30 minutes before can decrease the side effects. Side effects often improve after 7 to 10 days. The immediate-release formulation is more likely to produce side effects, but is also more effective at lowering cholesterol levels and less likely to injure the liver than certain sustained-release formulations. The sustained-release and extended-release formulations have fewer side effects and are usually taken at night with a meal or snack.",
"    </p>",
"    <p>",
"     Nicotinic acid can produce other side effects in some people, including insulin resistance, which can increase blood glucose levels in diabetics. It can increase uric acid levels in people with gout and is not recommended for this group. Nicotinic acid can also produce low blood pressure in people taking vasodilator medications such as nitroglycerin, and it can sometimes worsen angina pectoris (chest pain).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Fibrates",
"     </span>",
"     &nbsp;&mdash;&nbsp;Fibrate medications (gemfibrozil, fenofibrate and fenofibric acid) can lower triglyceride levels and raise HDL cholesterol levels (",
"     <a class=\"graphic graphic_table graphicRef70312 \" href=\"mobipreview.htm?42/50/43819\">",
"      table 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Fibrates may be recommended for people with elevated triglyceride levels and hyperlipidemia. Fibrates have been associated with muscle toxicity (causing muscle pain or weakness), especially when used by people with kidney insufficiency or when used in combination with a statin medication.",
"     <span class=\"nowrap\">",
"      Fenofibrate/fenofibric acid",
"     </span>",
"     (Tricor&reg;, Triglide&reg;, Trilipex&reg;) are less likely to interact with statins than gemfibrozil, and are safer in people who must use both medications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Nutritional supplements",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h3\">",
"      Fish oil",
"     </span>",
"     &nbsp;&mdash;&nbsp;Oily fish, such as anchovies and tuna, contain two important fatty acids, called DHA and EPA. Eating a diet that includes one to two servings of oily fish per week can reduce triglyceride levels and reduce the risk of death from coronary heart disease. Fish oil supplements are believed to have the same benefit. A daily 1 gram fish oil supplement may be recommended if you do not eat enough fish.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h3\">",
"      Soy protein",
"     </span>",
"     &nbsp;&mdash;&nbsp;Soy protein contains isoflavones, which mimic the action of estrogen. A diet high in soy protein can slightly lower levels of total cholesterol, LDL cholesterol, and triglycerides, and raise levels of HDL cholesterol. However, normal protein should not be replaced with soy protein or isoflavone supplements in an effort to lower cholesterol levels.",
"    </p>",
"    <p>",
"     Soy foods and food products (eg, tofu, soy butter, edamame, some soy burgers, etc.) are likely to have beneficial effects on lipids and cardiovascular health because they are low in saturated fats and high in unsaturated fats.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h3\">",
"      Garlic",
"     </span>",
"     &nbsp;&mdash;&nbsp;A large trial showed that garlic is not effective in lowering cholesterol [",
"     <a class=\"abstract\" href=\"mobipreview.htm?42/6/43108/abstract/1\">",
"      1",
"     </a>",
"     ]. In this study, participants with an elevated LDL took one of several types of garlic extract (raw, powdered, aged) or a placebo (inactive pill) six days per week for six months. At the end of the study, the LDL levels were not improved in the garlic group compared to the group that took the placebo. We do not recommend garlic to lower cholesterol.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h3\">",
"      Plant stanols and sterols",
"     </span>",
"     &nbsp;&mdash;&nbsp;Plant stanols and sterols may act by blocking the absorption of cholesterol in the intestine. They are naturally found in some fruits, vegetables, vegetable oils, nuts, seeds, and legumes. They are also available in commercially prepared products such as margarine (Promise Active&trade; and Benecol&reg;), orange juice (Minute Maid Premium Heart Wise&reg;), rice milk (Rice Dream Heart Wise&trade;), as well as dietary supplements (Benecol SoftGels&reg; and Cholest-Off&reg;). The margarines cost about five times what ordinary margarines cost.",
"    </p>",
"    <p>",
"     Despite lowering cholesterol levels, there are no studies demonstrating a reduced risk of coronary heart disease in people who consume supplemental plant stanols and sterols. There is some evidence that these supplements might actually increase risk.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      STICKING WITH TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The treatment of high cholesterol",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     triglycerides is a lifelong process. Although medications can rapidly lower your levels, it often takes 6 to 12 months before the effects of lifestyle modifications are noticeable. Once you have an effective treatment plan and you begin to see results, it is important to stick with the plan. Stopping treatment usually allows lipid levels to rise again.",
"    </p>",
"    <p>",
"     Most people who stop treatment do so because of side effects. However, there are a wide variety of medications available today, which should make it possible for most people to find an option that works for them. Talk with a healthcare provider if a specific medication is not working; he or she can recommend alternatives that are compatible with your lifestyle and beliefs.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H23\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3498610127\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2530845679\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/48/11011?source=see_link\">",
"      Patient information: High cholesterol (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/28/20930?source=see_link\">",
"      Patient information: High triglycerides (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/56/24450?source=see_link\">",
"      Patient information: Can foods or supplements lower cholesterol? (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2530845696\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?6/4/6212?source=see_link\">",
"      Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=see_link\">",
"      Patient information: Heart attack recovery (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/22/9572?source=see_link\">",
"      Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/42/7844?source=see_link\">",
"      Patient information: Exercise (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/62/28642?source=see_link\">",
"      Patient information: Diet and health (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/47/35578?source=see_link\">",
"      Approach to the patient with hypertriglyceridemia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/55/33656?source=see_link\">",
"      Cholesterol lowering after an acute coronary syndrome",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/2/39978?source=see_link\">",
"      HDL metabolism and approach to the patient with abnormal HDL-cholesterol levels",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=see_link\">",
"      Intensity of lipid lowering therapy in secondary prevention of coronary heart disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/26/25000?source=see_link\">",
"      Lipid abnormalities after cardiac transplantation",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/54/29546?source=see_link\">",
"      Lipid abnormalities after renal transplantation",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/56/28550?source=see_link\">",
"      Lipid abnormalities in thyroid disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/51/28474?source=see_link\">",
"      Lipid lowering with diet or dietary supplements",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/14/42217?source=see_link\">",
"      Lipid lowering with drugs other than statins and fibrates",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/39/7800?source=see_link\">",
"      Lipid lowering with fibric acid derivatives",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/45/18138?source=see_link\">",
"      Lipoprotein classification; metabolism; and role in atherosclerosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/19/40248?source=see_link\">",
"      Lipoprotein(a) and cardiovascular disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/3/49?source=see_link\">",
"      Management of dyslipidemia and cardiovascular risk in the HIV-infected patient",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31222?source=see_link\">",
"      Measurement of serum lipids and lipoproteins",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/2/32?source=see_link\">",
"      Mechanisms of benefit of lipid-lowering drugs in patients with coronary heart disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/29/33241?source=see_link\">",
"      Screening guidelines for dyslipidemia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/35/32314?source=see_link\">",
"      Statins: Actions, side effects, and administration",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/5/10329?source=see_link\">",
"      Treatment of drug-resistant hypercholesterolemia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/32/10760?source=see_link\">",
"      Treatment of dyslipidemia in the older adult",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/32/14856?source=see_link\">",
"      Treatment of lipids (including hypercholesterolemia) in primary prevention",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26122?source=see_link\">",
"      Treatment of lipids (including hypercholesterolemia) in secondary prevention",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Cholesterol Education Program of the National Heart, Lung, and Blood Institute of the NIH",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nhlbi.nih.gov/chd\">",
"      www.nhlbi.nih.gov/chd",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Heart Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.americanheart.org/\">",
"      www.americanheart.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Hormone Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.hormone.org/public/other.cfm\">",
"      www.hormone.org/public/other.cfm",
"     </a>",
"     , available in English, Spanish, and Portuguese)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Framingham Heart Study",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.framingham.com/heart/\">",
"      www.framingham.com/heart/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?42/6/43108/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 11, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?42/6/43108?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43108/abstract/1\">",
"      Gardner CD, Lawson LD, Block E, et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med 2007; 167:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43108/abstract/2\">",
"      Fedder DO, Koro CE, L'Italien GJ. New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population. Circulation 2002; 105:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43108/abstract/3\">",
"      Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110:227.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f42_6_43108=[""].join("\n");
var outline_f42_6_43108=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHO NEEDS TREATMENT FOR HIGH CHOLESTEROL?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           HIGH CHOLESTEROL TREATMENT OPTIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           STICKING WITH TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H23\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/50/43819\" title=\"table 1\">",
"           Lipid lowering tx PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        CALCULATORS",
"       </h1>",
"       <div id=\"relatedCalculators\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/19/15679?source=related_link\" title=\"calculator 1\">",
"           Calculator: 10 year risk of developing cardiovascular disease in women (Patient information)",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a class=\"calc calc_patient\" href=\"mobipreview.htm?15/14/15599?source=related_link\" title=\"calculator 2\">",
"           Calculator: 10 year risk of developing cardiovascular disease in men (Patient information)",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f42_6_43109="Trichuriasis life cycle";
var content_f42_6_43109=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 514px\">",
"   <div class=\"ttl\">",
"    Trichuriasis life cycle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 494px; height: 494px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The unembryonated eggs are passed with the stool",
"    <strong>",
"     (1)",
"    </strong>",
"    . In the soil, the eggs develop into a two-cell stage",
"    <strong>",
"     (2)",
"    </strong>",
"    , an advanced cleavage stage",
"    <strong>",
"     (3)",
"    </strong>",
"    , and then they embryonate",
"    <strong>",
"     (4)",
"    </strong>",
"    ; eggs become infective in 15 to 30 days. After ingestion (soil-contaminated hands or food), the eggs hatch in the small intestine, and release larvae",
"    <strong>",
"     (5)",
"    </strong>",
"    that mature and establish themselves as adults in the colon",
"    <strong>",
"     (6)",
"    </strong>",
"    . The adult worms (approximately 4 cm in length) live in the cecum and ascending colon. The adult worms are fixed in that location, with the anterior portions threaded into the mucosa. The females begin to oviposit 60 to 70 days after infection. Female worms in the cecum shed between 3000 and 20,000 eggs per day. The life span of the adults is about one year.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Trichuriasis. Available at:",
"     <a href=\"file://dpd.cdc.gov/dpdx/html/Trichuriasis.htm\" target=\"_blank\">",
"      file://dpd.cdc.gov/dpdx/html/Trichuriasis.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43109=[""].join("\n");
var outline_f42_6_43109=null;
var title_f42_6_43110="Bronchogenic cyst low";
var content_f42_6_43110=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bronchogenic cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph of a bronchogenic cyst shows a lining of bronchiolar epithelium (arrow) and thick fasicles of smooth muscle in the wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Colby, TV, Koss, MN, Travis, WD. Tumors of the Lower Respiratory Tract. Armed Forces Institute of Pathology, Washington, DC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43110=[""].join("\n");
var outline_f42_6_43110=null;
var title_f42_6_43111="Tamoxifen: Pediatric drug information";
var content_f42_6_43111=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tamoxifen: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"    see \"Tamoxifen: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/28/5574?source=see_link\">",
"    see \"Tamoxifen: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F15512098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Soltamox&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F224658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Tamox&reg;;",
"     </li>",
"     <li>",
"      Mylan-Tamoxifen;",
"     </li>",
"     <li>",
"      Nolvadex&reg;-D;",
"     </li>",
"     <li>",
"      PMS-Tamoxifen;",
"     </li>",
"     <li>",
"      Teva-Tamoxifen",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1037302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Estrogen Receptor Antagonist",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1037340\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"      see \"Tamoxifen: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children 2-10 years:",
"     <b>",
"      McCune-Albright syndrome; precocious puberty:",
"     </b>",
"     Limited data available: Oral: 20 mg once daily; dosing based on a trial of 25 girls &le;10 years of age (range: 2.9-10.9 years) who received treatment for 1 year; frequency of vaginal bleeding episodes were decreased; growth velocity was significantly decreased prior to pretreatment rates as was skeletal maturation; ovarian and uterine volumes were increased; further studies are needed (Eugester, 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"     <b>",
"      Note:",
"     </b>",
"     For the treatment of breast cancer, patients receiving both tamoxifen and chemotherapy should receive treatment sequentially, with tamoxifen following completion of chemotherapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Breast cancer treatment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Adjuvant therapy (females):",
"     </i>",
"     20 mg once daily for 5 years",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Metastatic (males and females):",
"     </i>",
"     20-40 mg/day (doses &gt;20 mg should be given in 2 divided doses).",
"     <b>",
"      Note:",
"     </b>",
"     Although the FDA-approved labeling recommends dosing up to 40 mg/day, clinical benefit has not been demonstrated with doses above 20 mg/day (Bratherton, 1984).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Premenopausal women: Duration of treatment is 5 years (NCCN Breast Cancer guidelines v.1.2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Postmenopausal women: Duration of tamoxifen treatment is 2-3 years followed by an aromatase inhibitor (AI) to complete 5 years; if contraindications or intolerant to AI, may take tamoxifen for the full 5 years",
"     <b>",
"      or",
"     </b>",
"     extended therapy: 4.5-6 years of tamoxifen followed by 5 years of an AI (NCCN Breast Cancer guidelines v.1.2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      DCIS (females), to reduce the risk for invasive breast cancer:",
"     </i>",
"     20 mg once daily for 5 years",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Breast cancer risk reduction (pre- and postmenopausal high-risk females):",
"     </b>",
"     20 mg once daily for 5 years",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     There are no dosage adjustments provided in the manufacturer&rsquo;s labeling (not studied).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     There are no dosage adjustments provided in the manufacturer&rsquo;s labeling; the effect of hepatic dysfunction on tamoxifen pharmacokinetics has not been determined.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F224631\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Soltamox&trade;: 10 mg/5 mL (150 mL) [sugar free; contains ethanol, propylene glycol; licorice flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 10 mg, 20 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F224614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication when used in females for breast cancer prevention or treatment of ductal carcinoma",
"     <i>",
"      in situ",
"     </i>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Nolvadex&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F5205195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     . Administer tablets or oral solution with or without food; use supplied dosing cup for oral solution.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1037328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral solution: Store at &le;25&deg;C (77&deg;F); do not freeze or refrigerate. Protect from light. Discard opened bottle after 3 months.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablets: Store at  20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); avoid excessive heat &gt;40&deg;C (&gt;104&deg;F). Protect from light.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1037303\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of metastatic (female and male) breast cancer; adjuvant treatment of breast cancer after primary treatment with surgery and radiation; reduce risk of invasive breast cancer in women with ductal carcinoma",
"     <i>",
"      in situ",
"     </i>",
"     (DCIS) after surgery and radiation; reduce the incidence of breast cancer in women at high risk (all indications: FDA approved in adults); has also been used in treatment of McCune-Albright Syndrome (MAS) in girls associated with precocious puberty",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F224713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Tamoxifen may be confused with pentoxifylline, Tambocor&trade;, tamsulosin, temazepam",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F224710\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Angina, cardiovascular ischemia, chest pain, deep venous thrombus, edema, flushing, hypertension, MI, peripheral edema, vasodilation, venous thrombotic events",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety, depression, dizziness, fatigue, headache, insomnia, mood changes, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, rash, skin changes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Altered menses, amenorrhea, breast neoplasm, breast pain, fluid retention, hot flashes, hypercholesterolemia, menstrual disorder, oligomenorrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, abdominal pain, anorexia, constipation, diarrhea, dyspepsia, nausea, throat irritation (oral solution), vomiting, weight gain/loss",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Leukorrhea, ovarian cyst, urinary tract infection, vaginal bleeding, vaginal discharge, vaginal hemorrhage, vaginitis, vulvovaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: AST increased, serum bilirubin increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, arthritis, arthrosis, back pain, bone pain, fracture, joint disorder, musculoskeletal pain, myalgia, osteoporosis, paresthesia, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Cataract",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Serum creatinine increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchitis, cough, dyspnea, pharyngitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction, cyst, diaphoresis, flu-like syndrome, infection/sepsis, lymphedema, neoplasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Angioedema, bullous pemphigoid, cholestasis, corneal changes, endometrial cancer, endometrial hyperplasia, endometrial polyps, endometriosis, erythema multiforme, fatty liver, hepatic necrosis, hepatitis, hypercalcemia, hyperlipidemia, hypersensitivity reactions, hypertriglyceridemia, impotence (males), interstitial pneumonitis, loss of libido (males), pancreatitis, phlebitis, pruritus vulvae, pulmonary embolism, retinal vein thrombosis, retinopathy, second primary tumors, Stevens-Johnson syndrome, stroke, ; tumor pain and local disease flare (including increase in lesion size and erythema) during treatment of metastatic breast cancer (generally resolves with continuation); uterine fibroids, vaginal dryness, visual color perception changes",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1037310\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to tamoxifen or any component; concurrent warfarin therapy or history of deep vein thrombosis or pulmonary embolism (when tamoxifen is used for cancer risk reduction in women at high risk for breast cancer and in women with DCIS)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F15952507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hyperlipidemia; infrequent postmarketing cases of hyperlipidemias have been reported. Use with caution in patient with metastatic breast cancer; local disease flare and increased bone and tumor pain may occur; may be associated with (good) tumor response; onset is shortly after therapy initiation and usually resolves rapidly. In patients with bone metastasis, hypercalcemia has occurred, usually within a few weeks of therapy initiation; monitor and institute appropriate hypercalcemia management; discontinue if severe.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use with caution with concomitant drug therapy affecting CYP and Pgp metabolic pathways; tamoxifen  is associated  with a high potential for drug interactions; decreased efficacy and an increased risk of breast cancer recurrence has been reported with concurrent moderate or strong CYP2D6 inhibitors (Aubert, 2009; Dezentje, 2009). Concomitant use with select SSRIs may result in decreased tamoxifen efficacy. Strong CYP2D6 inhibitors (eg, fluoxetine, paroxetine) and moderate CYP2D6 inhibitors (eg, sertraline) are reported to interfere with transformation to the active metabolite endoxifen. Weak CYP2D6 inhibitors (eg, venlafaxine, citalopram) have minimal effect on the conversion to endoxifen (Jin, 2005; NCCN Breast Cancer Risk Reduction Guidelines v.2.2010); escitalopram is also a weak CYP2D6 inhibitor. In a retrospective analysis of breast cancer patients taking tamoxifen and SSRIs, concomitant use of paroxetine and tamoxifen was associated with an increased risk of death due to breast cancer (Kelly, 2010). Lower plasma concentrations of endoxifen (active metabolite) have been observed in patients associated with reduced CYP2D6 activity (Jin, 2005) and may be associated with reduced efficacy.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1037311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     . Tamoxifen use for breast cancer risk reduction in women at high risk for breast cancer and in women with DCIS is associated with an increased incidence of uterine or endometrial cancers",
"     <b>",
"      [U. S. Boxed Warning]",
"     </b>",
"     ; endometrial hyperplasia, polyps, endometriosis, uterine fibroids, and ovarian cysts have occurred; amenorrhea and menstrual irregularities have been reported with tamoxifen use; monitor and promptly evaluate any report of abnormal vaginal bleeding.  In a year-long clinical trial of girls (2-10 years) with McCune-Albright syndrome (MAS) associated with precocious puberty, mean uterine volumes were increased after 6 months of therapy, and by study completion had doubled in volume; a causal relationship has not been determined; long-term effects of tamoxifen in this population have not been established; pelvic ultrasound monitoring is recommended (Eugester, 2003).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;display:inline\">",
"     Serious and life-threatening thromboembolic events, including stroke and pulmonary emboli have occurred at an incidence greater than placebo during use for breast cancer risk reduction in women at high risk for breast cancer and in women with DCIS",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; these events are rare, but require consideration in risk:benefit evaluation. In patients already diagnosed with breast cancer, the benefits of tamoxifen use are greater than the risks. An increased incidence of thromboembolic events has been associated with use; risk is increased with concomitant chemotherapy; use with caution in individuals with a history of thromboembolic events.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;display:inline\">",
"     Tamoxifen use may be associated with changes in bone mineral density (BMD) and the effects may be dependent upon menstrual status; in postmenopausal women, tamoxifen use is associated with a protective effect on bone mineral density (BMD), preventing loss of BMD which lasts over the 5-year treatment period. In premenopausal women, a decline (from baseline) in BMD mineral density has been observed in women who continued to menstruate; this may be associated with an increased risk of fractures.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;display:inline\">",
"     Liver abnormalities such as cholestasis, fatty liver, hepatitis, and hepatic necrosis have occurred; hepatocellular carcinomas have been reported in some studies; relationship to treatment is unclear. Thrombocytopenia and/or leukopenia may occur; neutropenia and pancytopenia have been reported rarely; hemorrhagic episodes have occurred in patients with significant thrombocytopenia. Decreased visual acuity, retinal vein thrombosis, retinopathy, corneal changes, color perception changes, and increased incidence of cataracts along with the need for cataract surgery have been reported.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F1037322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2A6 (minor), 2B6 (minor), 2C8/9 (major), 2D6 (major), 2E1 (minor), 3A4 (major);",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2B6 (weak), 2C8/9 (weak), 3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F224623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP2D6 Substrates. Management: Avoid concurrent use of abiraterone with CYP2D6 substrates that have a narrow therapeutic index whenever possible.  When concurrent use is not avoidable, monitor patients closely for signs/symptoms of toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglutethimide: May increase the metabolism of Tamoxifen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anastrozole: Tamoxifen may decrease the serum concentration of Anastrozole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bexarotene (Systemic): May decrease the serum concentration of Tamoxifen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Colchicine. Colchicine distribution into certain tissues (e.g., brain) may also be increased.  Management: Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a p-glycoprotein inhibitor.  In those with normal renal and hepatic function, reduce colchicine dose as directed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Substrates: CYP2C8 Inhibitors (Moderate) may decrease the metabolism of CYP2C8 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inducers (Strong): May increase the metabolism of CYP2C9 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Moderate): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Strong): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Moderate): May decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites. Management: Consider alternatives with less of an inhibitory effect on CYP2D6 activity when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Inhibitors (Strong): May decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, strong CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: P-glycoprotein/ABCB1 Inhibitors may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate.  Management: Dabigatran dose reductions may be needed.  Specific recommendations vary considerably according to US vs Canadian labeling, specific P-gp inhibitor, renal function, and indication for dabigatran treatment.  Refer to full monograph or dabigatran labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: May increase the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Letrozole: Tamoxifen may decrease the serum concentration of Letrozole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP2C9 Substrates. Management: Use CYP2C9 substrates at the lowest recommended dose, and monitor closely for adverse effects, during and in the 2 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mipomersen: Tamoxifen may enhance the hepatotoxic effect of Mipomersen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ospemifene: Selective Estrogen Receptor Modulators may enhance the adverse/toxic effect of Ospemifene. Ospemifene may also enhance adverse/toxic effects of other Selective Estrogen Receptor Modulators. Selective Estrogen Receptor Modulators may diminish the therapeutic effect of Ospemifene. Ospemifene may also diminish the therapeutic effects of other Selective Estrogen Receptor Modulators.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Substrates: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prucalopride: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Prucalopride.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Tamoxifen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Rivaroxaban.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Silodosin: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Silodosin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topotecan: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Topotecan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     VinCRIStine (Liposomal): P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of VinCRIStine (Liposomal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Tamoxifen may increase the serum concentration of Vitamin K Antagonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1037325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Grapefruit juice may decrease the metabolism of tamoxifen; avoid grapefruit juice.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F224626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F224641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have demonstrated fetal adverse effects and fetal loss. There have been reports of vaginal bleeding, birth defects and fetal loss in pregnant women. Tamoxifen use during pregnancy may have a potential long term risk to the fetus of a DES-like syndrome. For sexually-active women of childbearing age, initiate during menstruation (negative &beta;-hCG immediately prior to initiation in women with irregular cycles). Tamoxifen may induce ovulation. Barrier or nonhormonal contraceptives are recommended. Pregnancy should be avoided during treatment and for 2 months after treatment has been discontinued.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1037345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with platelets, serum calcium, LFTs; triglycerides and cholesterol (in patients with pre-existing hyperlipidemias); INR and PT (in patients on vitamin K antagonists); abnormal vaginal bleeding; breast and gynecologic exams (baseline and routine), mammogram (baseline and routine); signs/symptoms of DVT (leg swelling, tenderness) or PE (shortness of breath); ophthalmic exam (if vision problem or cataracts); bone mineral density (premenopausal women)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     McCune-Albright syndrome: In the pediatric clinical trial (study duration: 12 months), the following were monitored: Serum estradiol, estrone, DHEAS, LH, FSH, and IGF-1 (baseline, and at 6 and 12 months of therapy); liver function test (baseline and at 3, 6, and 12 months of therapy); CBC and INR at baseline; assessments of puberty status and growth at baseline and periodically during therapy (6 and 12 months): Height, weight, Tanner stage, bone age (radiographs), vaginal bleeding data, and  pelvic ultrasounds (Eugester, 2003)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1037330\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competitively binds to estrogen receptors on tumors and other tissue targets, producing a nuclear complex that decreases DNA synthesis and inhibits estrogen effects; nonsteroidal agent with potent antiestrogenic properties which compete with estrogen for binding sites in breast and other tissues; cells accumulate in the G",
"     <sub>",
"      0",
"     </sub>",
"     and G",
"     <sub>",
"      1",
"     </sub>",
"     phases; therefore, tamoxifen is cytostatic rather than cytocidal.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1037332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: High concentrations found in uterus, endometrial, and breast tissue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic; via CYP2D6 to 4-hydroxytamoxifen and via CYP3A4/5 to N-desmethyl-tamoxifen. Each is then further metabolized into endoxifen (4-hydroxy-tamoxifen via CYP3A4/5 and N-desmethyl-tamoxifen via CYP2D6); both 4-hydroxy-tamoxifen and endoxifen are 30- to 100-fold more potent than tamoxifen.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Tamoxifen: ~5-7 days; N-desmethyl tamoxifen: ~14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum concentrations:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 2-10 years (female): ~8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: ~5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Feces (26% to 51%); urine (9% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance: Higher (~2.3 fold) in female pediatric patients (2-10 years) compared to adult breast cancer patients; within pediatric population, clearance faster in children 2-6 years compared to older children",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1037349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/28/5574?source=see_link\">",
"      see \"Tamoxifen: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Read the Medication Guide received. May cause hot flashes, hair loss, or loss of libido in adults; these will subside when treatment is completed. May cause nausea, vomiting, and increased blood pressure. Notify prescriber if menstrual irregularities, vaginal bleeding, or intolerable hot flashes occur. Report unusual bleeding or bruising, severe weakness or unusual fatigue, CNS changes (depression, mood changes), persistent bone changes, changes in strength on one side of the body, chest pain or pressure, swelling or pain in calves, respiratory difficulty, or vision changes. Annual ophthalmic examinations and periodic monitoring of liver function may be necessary with treatment.",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F12807819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent: Use appropriate precautions for handling and disposal.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     A 0.5 mg/mL oral suspension may be prepared with tablets. Place two 10 mg tablets into 40 mL purified water and let stand ~2-5 minutes. Stir until tablets are completely disintegrated (dispersion time for each 10 mg tablet is ~2-5 minutes). Administer immediately after preparation. To ensure the full dose is administered, rinse glass several times with water and administer residue.",
"    </p>",
"    <div class=\"reference\">",
"     Lam MS, \"Extemporaneous Compounding of Oral Liquid Dosage Formulations and Alternative Drug Delivery Methods for Anticancer Drugs,\"",
"     <i>",
"      Pharmacotherapy",
"     </i>",
"     , 2011, 31(2):164-92.",
"     <span class=\"pubmed-id\">",
"      21275495",
"     </span>",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aubert RE, Stanek EJ, Yao J, et al, &ldquo;Risk of Breast Cancer Recurrence in Women Initiating Tamoxifen With CYP2D6 Inhibitors,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2009, 27(18S):CRA508 [abstract CRA508 from 2009 ASCO Annual Meeting].",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bratherton DG, Brown CH, Buchanan R, et al, \"A Comparison of Two Doses of Tamoxifen (Nolvadex) in Postmenopausal Women With Advanced Breast Cancer: 10 mg bd Versus 20 mg bd,\"",
"      <i>",
"       Br J Cancer",
"      </i>",
"      , 1984, 50(2):199-205.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/6380554/pubmed\" id=\"6380554\" target=\"_blank\">",
"        6380554",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dezentje V, Van Blijderveen NJ, Gelderblom H, et al, &ldquo;Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence in Early-Stage Breast Cancer: A Pharmacoepidemiologic Study,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2009, 27(18S):CRA509 [abstract CRA509 from 2009 ASCO Annual Meeting].",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Early Breast Cancer Trialists' Collaborative Group (EBCTCG), &ldquo;Effects of Chemotherapy and Hormonal Therapy for Early Breast Cancer on Recurrence and 15-Year Survival: An Overview of the Randomised Trials,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2005, 365(9472):1687-717.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/15894097/pubmed\" id=\"15894097\" target=\"_blank\">",
"        15894097",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eastell R, Adams JE, Coleman RE, et al, &ldquo;Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2008, 26(7):1051-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/18309940/pubmed\" id=\"18309940\" target=\"_blank\">",
"        18309940",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eugster EA, Rubin SD, Reiter EO, et al, &ldquo;Tamoxifen Treatment for Precocious Puberty in McCune-Albright Syndrome: A Multicenter Trial,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2003, 143(1):60-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/12915825/pubmed\" id=\"12915825\" target=\"_blank\">",
"        12915825",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goetz MP, Kamal A, and Ames MM, &ldquo;Tamoxifen Pharmacogenomics: The Role of CYP2D6 as a Predictor of Drug Response,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 2008, 83(1):160-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/17882159/pubmed\" id=\"17882159\" target=\"_blank\">",
"        17882159",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jin Y, Desta Z, Stearns V, et al, &ldquo;CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment,&rdquo;",
"      <i>",
"       J Natl Cancer Inst",
"      </i>",
"      , 2005, 97(1):30-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/15632378/pubmed\" id=\"15632378\" target=\"_blank\">",
"        15632378",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kelly CM, Juurlink DN, Gomes T, et al, &ldquo;Selective Serotonin Reuptake Inhibitors and Breast Cancer Mortality in Women Receiving Tamoxifen: A Population Based Cohort Study,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 2010, 340:c693.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/20142325/pubmed\" id=\"20142325\" target=\"_blank\">",
"        20142325",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Comprehensive Cancer Network&reg; (NCCN), &ldquo;Clinical Practice Guidelines in Oncology&trade;: Breast Cancer,&rdquo; Version 1.2011. Available at  file://www.nccn.org/professionals/physician_gls/PDF/breast.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Comprehensive Cancer Network&reg; (NCCN), &ldquo;Clinical Practice Guidelines in Oncology&trade;: Breast Cancer Risk Reduction, Version 2.2010.&rdquo; Available at file://www.nccn.org/professionals/physician_gls/PDF/breast_risk.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Comprehensive Cancer Network&reg; (NCCN), &ldquo;Clinical Practice Guidelines in Oncology&trade;: Ovarian Cancer,&rdquo; Version 2.2011. Available at file://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Comprehensive Cancer Network&reg; (NCCN), &ldquo;Clinical Practice Guidelines in Oncology&trade;: Uterine Neoplasms,&rdquo; Version 1.2011. Available at file://www.nccn.org/professionals/physician_gls/PDF/uterine.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sideras K, Ingle JN, Ames MM, et al, &ldquo;Coprescription of Tamoxifen and Medications That Inhibit CYP2D6,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2010, 28(16):2768-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/20439629/pubmed\" id=\"20439629\" target=\"_blank\">",
"        20439629",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vehmanen L, Elomaa I, Blomqvist C, et al, &ldquo;Tamoxifen Treatment After Adjuvant Chemotherapy Has Opposite Effects on Bone Mineral Density in Premenopausal Patients Depending on Menstrual Status,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2006, 24(4):675-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/16446340/pubmed\" id=\"16446340\" target=\"_blank\">",
"        16446340",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Visvanathan K, Chlebowski RT, Hurley P, et al, &ldquo;American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2009, 27(19):3235-58.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/6/43111/abstract-text/19470930/pubmed\" id=\"19470930\" target=\"_blank\">",
"        19470930",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 87811 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-62FEFCC119-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43111=[""].join("\n");
var outline_f42_6_43111=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709103\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15512098\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F224658\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037302\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037340\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F224631\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F224614\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874993\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5205195\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037328\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037303\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F224713\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F224710\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037310\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15952507\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037311\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037322\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F224623\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037325\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F224626\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F224641\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037345\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037330\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037332\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1037349\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12807819\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/87811\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/87811|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=related_link\">",
"      Tamoxifen: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/28/5574?source=related_link\">",
"      Tamoxifen: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_6_43112="Pathogenesis and clinical manifestations of disseminated histoplasmosis";
var content_f42_6_43112=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and clinical manifestations of disseminated histoplasmosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/6/43112/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43112/contributors\">",
"     Joseph Wheat, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43112/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/6/43112/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43112/contributors\">",
"     Kieren A Marr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/6/43112/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43112/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/6/43112/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histoplasmosis is the most prevalent endemic mycosis in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/1\">",
"     1",
"    </a>",
"    ]. While most infections are asymptomatic or self-limited, some individuals develop acute pulmonary infections or severe and progressive disseminated infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Progressive disseminated histoplasmosis occurs in about one in 2000 patients with acute infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2,5,6\">",
"     2,5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although hematogenous dissemination probably occurs in most patients during the acute infection before cellular immunity develops, progressive illness is unusual except in the host with altered immunity and those at the extremes of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2,3,6\">",
"     2,3,6",
"    </a>",
"    ]. The diagnosis of disseminated histoplasmosis requires a high index of suspicion, recognition of the common modes of presentation, and familiarity with the appropriate diagnostic tests.",
"   </p>",
"   <p>",
"    The pathogenesis of disseminated histoplasmosis, risk factors for dissemination, and clinical features of the infection will be reviewed here. The diagnosis and treatment of this infection and the manifestations of localized pulmonary histoplasmosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/6/9321?source=see_link\">",
"     \"Diagnosis and treatment of disseminated histoplasmosis in non-HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/24/42376?source=see_link\">",
"     \"Pathogenesis and clinical features of pulmonary histoplasmosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histoplasma capsulatum is a thermally dimorphic fungus, growing as a mold in the environment and as a yeast at 37&ordm;C. Infection develops when Histoplasma microconidia are inhaled into the lungs, where they change into the yeast form. Neutrophils, macrophages, lymphocytes, and natural killer (NK) cells are attracted in response to the infection. As in tuberculosis, macrophages assist in spreading the organism via lymphatics and the blood to the adjacent lymph nodes and throughout the reticuloendothelial system (liver, spleen, lymph nodes, adrenal glands, and bone marrow).",
"   </p>",
"   <p>",
"    In patients with progressive disseminated infection, macrophages are typically engorged with yeasts, supporting the important role of intracellular proliferation of the organism. Organisms are confined to macrophages, but less commonly can be seen within the tissue spaces. The organisms can occasionally be seen in peripheral white blood cells in patients with disseminated infection (",
"    <a class=\"graphic graphic_picture graphicRef57613 \" href=\"mobipreview.htm?7/22/7523\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    T cell immunity plays the predominant role in recovery from histoplasmosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/7\">",
"     7",
"    </a>",
"    ]. Once cellular immunity to Histoplasma develops, macrophages become activated to kill the organism. Cytokines including interleukin (IL)-12 and interferon-gamma (IFN-gamma) arm macrophages to kill the fungus and halt progression of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Failure to activate macrophage fungicidal capacity appears to be the key defect in immunity to H. capsulatum in patients with progressive disseminated histoplasmosis. In one study in mice with severe combined immunodeficiency, exogenous IL-12 increased IFN-gamma, tumor necrosis factor (TNF)-alpha, and nitric oxide production in splenocytes and resulted in decreased colony counts of H. capsulatum and increased survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/8\">",
"     8",
"    </a>",
"    ]. Antibody to IFN-gamma eliminated the protective effect of IL-12 in this model. The important role of TNF-alpha and IFN-gamma in patients with histoplasmosis is substantiated by the occurrence of severe disease in those receiving TNF inhibitor therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/10\">",
"     10",
"    </a>",
"    ], and in hosts with IFN-gamma receptor deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These defense mechanisms are generally sufficient to control the infection in immunocompetent individuals, explaining the subclinical or self-limited course characteristic of acute histoplasmosis. Individuals with underlying conditions, such as AIDS, that impair these defenses are at risk for developing more severe, and often fatal, progressive forms of infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Reinfection and reactivation of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reinfection can occur in patients who previously had documented histoplasmosis. In persons with impaired immunity and in those who have a massive reexposure to H. capsulatum, host defenses against this organism can be overwhelmed and disease can recur.",
"   </p>",
"   <p>",
"    Reactivation of latent histoplasmosis can also occur in immunocompromised patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/6,12\">",
"     6,12",
"    </a>",
"    ]. Presumably, viable organisms persist in the tissues following recovery from the initial episode of histoplasmosis. Development of disseminated histoplasmosis in individuals who left the endemic area years before is thought to be caused by reactivation of these quiescent foci. The finding of a mitochondrial DNA pattern characteristic of Panamanian strains of H. capsulatum in five Puerto Rican immigrants to New York City provided convincing evidence for reactivation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/13\">",
"     13",
"    </a>",
"    ]. However, reinfection caused by exposure to isolated microfoci contaminated with H. capsulatum outside the endemic area cannot be excluded in many cases.",
"   </p>",
"   <p>",
"    Cases of progressive pulmonary or disseminated histoplasmosis occurring shortly after initiation of immunosuppressive therapy with TNF inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/10,14,15\">",
"     10,14,15",
"    </a>",
"    ] could represent worsening of smoldering infection exacerbated by recently intensified immunosuppression, or newly acquired infection as well as reactivation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32538?source=see_link&amp;anchor=H17#H17\">",
"     \"Tumor necrosis factor-alpha inhibitors: Risk of bacterial, viral, and fungal infections\", section on 'Histoplasmosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three types of tissue response have been described in disseminated histoplasmosis: diffuse histiocytosis, focal histiocytosis, and tuberculoid granulomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ]. Histiocytosis refers to macrophage infiltration into the infected tissues. In comparison, infiltration of neutrophils, lymphocytes, and plasma cells are not usually noted in the tissues of patients with progressive disseminated histoplasmosis. Granulomas are less common with disseminated infection than with other types of histoplasmosis, and usually are seen in patients with lower fungal burdens (",
"    <a class=\"graphic graphic_picture graphicRef56193 \" href=\"mobipreview.htm?2/23/2419\">",
"     picture 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ]. Heavy infections may cause marked enlargement of the involved organs (liver, spleen, adrenal glands, lymph nodes), occasionally displacing normal parenchymal cells and causing organ dysfunction.",
"   </p>",
"   <p>",
"    At autopsy, many patients with disseminated histoplasmosis demonstrate involvement of the liver, spleen, lymph nodes, bone marrow, adrenal glands, and gastrointestinal tract mucosa; of those undergoing examination of the brain or meninges, two-thirds demonstrate central nervous system (CNS) involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ]. Since autopsy experience may be biased toward the severe end of the disease spectrum, these tissues are probably less commonly involved in milder cases. Perivasculitis with necrosis is seen histopathologically in patients with more severe involvement of the meninges and adrenal glands.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with disseminated histoplasmosis have underlying conditions that impair their ability to defend against intracellular pathogens. A variety of conditions have been found to predispose to disseminated histoplasmosis, including [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/5,6,16,17\">",
"     5,6,16,17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      AIDS",
"     </li>",
"     <li>",
"      Primary immunodeficiency or other immunosuppressive disorders",
"     </li>",
"     <li>",
"      Immunosuppressive medications, such as glucocorticoids, antirejection therapies in solid organ transplant recipients, or TNF-alpha inhibitor therapies",
"     </li>",
"     <li>",
"      Extremes of age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A separate group of patients, most of whom are middle-aged to older men, have chronic progressive disseminated histoplasmosis and have no known underlying immunosuppression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ]. In these patients, unidentified defects in cellular immunity likely explain their inability to control the infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Transplant recipients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solid organ transplantation is a risk factor for disseminated histoplasmosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/18\">",
"     18",
"    </a>",
"    ]. Infection in solid organ transplant recipients can occur as a new infection by inhalation of conidia, or by reactivation of quiescent disease. Infection can also be transmitted from the transplant donor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. This was illustrated in a report of two kidney transplant recipients who developed disseminated histoplasmosis eight and nine months after transplantation. The recipients lived in different states from one another, neither of which were endemic regions, had never traveled to endemic areas, and had no prior serological evidence of exposure to the fungus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/19\">",
"     19",
"    </a>",
"    ]. Both received cadaveric kidneys from the same donor who had serum antibody titers of 1:16 by complement fixation, and their isolates of H. capsulatum had identical patterns by both polymerase chain reaction and DNA analysis, reflecting transmission from the organs. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Reinfection and reactivation of infection'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/47/29433?source=see_link&amp;anchor=H8#H8\">",
"     \"Infection in the solid organ transplant recipient\", section on 'Donor-derived infections'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Histoplasmosis appears to be very rare among hematopoietic stem cell transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/21-23\">",
"     21-23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Anti-TNF-alpha therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anti-TNF-alpha therapies (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/24/39303?source=see_link\">",
"     adalimumab",
"    </a>",
"    ) are an increasingly reported cause of disseminated histoplasmosis in patients with rheumatoid arthritis or inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/10,14,24\">",
"     10,14,24",
"    </a>",
"    ]. The onset of clinical symptoms may differ depending upon the therapy used. Cases typically occur earlier after the initiation of therapy with infliximab and later following initiation of etanercept therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32538?source=see_link&amp;anchor=H17#H17\">",
"     \"Tumor necrosis factor-alpha inhibitors: Risk of bacterial, viral, and fungal infections\", section on 'Histoplasmosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV infection is a significant risk factor for disseminated histoplasmosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective study of 72 HIV-infected patients with histoplasmosis in Europe, 88 percent had disseminated disease at presentation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/25\">",
"       25",
"      </a>",
"      ]. Furthermore, disseminated disease was the AIDS-presenting illness in 61 percent. Pulmonary infiltrates occurred in more than half of the cases. The vast majority of patients acquired their infection from travel to endemic areas.",
"     </li>",
"     <li>",
"      A retrospective review of 155 HIV-infected patients with histoplasmosis revealed 28 cases of severe disease; 53 percent had disseminated infection only, and 41 percent had pulmonary as well as disseminated infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/26\">",
"       26",
"      </a>",
"      ]. Serum creatinine concentration &gt;2.1",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      and albumin &lt;3.5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      were significant risk factors for severe disease by multivariate analysis;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"       zidovudine",
"      </a>",
"      administration was associated with a decreased risk.",
"     </li>",
"     <li>",
"      A retrospective study of histoplasmosis in 200 HIV-infected patients from French Guiana demonstrated that more than one-third of patients at clinical presentation also had evidence of other major concurrent opportunistic infections, such as tuberculosis, candida esophagitis, herpes simplex, toxoplasmosis, and Pneumocystis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Risk of disease in HIV-infected patients has declined with effective antiretroviral therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33450?source=see_link\">",
"     \"Primary prevention of opportunistic infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3054577\">",
"    <span class=\"h2\">",
"     Cellular immunodeficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients without known underlying risk factors, careful immunologic investigation of cellular immunity should be considered, especially if disease relapses. The testing should include T cell subset quantitation and HIV antibody assays. In vitro tests of lymphocyte proliferative responses and induced interferon-gamma responses to H. capsulatum antigens also can be measured in the research laboratory. Identification of new defects, such as those described in patients with abnormalities in cytokine pathways, will require specialized testing in laboratories that investigate cellular immune mechanisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of disseminated histoplasmosis as well as the timing of presentation vary based on host immunodeficiency and the degree of exposure to the fungus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Patients may present shortly after the exposure or years later and may experience asymptomatic periods interrupted by symptomatic relapses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ]. Progressive disseminated histoplasmosis occurs in two forms, partly based upon the time course of the illness and partly upon the extent of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute infection, which is mostly seen in infants and heavily immunocompromised hosts, including those treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/6\">",
"       6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Chronic infection is noted mostly in older adults and in men more often than women",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with chronic infection often present with pancytopenia, hepatosplenomegaly, hepatic enzyme elevation, and oropharyngeal or gastrointestinal lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ]. Other sites include the skin, brain, and adrenal glands (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70552 \" href=\"mobipreview.htm?16/46/17120\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82224 \" href=\"mobipreview.htm?39/10/40111\">",
"     image 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef50609 \" href=\"mobipreview.htm?1/46/1774\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Patients with acute infection present with fever, fatigue, hepatosplenomegaly, and pancytopenia. Diarrhea and dyspnea occur less commonly. Severely immunodeficient patients, such as those with AIDS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/6\">",
"     6",
"    </a>",
"    ] or those receiving treatment with immunosuppressive medications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ], can present with overwhelming infection manifested by shock, respiratory distress, hepatic and renal failure, obtundation, and coagulopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/6\">",
"     6",
"    </a>",
"    ]. The mortality in spite of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    treatment approaches 50 percent in such cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These manifestations were more common early in the course of the AIDS epidemic, prior to the wide recognition of the importance of histoplasmosis as a complication of AIDS and AIDS as a risk factor for histoplasmosis. In the post-HAART era, unusual manifestations of disseminated disease have been reported in severely immunosuppressed patients within three months of initiating antiretroviral therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/30\">",
"     30",
"    </a>",
"    ]. Atypical signs (eg, splenic infarction, ulcerative skin lesions) were attributed to the immune reconstitution inflammatory syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/35/23098?source=see_link\">",
"     \"Immune reconstitution inflammatory syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Gastrointestinal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 70 percent of patients with disseminated histoplasmosis have involvement of the gastrointestinal tract at autopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ]. Gastrointestinal manifestations are recognized clinically in less than 10 percent of cases, however [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/31\">",
"     31",
"    </a>",
"    ]. Lesions include ulcerations or polypoid masses, leading to misdiagnoses of colitis or malignancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. Lesions most often involve the colon or ileum, especially the ileocecal area, but may occur from the mouth to the anus. Mouth lesions are usually painful and may have heaped up borders, resembling malignancies.",
"   </p>",
"   <p>",
"    Other findings include esophageal pain or difficulty swallowing, abdominal pain, gastrointestinal bleeding, colonic perforation, and polypoid lesions resembling cancer (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69668 \" href=\"mobipreview.htm?28/14/28911\">",
"     image 3",
"    </a>",
"    ). Ulcerative lesions in the intestines may be mistakenly diagnosed as Crohn's disease or ulcerative colitis. Care must be taken to exclude histoplasmosis as the cause for ulcerative bowel disease before initiating immunosuppressive therapy, especially with TNF inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluation of patients with febrile illnesses accompanied by intestinal lesions should include tests to exclude histoplasmosis in persons from endemic areas or with history of possible exposure to H. capsulatum. Histologic examination reveals parasitized macrophages in the submucosa and lamina propria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Skin involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin lesions have been reported in 10 to 15 percent of cases of disseminated histoplasmosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/5\">",
"     5",
"    </a>",
"    ]. In series of histoplasmosis in persons with AIDS, skin lesions are seen much more frequently [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. The characteristic lesions include nodules, papules, plaques, ulcers, vesicles, pustules, abscesses, and generalized dermatitis (",
"    <a class=\"graphic graphic_picture graphicRef78902 \" href=\"mobipreview.htm?41/9/42132\">",
"     picture 3",
"    </a>",
"    ). Less common but recognized manifestations include exfoliative erythroderma, necrotizing vasculitis, cellulitis, panniculitis, petechiae, purpura, and ecchymoses.",
"   </p>",
"   <p>",
"    In two studies, stains for fungi performed on skin biopsy specimens revealed the organism in 86 to 100 percent of cases of HIV-associated disseminated histoplasmosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/5,36\">",
"     5,36",
"    </a>",
"    ]. Organisms may primarily be seen extracellularly, making it more difficult to suspect the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/37\">",
"     37",
"    </a>",
"    ]. Another problem is that the pathologic findings may resemble leukocytoclastic vasculitis, causing diagnostic errors in some cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/37\">",
"     37",
"    </a>",
"    ]. Granulomas are uncommon; more characteristic is the presence of an infiltrate composed of macrophages that are heavily parasitized with H. capsulatum. These lesions respond well to therapy, usually resolving within a few weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Adrenal involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal involvement is common (80 to 90 percent of autopsied cases), but overt adrenal insufficiency is found in less than 10 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ]. Adrenal involvement may be unilateral or bilateral (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82224 \" href=\"mobipreview.htm?39/10/40111\">",
"     image 2",
"    </a>",
"    ). The adrenal sinusoids may be diffusely involved, or focal collections of parasitized macrophages may be seen in the medulla, zona reticularis of the cortex, or corticomedullary junction.",
"   </p>",
"   <p>",
"    Perivasculitis may be a prominent feature, causing thrombosis and infarction of the adrenal gland and adrenal insufficiency. Thus, clinicians should exclude histoplasmosis in patients with adrenal masses or adrenal insufficiency, and should consider adrenal insufficiency in patients with disseminated histoplasmosis who present with electrolyte abnormalities, orthostatic hypotension, or hypoglycemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Central nervous system disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central nervous system involvement occurs in 5 to 20 percent of cases of disseminated histoplasmosis and is more common in those with underlying immunosuppressive disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/5,38\">",
"     5,38",
"    </a>",
"    ]. In one series, meningitis or brain lesions were found in two-thirds of cases undergoing CNS examination at autopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical presentations include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/38\">",
"     38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Meningitis plus other symptoms of disseminated histoplasmosis",
"     </li>",
"     <li>",
"      Isolated chronic meningitis",
"     </li>",
"     <li>",
"      Focal brain lesions",
"     </li>",
"     <li>",
"      Encephalitis",
"     </li>",
"     <li>",
"      Localized involvement of the spinal cord",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, histoplasmosis should be considered in the differential diagnosis of patients with chronic meningitis, focal brain or spinal cord lesions, and encephalitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare manifestations of disseminated histoplasmosis include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thrombotic microangiopathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hemophagocytic syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hypercalcemia due to calcitriol production by activated macrophages [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/42,43\">",
"       42,43",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/16/2310?source=see_link\">",
"       \"Hypercalcemia in granulomatous diseases\"",
"      </a>",
"      ). Hypercalcemia may lead to the incorrect diagnosis of sarcoidosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chorioretinitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/45\">",
"       45",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pleuritis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/46\">",
"       46",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pericarditis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/47\">",
"       47",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Endocarditis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/48-50\">",
"       48-50",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Peritonitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/51\">",
"       51",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pancreatitis and cholecystitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/52\">",
"       52",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Panniculitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/53\">",
"       53",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Mastitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/54\">",
"       54",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Osteomyelitis and septic arthritis of both native and prosthetic joints [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/55-57\">",
"       55-57",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Tenosynovitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/58\">",
"       58",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Prostatitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/59\">",
"       59",
"      </a>",
"      ], epididymitis, or involvement of the penis or vagina [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43112/abstract/60-62\">",
"       60-62",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/5/13393?source=see_link\">",
"       \"Patient information: Histoplasmosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30598196\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Histoplasmosis is the most prevalent endemic mycosis in the United States. While most infections are asymptomatic or self-limited, some individuals develop acute pulmonary infections or severe and progressive disseminated infection. Progressive illness is unusual except in the host with altered immunity and those at the extremes of age. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Histoplasma capsulatum is a thermally dimorphic fungus, growing as a mold in the environment and as a yeast at 37&ordm;C. Infection develops when Histoplasma microconidia are inhaled into the lungs, where they change into the yeast form. In patients with progressive disseminated infection, macrophages are typically engorged with yeasts, supporting the important role of intracellular proliferation of the organism. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      T cell immunity plays the predominant role in recovery from histoplasmosis. Once cellular immunity to Histoplasma develops, macrophages become activated to kill the organism. Failure to activate macrophage fungicidal capacity appears to be the key defect in immunity to H. capsulatum in patients with progressive disseminated histoplasmosis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reinfection can occur in patients who previously had documented histoplasmosis. In persons with impaired immunity or in those with massive exposure, reexposure to H. capsulatum can overcome residual host defenses against this organism. Reactivation of latent histoplasmosis can also occur in immunocompromised patients. Presumably, viable organisms persist in the tissues following recovery from the initial episode of histoplasmosis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Reinfection and reactivation of infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      At autopsy, most patients with disseminated histoplasmosis demonstrate involvement of the liver, spleen, lymph nodes, bone marrow, adrenal glands, and gastrointestinal tract mucosa; of those undergoing examination of the brain or meninges, two-thirds demonstrate central nervous system (CNS) involvement. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with disseminated histoplasmosis have underlying conditions that impair their ability to defend against intracellular pathogens. A variety of conditions have been found to predispose to disseminated histoplasmosis, including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      AIDS",
"     </li>",
"     <li>",
"      Primary immunodeficiency or other immunosuppressive disorders",
"     </li>",
"     <li>",
"      Immunosuppressive medications, such as glucocorticoids, antirejection therapies in solid organ transplant recipients, or TNF-alpha inhibitor therapies",
"     </li>",
"     <li>",
"      Extremes of age (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A separate group of patients, most of whom are middle-aged to older men, have chronic progressive disseminated histoplasmosis and have no known underlying immunosuppression. In these patients, unidentified defects in cellular immunity likely explain their inability to control the infection. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical manifestations of disseminated histoplasmosis as well as the timing of presentation vary based on host immunity and the degree of exposure to the fungus. Patients may present shortly after the exposure or years later and may experience asymptomatic periods interrupted by symptomatic relapses. Progressive disseminated histoplasmosis occurs in two forms, partly based upon the time course of the illness and partly upon the extent of infection:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Acute infection, which is mostly seen in infants and heavily immunocompromised hosts, including those treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"     </li>",
"     <li>",
"      Chronic infection, noted mostly in older adults and men more often than women (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical manifestations'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severely immunodeficient patients, such as those with AIDS or those receiving treatment with immunosuppressive medications, may present with overwhelming infection manifested by shock, respiratory distress, hepatic and renal failure, obtundation, and coagulopathy. The mortality in spite of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"       amphotericin B",
"      </a>",
"      treatment approaches 50 percent in such cases. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with chronic infection often present with pancytopenia, hepatosplenomegaly, hepatic enzyme elevation, and oropharyngeal lesions. Other sites include the skin, brain, and adrenal glands (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef70552 \" href=\"mobipreview.htm?16/46/17120\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef82224 \" href=\"mobipreview.htm?39/10/40111\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef50609 \" href=\"mobipreview.htm?1/46/1774\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/1\">",
"      Chu JH, Feudtner C, Heydon K, et al. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis 2006; 42:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/2\">",
"      Goodwin RA Jr, Shapiro JL, Thurman GH, et al. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 1980; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/3\">",
"      Sathapatayavongs B, Batteiger BE, Wheat J, et al. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 1983; 62:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/4\">",
"      Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 2007; 20:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/5\">",
"      Assi MA, Sandid MS, Baddour LM, et al. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) 2007; 86:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/6\">",
"      Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69:361.",
"     </a>",
"    </li>",
"    <li>",
"     Deepe GS Jr, Bullock WE. Histoplasmosis: a granulomatous inflammatory response. In: Basic Principals and Clinical Correlates, Gallin JI, Goldstein IM, Snyderman R (Eds), Raven, New York 1988. p.733.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/8\">",
"      Zhou P, Sieve MC, Tewari RP, Seder RA. Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum. Infect Immun 1997; 65:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/9\">",
"      Wu-Hsieh BA, Lee GS, Franco M, Hofman FM. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect Immun 1992; 60:4230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/10\">",
"      Wallis RS, Broder MS, Wong JY, et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/11\">",
"      Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005; 41:e38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/12\">",
"      Davies SF, Khan M, Sarosi GA. Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. Am J Med 1978; 64:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/13\">",
"      Keath EJ, Kobayashi GS, Medoff G. Typing of Histoplasma capsulatum by restriction fragment length polymorphisms in a nuclear gene. J Clin Microbiol 1992; 30:2104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/14\">",
"      Wood KL, Hage CA, Knox KS, et al. Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am J Respir Crit Care Med 2003; 167:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/15\">",
"      Hage CA, Bowyer S, Tarvin SE, et al. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010; 50:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/16\">",
"      Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med 1982; 96:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/17\">",
"      Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med 1993; 328:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/18\">",
"      Cuellar-Rodriguez J, Avery RK, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/19\">",
"      Limaye AP, Connolly PA, Sagar M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000; 343:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/20\">",
"      Botterel F, Romand S, Saliba F, et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis 1999; 18:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/21\">",
"      Peterson MW, Pratt AD, Nugent KM. Pneumonia due to Histoplasma capsulatum in a bone marrow transplant recipient. Thorax 1987; 42:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/22\">",
"      Walsh TJ, Catchatourian R, Cohen H. Disseminated histoplasmosis complicating bone marrow transplantation. Am J Clin Pathol 1983; 79:509.",
"     </a>",
"    </li>",
"    <li>",
"     Kauffman, CA. Endemic mycoses after hematopoietic stem cell or solid organ transplantation. In: Transplant Infections, 3rd edition, Bowden, R, Ljungman, P, Snydman, DR (Eds), Lippincott Williams and Wilkins, Philadelphia 2010. p.607.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/24\">",
"      Lee JH, Slifman NR, Gershon SK, et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 2002; 46:2565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/25\">",
"      Antinori S, Magni C, Nebuloni M, et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 2006; 85:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/26\">",
"      Wheat LJ, Chetchotisakd P, Williams B, et al. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 2000; 30:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/27\">",
"      Huber F, Nacher M, Aznar C, et al. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana. AIDS 2008; 22:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/28\">",
"      Hajjeh RA, Pappas PG, Henderson H, et al. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis 2001; 32:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/29\">",
"      Wheat J. Histoplasmosis in the acquired immunodeficiency syndrome. Curr Top Med Mycol 1996; 7:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/30\">",
"      Shelburne SA 3rd, Visnegarwala F, Adams C, et al. Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy. Am J Med 2005; 118:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/31\">",
"      Kahi CJ, Wheat LJ, Allen SD, Sarosi GA. Gastrointestinal histoplasmosis. Am J Gastroenterol 2005; 100:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/32\">",
"      Goulet CJ, Moseley RH, Tonnerre C, et al. Clinical problem-solving. The unturned stone. N Engl J Med 2005; 352:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/33\">",
"      Cunha VS, Zampese MS, Aquino VR, et al. Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population. Clin Exp Dermatol 2007; 32:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/34\">",
"      Karimi K, Wheat LJ, Connolly P, et al. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 2002; 186:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/35\">",
"      Tob&oacute;n AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005; 73:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/36\">",
"      Cohen PR, Bank DE, Silvers DN, Grossman ME. Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virus-infected patients. J Am Acad Dermatol 1990; 23:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/37\">",
"      Eidbo J, Sanchez RL, Tschen JA, Ellner KM. Cutaneous manifestations of histoplasmosis in the acquired immune deficiency syndrome. Am J Surg Pathol 1993; 17:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/38\">",
"      Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore) 1990; 69:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/39\">",
"      Wheat LJ, Musial CE, Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005; 40:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/40\">",
"      Dwyre DM, Bell AM, Siechen K, et al. Disseminated histoplasmosis presenting as thrombotic microangiopathy. Transfusion 2006; 46:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/41\">",
"      Koduri PR, Chundi V, DeMarais P, et al. Reactive hemophagocytic syndrome: a new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 1995; 21:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/42\">",
"      Walker JV, Baran D, Yakub N, Freeman RB. Histoplasmosis with hypercalcemia, renal failure, and papillary necrosis. Confusion with sarcoidosis.. JAMA 1977; 237:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/43\">",
"      Murray JJ, Heim CR. Hypercalcemia in disseminated histoplasmosis. Aggravation by vitamin D. Am J Med 1985; 78:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/44\">",
"      Gulati M, Saint S, Tierney LM Jr. Clinical problem-solving. Impatient inpatient care. N Engl J Med 2000; 342:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/45\">",
"      Macher A, Rodrigues MM, Kaplan W, et al. Disseminated bilateral chorioretinitis due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome. Ophthalmology 1985; 92:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/46\">",
"      Kilburn CD, McKinsey DS. Recurrent massive pleural effusion due to pleural, pericardial, and epicardial fibrosis in histoplasmosis. Chest 1991; 100:1715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/47\">",
"      Young EJ, Vainrub B, Musher DM. Pericarditis due to histoplasmosis. JAMA 1978; 240:1750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/48\">",
"      Bhatti S, Vilenski L, Tight R, Smego RA Jr. Histoplasma endocarditis: clinical and mycologic features and outcomes. J Infect 2005; 51:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/49\">",
"      Gaynes RP, Gardner P, Causey W. Prosthetic valve endocarditis caused by Histoplasma capsulatum. Arch Intern Med 1981; 141:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/50\">",
"      Ellis ME, Al-Abdely H, Sandridge A, et al. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001; 32:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/51\">",
"      Reddy PA, Brasher CA, Christianson C, et al. Peritonitis due to histoplasmosis. Ann Intern Med 1969; 72:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/52\">",
"      Patrick CC, Flynn PM, Henwick S, Pui CH. Disseminated histoplasmosis presenting as a cystic duct obstruction. Pediatr Infect Dis J 1992; 11:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/53\">",
"      Pottage JC Jr, Trenholme GM, Aronson IK, Harris AA. Panniculitis associated with histoplasmosis and alpha 1-antitrypsin deficiency. Am J Med 1983; 75:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/54\">",
"      Osborne BM. Granulomatous mastitis caused by histoplasma and mimicking inflammatory breast carcinoma. Hum Pathol 1989; 20:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/55\">",
"      Darouiche RO, Cadle RM, Zenon GJ, et al. Articular histoplasmosis. J Rheumatol 1992; 19:1991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/56\">",
"      Jones PG, Rolston K, Hopfer RL. Septic arthritis due to Histoplasma capsulatum in a leukaemic patient. Ann Rheum Dis 1985; 44:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/57\">",
"      Fowler VG Jr, Nacinovich FM, Alspaugh JA, Corey GR. Prosthetic joint infection due to Histoplasma capsulatum: case report and review. Clin Infect Dis 1998; 26:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/58\">",
"      Cucurull E, Sarwar H, Williams CS 4th, Espinoza LR. Localized tenosynovitis caused by Histoplasma capsulatum: case report and review of the literature. Arthritis Rheum 2005; 53:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/59\">",
"      Zighelboim J, Goldfarb RA, Mody D, et al. Prostatic abscess due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome. J Urol 1992; 147:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/60\">",
"      Kauffman CA, Slama TG, Wheat LJ. Histoplasma capsulatum epididymitis. J Urol 1981; 125:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/61\">",
"      Sills M, Schwartz A, Weg JG. Conjugal histoplasmosis. A consequence of progressive dissemination in the index case after steroid therapy. Ann Intern Med 1973; 79:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43112/abstract/62\">",
"      Jayalakshmi P, Goh KL, Soo-Hoo TS, Daud A. Disseminated histoplasmosis presenting as penile ulcer. Aust N Z J Med 1990; 20:175.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2455 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.111.122.2-33308A762F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43112=[""].join("\n");
var outline_f42_6_43112=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30598196\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Reinfection and reactivation of infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Anti-TNF-alpha therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3054577\">",
"      Cellular immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Skin involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Adrenal involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Central nervous system disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30598196\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2455\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2455|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?16/46/17120\" title=\"diagnostic image 1\">",
"      CNS histoplasmosis MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?39/10/40111\" title=\"diagnostic image 2\">",
"      Adrenal mass CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/14/28911\" title=\"diagnostic image 3\">",
"      Colon mass disseminated histo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2455|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/46/1774\" title=\"figure 1\">",
"      Clinical findings in histo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2455|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/22/7523\" title=\"picture 1\">",
"      Histoplasma blood smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/23/2419\" title=\"picture 2\">",
"      Disseminated histo bone marrow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/9/42132\" title=\"picture 3\">",
"      Disseminated histoplasmosis - papules",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/6/9321?source=related_link\">",
"      Diagnosis and treatment of disseminated histoplasmosis in non-HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/16/2310?source=related_link\">",
"      Hypercalcemia in granulomatous diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/35/23098?source=related_link\">",
"      Immune reconstitution inflammatory syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/47/29433?source=related_link\">",
"      Infection in the solid organ transplant recipient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/24/42376?source=related_link\">",
"      Pathogenesis and clinical features of pulmonary histoplasmosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/5/13393?source=related_link\">",
"      Patient information: Histoplasmosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33450?source=related_link\">",
"      Primary prevention of opportunistic infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32538?source=related_link\">",
"      Tumor necrosis factor-alpha inhibitors: Risk of bacterial, viral, and fungal infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_6_43113="Nutrient deficiencies in inflammatory bowel disease";
var content_f42_6_43113=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nutrient deficiencies in inflammatory bowel disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/6/43113/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43113/contributors\">",
"     Jonathan E Teitelbaum, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/6/43113/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43113/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43113/contributors\">",
"     Timothy O Lipman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43113/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/6/43113/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43113/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/6/43113/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/6/43113/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with inflammatory bowel disease (IBD) and, particularly, those with Crohn's disease (CD) are at risk for a variety of nutritional deficiencies because of decreased nutrient intake or absorption",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increased losses. The most common problems are deficiencies of micronutrients (nutrients needed for life in small quantities) (",
"    <a class=\"graphic graphic_table graphicRef72725 \" href=\"mobipreview.htm?22/0/22540\">",
"     table 1",
"    </a>",
"    ), including several water-soluble and fat-soluble vitamins, microminerals including iron and calcium, and trace minerals.",
"   </p>",
"   <p>",
"    Clinically important deficiencies in macronutrients (providing total energy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    protein) are less common in adults. However, these are very important issues in children with IBD, as discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/46/2794?source=see_link\">",
"     \"Growth failure and poor weight gain in children with inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Micronutrient deficiencies in adults and children with inflammatory bowel disease will be reviewed here. Weight loss and other manifestations of macronutrient deficiency in adults will be mentioned briefly. Diet and Inflammatory Bowel Disease are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/7/44152?source=see_link\">",
"     \"Nutrition and dietary interventions in adults with inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A combination of factors contributes to deficits in energy and protein in IBD. Reduced nutrient intake is common; it is associated with disease activity and may be mediated by proinflammatory cytokines, such as tumor necrosis factor alpha. Malabsorption, maldigestion, increased energy expenditure, and gastrointestinal protein loss also contribute to deficiencies of energy and protein, and are usually correlated with disease activity. These mechanisms are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/46/2794?source=see_link&amp;anchor=H2#H2\">",
"     \"Growth failure and poor weight gain in children with inflammatory bowel disease\", section on 'Pathogenesis of growth failure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similar mechanisms also contribute to micronutrient deficiencies in IBD. In addition, because some nutrients are digested and absorbed within specific locations within the gastrointestinal tract, the activity and location of a patient's intestinal disease determines risk for specific micronutrient deficiencies. As examples, patients with disease of the terminal ileum are at risk for vitamin B12 deficiency, and those with disease of the proximal small intestine are more likely to malabsorb calcium and iron.",
"   </p>",
"   <p>",
"    Individuals who have undergone small bowel resection are also at risk for micronutrient deficiencies, the nature of which depends on the extent and location of the resected bowel. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/37/18007?source=see_link\">",
"     \"Chronic complications of the short bowel syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/45/29400?source=see_link\">",
"     \"Chronic complications of the short bowel syndrome in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     WATER-SOLUBLE VITAMINS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Folic acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Folate deficiency was observed in 20 to 60 percent of adults with IBD in older series, and is uncommon in studies from the last decade [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. This historical difference may reflect changes in medical therapy (eg, less use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    )",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    higher levels of folate intake through supplements or foods. In modern series of children with newly diagnosed IBD, folate concentrations were normal or higher than those of controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The clinical implications of this finding have yet to be determined.",
"   </p>",
"   <p>",
"    The diet of patients with inflammatory bowel disease often contains insufficient amounts of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. In addition, treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    may exacerbate folate deficiency, since the drug's sulfa moiety can bind folate in the gut lumen, leaving it unavailable for absorption. This is not true for other aminosalicylates, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/44/22215?source=see_link\">",
"     mesalamine",
"    </a>",
"    . Treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    (a folic acid antagonist) can also contribute to folate deficiency. Folate deficiency may contribute to the development of anemia in patients with IBD.",
"   </p>",
"   <p>",
"    Retrospective studies have raised the possibility that folate supplementation induces a protective effect against dysplasia and colorectal cancer in patients with ulcerative colitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/5\">",
"     5",
"    </a>",
"    ]. Another study suggested that this is the case only for the subgroup of patients with high serum levels of homocysteine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/6\">",
"     6",
"    </a>",
"    ]. The possible effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    supplementation on colorectal cancer risk have been better studied in patients without IBD, as discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link&amp;anchor=H3#H3\">",
"     \"Vitamin supplementation in disease prevention\", section on 'Folic acid'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Supplementation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    is generally recommended in IBD patients who are treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and in others if low serum folate levels are found on laboratory screening. However, there is insufficient evidence to support the use of supplemental folic acid for other patients with IBD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20344?source=see_link&amp;anchor=H11#H11\">",
"     \"Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease\", section on 'Side effects'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/54/19305?source=see_link\">",
"     \"Overview of the medical management of mild to moderate Crohn's disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41722?source=see_link\">",
"     \"Overview of the management of Crohn's disease in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Vitamin B12",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory evidence of vitamin B12 deficiency has been reported in about 20 percent of adult and pediatric patients with CD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/7,8\">",
"     7,8",
"    </a>",
"    ], although it appears to be rare in children with newly diagnosed IBD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/4\">",
"     4",
"    </a>",
"    ]. Factors contributing to vitamin B12 deficiency include disease or resection of the terminal ileum, gastritis, and bacterial overgrowth. Vitamin B12 deficiency can contribute to the increased incidence of anemia seen in patients with IBD.",
"   </p>",
"   <p>",
"    Serum vitamin B12 levels should be monitored periodically in all patients with ileal CD and in those who have undergone an ileal resection. The diagnosis can be confirmed by measuring serum homocysteine levels and methylmalonic acid. The diagnosis and treatment of this issue is discussed in separate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/0/20490?source=see_link&amp;anchor=H12689078#H12689078\">",
"     \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\", section on 'Malabsorption'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/0/5130?source=see_link\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Niacin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low plasma concentrations of niacin are common among patients with CD, but clinically apparent disease is rare. In one study of adults with CD in remission, low plasma concentrations of niacin were found in 77 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/9\">",
"     9",
"    </a>",
"    ]. Pellagra (the clinical manifestations of niacin deficiency) has been described in adult patients with CD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/62/28650?source=see_link&amp;anchor=H22#H22\">",
"     \"Overview of water-soluble vitamins\", section on 'Vitamin B3 (niacin)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     FAT-SOLUBLE VITAMINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fat-soluble vitamin deficiency (vitamins A, D, E, and K) can occur in patients with Crohn's disease (CD) if it is complicated by fat malabsorption. Fat malabsorption may be caused by bile acid deficiency due to terminal ileal disease or resection (because bile acids undergo active resorption in the terminal ileum), or by the use of medicines, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    , that bind bile acids. Currently, the recommended intake of fat-soluble vitamins for patients with IBD is no different from the recommended intake for healthy individuals. However, patients with active IBD appear to be at increased risk for these deficiencies, so focused counseling and monitoring is warranted, as detailed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Vitamin A",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin A (retinol) deficiency has been described in IBD. In one study of adult patients with CD, 5 percent had clinically significant vitamin A deficiency characterized by impaired dark adaptation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/12\">",
"     12",
"    </a>",
"    ]. Low serum levels of vitamin A do not always indicate clinical deficiency because this finding can be caused by hypoproteinemia. Vitamin A is considered an antioxidant, but there is no clear evidence that deficiency of this or other antioxidants are involved in the pathogenesis of inflammation in IBD. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Antioxidant vitamins'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Excessive vitamin A supplementation should be avoided because high intakes of vitamin A are associated with an increased risk of bone fractures, as well as other effects including pseudotumor cerebri. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/14/21736?source=see_link&amp;anchor=H18#H18\">",
"     \"Overview of vitamin A\", section on 'Adverse effects on bone'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin D insufficiency is common in patients with inflammatory bowel disease. In one study, 25 percent of adults with CD had deficient serum 25-hydroxyvitamin D (calcidiol) concentrations (&lt;10",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/13\">",
"     13",
"    </a>",
"    ]. Studies in children report that 6 to 36 percent of children with IBD have deficient 25-hydroxyvitamin D concentrations (&lt;15",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Several factors probably contribute to the variability in reported vitamin D concentrations, including genetic and environmental factors (diet and sun exposure), as well as factors related to the IBD itself (malabsorption and anorexia). One study suggests that only about 10 percent of patients with IBD malabsorb vitamin D [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/17\">",
"     17",
"    </a>",
"    ]. Vitamin D deficiency is one of several mechanisms for bone disease in inflammatory bowel disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30569?source=see_link\">",
"     \"Metabolic bone disease in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The recommended intake of vitamin D for children and adults with IBD is the same as for healthy individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/18,19\">",
"     18,19",
"    </a>",
"    ], (ie, 600 IU daily according to a 2010 report by the Institute of Medicine) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/20\">",
"     20",
"    </a>",
"    ]. Because patients with IBD have an increased risk for vitamin D insufficiency and metabolic bone disease, we suggest that intake recommendations be reinforced by focused dietary counseling, and that vitamin D intake be augmented by supplements if necessary. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/3/39990?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of vitamin D\", section on 'Requirements'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Individuals with malabsorption or established vitamin D deficiency may require higher doses of vitamin D to reach target levels of serum 25-hydroxyvitamin D. In such patients, the adequacy of the calcium and vitamin D supplementation should be confirmed by measurements of serum calcium, phosphate, 25-hydroxyvitamin D, and parathyroid hormone. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/21/3417?source=see_link\">",
"     \"Treatment of vitamin D deficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Vitamin E",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin E (tocopherol, in several forms) acts as a free radical scavenger, protecting cell membranes from peroxidation. One form of vitamin E, gamma tocopherol, has antiinflammatory processes, but this form is not included in vitamin E supplements. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/12/28871?source=see_link\">",
"     \"Overview of vitamin E\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The majority of individuals with IBD consume less than the recommended intake of vitamin E [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/2,21\">",
"     2,21",
"    </a>",
"    ]. Mean levels of vitamin E were lower in adult patients with IBD as compared with healthy controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/22\">",
"     22",
"    </a>",
"    ], but this was not the case in a series in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/23\">",
"     23",
"    </a>",
"    ]. Deficient serum vitamin E levels (eg, &lt;0.5",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    are unusual [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been suggested that depletion of vitamin E and other antioxidant vitamins may contribute to the pathogenesis of IBD, but such pathways have not been established. High dose vitamin E supplementation is not recommended because it may be associated with increased mortality in individuals without IBD. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Antioxidant vitamins'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/12/28871?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of vitamin E\", section on 'Excess and toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Vitamin K",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin K is a cofactor in the carboxylation of osteocalcin, a protein essential for calcium binding to bone. Vitamin K deficiency may be a cause of decreased bone mineral density in patients with CD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. However, this association is based on indirect evidence, and whether supplementation with vitamin K in patients with IBD can help prevent or treat bone disease has not been established. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9562?source=see_link&amp;anchor=H6#H6\">",
"     \"Drugs that affect bone metabolism\", section on 'Warfarin'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30569?source=see_link\">",
"     \"Metabolic bone disease in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ANTIOXIDANT VITAMINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with Crohn's disease (CD) have greater oxidative stress than healthy individuals, even at times when their disease is relatively quiescent. In a study of adults with CD, there was an association between oxidative stress (as measured by breath pentane and ethane output) as compared to healthy controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/26\">",
"     26",
"    </a>",
"    ]. Other studies document lower total antioxidant capacity in patients with CD or UC as compared with healthy controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These observations raise the possibility that depletion of dietary antioxidants contributes to the oxidative stress in IBD. Indeed, a few studies have documented lower plasma concentrations of antioxidant vitamins (ascorbic acid, vitamin A [alpha- and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    ], lycopene, and beta-cryptoxanthin) in patients with CD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/22,26\">",
"     22,26",
"    </a>",
"    ]. Supplementation with high-dose vitamin E (800 International Units) and C (1000 mg) significantly reduced laboratory measures of oxidative stress in a similar group of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/28\">",
"     28",
"    </a>",
"    ]. A few other randomized trials using smaller doses of antioxidants in various combinations generally reduced measures of oxidative stress but did not show effects on disease activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In another trial, treatment with an antioxidant cocktail was associated with a reduced glucocorticoid requirement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of wide variability in antioxidant combinations, dose, and outcomes used in these trials, the clinical significance of these findings remains uncertain. Thus, there is no direct evidence suggesting that supplementation with antioxidant vitamins can reduce inflammation in patients with IBD. Moreover, high dose supplementation of vitamins A or E may have adverse effects on bone or cardiovascular health, respectively, and is not recommended. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Fat-soluble vitamins'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     MINERALS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Iron",
"    </span>",
"    &nbsp;&mdash;&nbsp;Literature reviews suggest that 35 to 90 percent of adults with IBD are iron deficient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/32\">",
"     32",
"    </a>",
"    ]. Iron deficiency is probably the primary cause of the anemia that affects 16 percent of outpatients and up to 70 percent of inpatients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/1,32\">",
"     1,32",
"    </a>",
"    ]. Iron deficiency has a significant negative impact on quality of life and can lead to developmental and cognitive abnormalities in children and adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/33\">",
"     33",
"    </a>",
"    ]. A study in adults with IBD and anemia demonstrated that oral iron supplementation increased hemoglobin concentration and improved quality of life without changing disease activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Other causes of anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iron deficiency in IBD is usually caused by chronic blood loss. The resulting anemia is compounded by suppression of erythropoietin production and alteration of iron metabolism caused by proinflammatory cytokines, reactive oxygen metabolites, and nitric oxide, a condition called the anemia of chronic inflammation (anemia of chronic disease) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/35\">",
"     35",
"    </a>",
"    ]. Other potential contributors to anemia in patients with IBD include vitamin B12 deficiency,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    deficiency, or drug-induced anemia (eg, in patients treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    or thiopurines). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9434?source=see_link\">",
"     \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of iron deficiency in patients with IBD is complicated by the fact that ferritin is an acute phase reactant. Because serum ferritin levels increase in the setting of inflammation, patients with active IBD or acute infection may have a \"falsely\" normal ferritin concentration. Thus, patients with anemia and active IBD may be iron deficient regardless of the serum ferritin levels. Some have suggested that for patients with active inflammatory disease, serum ferritin levels below 100",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    should be considered abnormal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/32\">",
"     32",
"    </a>",
"    ]. In addition, serum ferritin may be falsely normal in a patient with hypoalbuminemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Supplementation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two main issues related to iron supplementation in patients with IBD:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral iron supplementation can potentially worsen symptoms",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      IBD activity. The available data suggest that many patients (approximately 75 percent) tolerate oral supplementation without worsening of disease activity, but some develop gastrointestinal side effects, a subset of which may be attributable to worsening IBD disease activity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/34,36-38\">",
"       34,36-38",
"      </a>",
"      ]. There are no established predictors of tolerance.",
"     </li>",
"     <li>",
"      Iron might increase oxidative stress and thereby contribute to carcinogenesis in IBD by augmenting oxidative damage and epithelial proliferation due to inflammation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/39-45\">",
"       39-45",
"      </a>",
"      ]. This is a theoretical concern, mainly from animal models. Whether these observations are clinically important in humans with IBD is unclear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are two general options to replete iron stores in patients with IBD: oral and parenteral (intramuscular, intravenous) supplementation. Oral formulations are much more convenient and less expensive and have, thus, generally been preferred as a first-line option. Indications for parenteral supplementation in adults include severe anemia (hemoglobin less than 10 grams per dL), intolerance, or inappropriate response to oral iron (a response is considered appropriate if the hemoglobin concentration increases by at least 2",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    or reaches normal within four weeks of treatment), severe intestinal disease activity, concomitant therapy with an erythropoietic agent, or patient preference [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/46\">",
"     46",
"    </a>",
"    ]. The dosing and administration are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=see_link\">",
"     \"Treatment of anemia due to iron deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/14/4329?source=see_link\">",
"     \"Iron requirements and iron deficiency in adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tolerance to oral iron therapy varies substantially among patients with IBD. Those with mild intolerance (eg, mild nausea, bloating, diarrhea, upper gastrointestinal complaints) thought to be due to the iron may still be able to take oral iron supplements by taking smaller doses. Several oral formulations are available, some of which may be better tolerated than others. However, differences in tolerability may in part be due to variations in their iron content (with better tolerability in preparations containing less iron). Thus, whether one or another formulation has an optimal",
"    <span class=\"nowrap\">",
"     efficacy/safety",
"    </span>",
"    profile is unclear since there have been no direct comparisons in patients with IBD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of anemia due to iron deficiency\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among the parenteral formulations, intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/31/41461?source=see_link\">",
"     iron sucrose",
"    </a>",
"    has been most extensively studied in IBD and appears to be well-tolerated, effective, and safer than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/46/21222?source=see_link\">",
"     iron dextran",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/36,37,47,48\">",
"     36,37,47,48",
"    </a>",
"    ]. A multicenter randomized, controlled trial showed that intravenous iron sucrose treatment is superior to oral iron in correcting hemoglobin and iron stores in IBD patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/49\">",
"     49",
"    </a>",
"    ]. The main disadvantages of intravenous iron sucrose are its relatively higher cost, the need for parenteral administration, and the possibility of allergic reactions. Another disadvantage of intravenous iron sucrose is the dose limitation of 200 mg iron per infusion because anemic patients with IBD frequently have an iron deficit of 1000 mg or more. Thus, multiple infusions of iron sucrose are required. Ferric carboxymaltose (FCM) is an intravenous iron preparation that can be administered in single doses of up to 1000 mg iron within 15 minutes. Fixed dose FCM has been demonstrated to have better efficacy and compliance than individually calculated iron sucrose doses in patients with IBD and iron deficiency anemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=see_link&amp;anchor=H21#H21\">",
"     \"Treatment of anemia due to iron deficiency\", section on 'Ferric carboxymaltose'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the available data are limited, we suggest the following approach to iron supplementation in patients with IBD and evidence of iron deficiency:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with mild to moderate IBD disease activity who have no known sensitivity to oral iron, we suggest supplementation with oral iron. Specific suggestions for initial treatment are presented elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=see_link&amp;anchor=H7#H7\">",
"       \"Treatment of anemia due to iron deficiency\", section on 'Choice of preparation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=see_link&amp;anchor=H9#H9\">",
"       \"Treatment of anemia due to iron deficiency\", section on 'Expected response'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with severe IBD disease activity, we suggest intravenous FCM to avoid worsening gastrointestinal symptoms, since these patients are already particularly fragile. Other indications for parenteral iron supplementation in adults include severe anemia (hemoglobin less than 10 grams per dL), intolerance, or inappropriate response to oral iron (a response is considered appropriate if the hemoglobin concentration increases by at least 2",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      or reaches normal within four weeks of treatment), concomitant therapy with an erythropoietic agent, or patient preference. Intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?30/53/31573?source=see_link\">",
"       ferric gluconate",
"      </a>",
"      complex may be an acceptable alternative in centers where",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/31/41461?source=see_link\">",
"       iron sucrose",
"      </a>",
"      is unavailable, although its efficacy and safety in IBD have not been evaluated directly. Specific suggestions for the choice of agent and calculation of the dose of iron are presented elsewhere. Blood transfusion is generally reserved for patients with severe anemia or hemodynamic instability. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=see_link&amp;anchor=H14#H14\">",
"       \"Treatment of anemia due to iron deficiency\", section on 'Parenteral iron therapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=see_link&amp;anchor=H28#H28\">",
"       \"Treatment of anemia due to iron deficiency\", section on 'Blood transfusion'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children and adolescents with iron deficiency anemia are managed similarly to adults, although the clinical indications for instituting parenteral treatment or transfusion vary. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/14/4329?source=see_link\">",
"       \"Iron requirements and iron deficiency in adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18808?source=see_link\">",
"       \"Indications for red blood cell transfusion in infants and children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/2/38949?source=see_link&amp;anchor=H17785797#H17785797\">",
"       \"Iron deficiency in infants and young children: Treatment\", section on 'Oral iron therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Options for patients who have previously been intolerant to oral iron therapy include parenteral iron preparations, a trial with an alternative oral agent, or a gradual increase in the dose of iron (which can be accomplished by using a liquid formulation of iron sulfate). Administration with food may improve tolerability, albeit while also reducing absorption. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=see_link&amp;anchor=H6#H6\">",
"       \"Treatment of anemia due to iron deficiency\", section on 'General principles'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=see_link&amp;anchor=H10#H10\">",
"       \"Treatment of anemia due to iron deficiency\", section on 'Side effects'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Failure of the anemia to respond to treatment with oral or parenteral iron may indicate either an erroneous diagnosis of iron deficiency or the presence of a component of the anemia of chronic disease (anemia of chronic inflammation). In such cases, addition of erythropoietin to the treatment program may result in improvement of the anemia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/51,52\">",
"       51,52",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9434?source=see_link\">",
"       \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Zinc",
"    </span>",
"    &nbsp;&mdash;&nbsp;As many as 65 percent of patients with CD have decreased serum zinc concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/4,9,53\">",
"     4,9,53",
"    </a>",
"    ]. However, serum zinc levels vary with albumin and correlate poorly with total body zinc stores; clinically significant zinc deficiency is probably much less common. A deficient state is often reflected by a decreased serum alkaline phosphatase concentration since alkaline phosphatase is a zinc metalloenzyme. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39226?source=see_link&amp;anchor=H58#H58\">",
"     \"Overview of dietary trace minerals\", section on 'Zinc'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Excessive losses of zinc may be observed in patients with ostomies, fistulas, and profuse diarrhea, or in those with prolonged parenteral nutrition unless trace minerals are included. Several clinical manifestations of zinc deficiency have been described (",
"    <a class=\"graphic graphic_table graphicRef55126 \" href=\"mobipreview.htm?40/7/41083\">",
"     table 2",
"    </a>",
"    ). The skin changes are the most distinctive manifestations. These usually consist of dry scaly eczematous plaques, often on the face and anogenital area; the lesions often resemble psoriasis. Many other manifestations, such as growth failure, are nonspecific and are more likely to be caused by mechanisms other than zinc deficiency in patients with IBD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/46/2794?source=see_link\">",
"     \"Growth failure and poor weight gain in children with inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptomatic zinc deficiency in patients with IBD is treated with oral or parenteral zinc at replacement doses. A low serum alkaline phosphatase concentration is also suggestive of zinc deficiency, since alkaline phosphatase is a zinc-dependent enzyme. In our practice, we also provide zinc supplements to asymptomatic patients with low serum zinc concentrations, using maintenance doses of 10 to 15 mg of elemental zinc daily, because the symptoms of zinc deficiency may be subtle, and zinc supplementation at these doses is generally safe. Appropriate dosing of zinc supplements is discussed separately. (See",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?28/39/29301?source=see_link\">",
"     \"Zinc sulfate: Pediatric drug information\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because zinc supplementation has been useful in the treatment of chronic diarrhea, it has been suggested that supraphysiologic zinc replacement might be a helpful adjunct to treatment of patients with IBD. A small uncontrolled study of patients with CD in remission suggested that zinc supplementation reduced intestinal permeability, but the clinical relevance of this finding has not been established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/54\">",
"     54",
"    </a>",
"    ]. Zinc is also a common component of antioxidant combinations that are occasionally given to patients with CD, although there is little evidence to support this practice. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Antioxidant vitamins'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Calcium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 13 percent of adults with CD malabsorbs calcium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/55\">",
"     55",
"    </a>",
"    ]. This can occur due to the binding of calcium to undigested fats in the intestinal lumen, loss of the ileum leading to vitamin D deficiency, and possibly as a result of genetic factors and the effects of inflammatory cytokines. In addition, patients may have inadequate intake of calcium in their diets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/2\">",
"     2",
"    </a>",
"    ]. Negative calcium balance is one of several factors contributing to bone disease in patients with inflammatory bowel disease.",
"   </p>",
"   <p>",
"    The recommended intake of elemental calcium for children and adults with IBD is the same as for the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      1 to 3 years &mdash; 700 mg daily",
"     </li>",
"     <li>",
"      4 to 8 years &mdash; 1000 mg daily",
"     </li>",
"     <li>",
"      9 to 18 years &mdash; 1300 mg daily",
"     </li>",
"     <li>",
"      Men and premenopausal women &mdash; 1000 mg daily",
"     </li>",
"     <li>",
"      Postmenopausal women and men older than 70 years &mdash; 1200 mg daily",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To minimize risks for metabolic bone disease, patients with IBD should be given focused nutritional counseling, and calcium supplements used as needed to meet the recommended target for calcium intake. This is particularly important in patients treated with glucocorticoid therapy. In patients with extensive CD of the small bowel, somewhat higher doses of calcium may be needed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30569?source=see_link\">",
"     \"Metabolic bone disease in inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Negative calcium balance does not usually cause hypocalcemia. If the total serum calcium concentration is low, this may be caused by hypoalbuminemia, which lowers the total plasma calcium concentration without affecting the physiologically important free (ionized) calcium concentration. If the serum free calcium is low, this may be caused by concurrent vitamin D deficiency or hypoparathyroidism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23685?source=see_link\">",
"     \"Relation between total and ionized serum calcium concentration\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/25/24984?source=see_link\">",
"     \"Etiology of hypocalcemia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation and management of IBD-associated bone disease in children differs in several respects from that in adults, as discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/46/2794?source=see_link&amp;anchor=H17#H17\">",
"     \"Growth failure and poor weight gain in children with inflammatory bowel disease\", section on 'Bone disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Phosphate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Poor intake alone is rarely responsible for phosphate depletion because of rapid renal adaptation. However, phosphate stores can be depleted in patients with chronic diarrhea because of malabsorption of phosphate and vitamin D. In malnourished patients, sudden increases in nutrition can cause acute hypophosphatemia (refeeding syndrome). Thus, malnourished patients with CD and chronic diarrhea are at risk for hypophosphatemia and require close monitoring and phosphate replacement. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/25/15767?source=see_link\">",
"     \"Causes of hypophosphatemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44023?source=see_link&amp;anchor=H252082#H252082\">",
"     \"Eating disorders: Treatment\", section on 'Refeeding syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Selenium",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/37/13907?source=see_link\">",
"     Selenium",
"    </a>",
"    occurs naturally in meats, cereals, and fish. It has multiple biological roles. It is a component of the antioxidant glutathione peroxidase, and is also required for formation of thyroid hormone. Clinical manifestations of prolonged selenium deficiency include erythrocyte macrocytosis and muscle dysfunction, cardiomyopathy, and encephalitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39226?source=see_link&amp;anchor=H48#H48\">",
"     \"Overview of dietary trace minerals\", section on 'Selenium'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/37/13907?source=see_link\">",
"     Selenium",
"    </a>",
"    concentration in whole blood and glutathione peroxidase activity are often somewhat lower in adults or children with IBD as compared with healthy individuals, but biochemical or clinical evidence of deficiency is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/56-58\">",
"     56-58",
"    </a>",
"    ]. Deficient levels of selenium are more common among patients with CD who have undergone small bowel resection of &gt;200 cm and those receiving exclusive enteral nutrition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/59-61\">",
"     59-61",
"    </a>",
"    ]. A few reports describe patients with IBD receiving long-term parenteral nutrition without trace minerals who displayed potentially life-threatening manifestations of selenium deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/62-64\">",
"     62-64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Like zinc,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    is sometimes a component of antioxidant combinations that are occasionally given to patients with CD, although there is little firm evidence to support this practice. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Antioxidant vitamins'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Copper",
"    </span>",
"    &nbsp;&mdash;&nbsp;Copper is an essential trace element used in many enzyme complexes, and is required for normal iron absorption. Clinical manifestations of copper deficiency include abnormally-formed hair, depigmentation of the skin, and microcytic anemia. The neurologic manifestations include ataxia, neuropathy, and cognitive deficits that can mimic vitamin B12 deficiency. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39226?source=see_link&amp;anchor=H9#H9\">",
"     \"Overview of dietary trace minerals\", section on 'Copper'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most adults and children with IBD do not demonstrate copper deficiency; indeed, some series report relatively high copper levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/9,57,58,61,65\">",
"     9,57,58,61,65",
"    </a>",
"    ]. However, increased losses are observed in those with profuse diarrhea, fistulas, or ostomies, or those maintained on parenteral nutrition without mineral supplements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. Because copper and zinc are competitively absorbed from the jejunum, high doses of zinc (eg, from prolonged ingestion of zinc supplements) can result in copper deficiency. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39226?source=see_link\">",
"     \"Overview of dietary trace minerals\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Magnesium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnesium deficiency in patients with IBD may result from decreased oral intake, malabsorption, increased intestinal losses, or low concentrations of magnesium in a formula used for enteral nutrition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/68-70\">",
"     68-70",
"    </a>",
"    ]. Magnesium deficiency may contribute to osteopenia.",
"   </p>",
"   <p>",
"    Mild or chronic deficiencies can be supplemented orally with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/22/24933?source=see_link\">",
"     magnesium chloride",
"    </a>",
"    . However, large doses given orally can lead to diarrhea, so parenteral administration of magnesium may be necessary in patients with very low serum magnesium levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     LABORATORY MEASURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory monitoring of nutritional status for patients with inflammatory bowel disease depends on the patient's disease activity and location, general nutritional status, and specific risk factors such as exclusive parenteral or enteral nutrition. In our practice, we use the following approach (",
"    <a class=\"graphic graphic_table graphicRef66288 \" href=\"mobipreview.htm?0/33/541\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with quiescent IBD, we routinely perform a complete blood count at each office visit, including red blood cell parameters to screen for iron deficiency. We measure vitamin D (measured as 25-hydroxyvitamin D) every one to two years. We also measure serum albumin at the same intervals, but consider this a marker of protein loss and disease activity rather than protein intake.",
"     </li>",
"     <li>",
"      We perform the above measures more frequently for patients with active disease, or CD affecting the small bowel, in growing children, or in patients on medications that may affect nutrient status (eg, we also measure folate regularly in patients on",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/28/8647?source=see_link\">",
"       sulfasalazine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In patients with Crohn's disease, we also measure vitamin B12 every one to two years, or more frequently in those with disease of the terminal ileum. We measure levels of calcium, phosphorus, and magnesium in patients with chronic diarrhea or active small bowel disease, or during refeeding in severely malnourished patients.",
"     </li>",
"     <li>",
"      Measurement of serum concentrations of vitamins A and E, prothrombin time, and zinc may also be indicated based upon disease severity and location. Hyperlipidemia reduces the effective tissue level of vitamin E; laboratory results should be adjusted for serum lipids. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/12/28871?source=see_link\">",
"       \"Overview of vitamin E\"",
"      </a>",
"      .) Measurement of parathyroid hormone is helpful in patients with bone disease or low serum levels of 25-hydroxyvitamin D. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Vitamin D'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do not usually test for deficiencies of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/37/13907?source=see_link\">",
"       selenium",
"      </a>",
"      or copper unless a patient has profuse diarrhea and exhibit other signs of nutritional deficiency, or other risk factors for deficiencies, such as insufficient intake through parenteral or enteral nutrition.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional markers that reflect changes in nutritional status are also available, but many are not routinely used or are investigational, and have not been shown to be clinically useful. Examples include somatomedin C, prealbumin, carboxy-terminal propeptide of type I procollagen, and amino-terminal propeptide of type III procollagen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/6/43113/abstract/71,72\">",
"     71,72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Historically, nutritional deficiencies or the inability to maintain ideal body weight were common in adults with Crohn's disease (CD). Advances in diagnosis and medical therapy have decreased the incidence of this problem. By contrast, these issues continue to be a concern in children with inflammatory bowel disease (IBD). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/46/2794?source=see_link\">",
"       \"Growth failure and poor weight gain in children with inflammatory bowel disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A combination of factors contributes to the pathogenesis of malnutrition in IBD including reduced nutrient intake, malabsorption, increased energy expenditure, and enteral protein loss. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Micronutrient deficiencies are common in patients with IBD; the frequency depends on the type of disease (most are more common in Crohn disease than in ulcerative colitis), disease location, and disease activity (",
"      <a class=\"graphic graphic_table graphicRef72725 \" href=\"mobipreview.htm?22/0/22540\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Because vitamin deficiencies are prevalent in patients with IBD, a multivitamin and mineral supplement is suggested.",
"     </li>",
"     <li>",
"      Malnutrition is an important contributor to bone disease in individuals with inflammatory bowel disease; other factors include glucocorticoid treatment and pubertal delay. All patients with IBD should be counseled to ensure recommended intake of calcium (1300 mg daily in adolescents and 1000 to 1500 mg daily in adults) and vitamin D (600 International Units daily), and monitored for vitamin D deficiency. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Vitamin D'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Calcium'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30569?source=see_link\">",
"       \"Metabolic bone disease in inflammatory bowel disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Routine laboratory studies indicated for nutritional assessment in patients with IBD include hemoglobin, albumin, and vitamin D. We also monitor vitamin B12 in patients with Crohn's disease affecting the terminal ileum. Measurement of serum concentrations of folate, vitamins A and E, parathyroid hormone, prothrombin time, magnesium, calcium, phosphorus and zinc may also be indicated based upon disease severity and location (",
"      <a class=\"graphic graphic_table graphicRef66288 \" href=\"mobipreview.htm?0/33/541\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Laboratory measures'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/1\">",
"      Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006; 24:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/2\">",
"      Vagianos K, Bector S, McConnell J, Bernstein CN. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2007; 31:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/3\">",
"      Heyman MB, Garnett EA, Shaikh N, et al. Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease. Am J Clin Nutr 2009; 89:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/4\">",
"      Alkhouri RH, Hashmi H, Baker RD, et al. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013; 56:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/5\">",
"      Lashner BA, Provencher KS, Seidner DL, et al. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997; 112:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/6\">",
"      Phelip JM, Ducros V, Faucheron JL, et al. Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Inflamm Bowel Dis 2008; 14:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/7\">",
"      Seidman E, LeLeiko N, Ament M, et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991; 12:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/8\">",
"      Headstrom PD, Rulyak SJ, Lee SD. Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn's disease. Inflamm Bowel Dis 2008; 14:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/9\">",
"      Filippi J, Al-Jaouni R, Wiroth JB, et al. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis 2006; 12:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/10\">",
"      Abu-Qurshin R, Naschitz JE, Zuckermann E, et al. Crohn's disease associated with pellagra and increased excretion of 5-hydroxyindolacetic acid. Am J Med Sci 1997; 313:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/11\">",
"      Pollack S, Enat R, Haim S, et al. Pellagra as the presenting manifestation of Crohn's disease. Gastroenterology 1982; 82:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/12\">",
"      Main AN, Mills PR, Russell RI, et al. Vitamin A deficiency in Crohn's disease. Gut 1983; 24:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/13\">",
"      Driscoll RH Jr, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982; 83:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/14\">",
"      Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 2006; 12:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/15\">",
"      Sentongo TA, Semaeo EJ, Stettler N, et al. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 2002; 76:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/16\">",
"      Pappa HM, Langereis EJ, Grand RJ, Gordon CM. Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011; 53:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/17\">",
"      Vogelsang H, Sch&ouml;fl R, Tillinger W, et al. 25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency. Wien Klin Wochenschr 1997; 109:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/18\">",
"      Kleinman RE, Baldassano RN, Caplan A, et al. Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology And Nutrition. J Pediatr Gastroenterol Nutr 2004; 39:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/19\">",
"      American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003; 124:791.",
"     </a>",
"    </li>",
"    <li>",
"     Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. National Academy Press, Washington DC, 2010. Available at:  file://books.nap.edu/openbook.php?record_id=13050.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/21\">",
"      Hengstermann S, Valentini L, Schaper L, et al. Altered status of antioxidant vitamins and fatty acids in patients with inactive inflammatory bowel disease. Clin Nutr 2008; 27:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/22\">",
"      D'Odorico A, Bortolan S, Cardin R, et al. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 2001; 36:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/23\">",
"      Bousvaros A, Zurakowski D, Duggan C, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr 1998; 26:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/24\">",
"      Duggan P, O'Brien M, Kiely M, et al. Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am J Gastroenterol 2004; 99:2178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/25\">",
"      Schoon EJ, M&uuml;ller MC, Vermeer C, et al. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? Gut 2001; 48:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/26\">",
"      Wendland BE, Aghdassi E, Tam C, et al. Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr 2001; 74:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/27\">",
"      Koutroubakis IE, Malliaraki N, Dimoulios PD, et al. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 2004; 49:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/28\">",
"      Aghdassi E, Wendland BE, Steinhart AH, et al. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial. Am J Gastroenterol 2003; 98:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/29\">",
"      Trebble TM, Stroud MA, Wootton SA, et al. High-dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: a randomised controlled trial. Br J Nutr 2005; 94:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/30\">",
"      Geerling BJ, Badart-Smook A, van Deursen C, et al. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 2000; 6:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/31\">",
"      Seidner DL, Lashner BA, Brzezinski A, et al. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 2005; 3:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/32\">",
"      Gisbert JP, Gomoll&oacute;n F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008; 103:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/33\">",
"      Cronin CC, Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol 2001; 96:2296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/34\">",
"      Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006; 12:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/35\">",
"      Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004; 53:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/36\">",
"      Schr&ouml;der O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005; 100:2503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/37\">",
"      Erichsen K, Ulvik RJ, Nysaeter G, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005; 40:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/38\">",
"      de Silva AD, Mylonaki M, Rampton DS. Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis 2003; 9:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/39\">",
"      Seril DN, Liao J, Ho KL, et al. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002; 47:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/40\">",
"      Erichsen K, Hausken T, Ulvik RJ, et al. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 2003; 38:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/41\">",
"      Erichsen K, Ulvik RJ, Grimstad T, et al. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005; 22:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/42\">",
"      Troost FJ, Saris WH, Haenen GR, et al. New method to study oxidative damage and antioxidants in the human small bowel: effects of iron application. Am J Physiol Gastrointest Liver Physiol 2003; 285:G354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/43\">",
"      Oldenburg B, van Berge Henegouwen GP, Rennick D, et al. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 2000; 30:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/44\">",
"      Carrier J, Aghdassi E, Platt I, et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001; 15:1989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/45\">",
"      Uritski R, Barshack I, Bilkis I, et al. Dietary iron affects inflammatory status in a rat model of colitis. J Nutr 2004; 134:2251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/46\">",
"      Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/47\">",
"      Bodemar G, Kechagias S, Almer S, Danielson BG. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Scand J Gastroenterol 2004; 39:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/48\">",
"      Mamula P, Piccoli DA, Peck SN, et al. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002; 34:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/49\">",
"      Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009; 44:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/50\">",
"      Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011; 141:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/51\">",
"      Schreiber S, Howaldt S, Schnoor M, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996; 334:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/52\">",
"      Gasche C, Waldhoer T, Feichtenschlager T, et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001; 96:2382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/53\">",
"      McClain C, Soutor C, Zieve L. Zinc deficiency: a complication of Crohn's disease. Gastroenterology 1980; 78:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/54\">",
"      Sturniolo GC, Di Leo V, Ferronato A, et al. Zinc supplementation tightens \"leaky gut\" in Crohn's disease. Inflamm Bowel Dis 2001; 7:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/55\">",
"      Krawitt EL, Beeken WL, Janney CD. Calcium absorption in Crohn's disease. Gastroenterology 1976; 71:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/56\">",
"      Thomson CD, Rea HM, Doesburg VM, Robinson MF. Selenium concentrations and glutathione peroxidase activities in whole blood of New Zealand residents. Br J Nutr 1977; 37:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/57\">",
"      Ojuawo A, Keith L. The serum concentrations of zinc, copper and selenium in children with inflammatory bowel disease. Cent Afr J Med 2002; 48:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/58\">",
"      Ringstad J, Kildebo S, Thomassen Y. Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1993; 28:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/59\">",
"      Rannem T, Ladefoged K, Hylander E, et al. Selenium status in patients with Crohn's disease. Am J Clin Nutr 1992; 56:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/60\">",
"      Kuroki F, Matsumoto T, Iida M. Selenium is depleted in Crohn's disease on enteral nutrition. Dig Dis 2003; 21:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/61\">",
"      Johtatsu T, Andoh A, Kurihara M, et al. Serum concentrations of trace elements in patients with Crohn's disease receiving enteral nutrition. J Clin Biochem Nutr 2007; 41:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/62\">",
"      Quercia RA, Korn S, O'Neill D, et al. Selenium deficiency and fatal cardiomyopathy in a patient receiving long-term home parenteral nutrition. Clin Pharm 1984; 3:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/63\">",
"      Kawakubo K, Iida M, Matsumoto T, et al. Progressive encephalopathy in a Crohn's disease patient on long-term total parenteral nutrition: possible relationship to selenium deficiency. Postgrad Med J 1994; 70:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/64\">",
"      Ishida T, Himeno K, Torigoe Y, et al. Selenium deficiency in a patient with Crohn's disease receiving long-term total parenteral nutrition. Intern Med 2003; 42:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/65\">",
"      Geerling BJ, Badart-Smook A, Stockbr&uuml;gger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 1998; 67:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/66\">",
"      Goldschmid S, Graham M. Trace element deficiencies in inflammatory bowel disease. Gastroenterol Clin North Am 1989; 18:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/67\">",
"      Spiegel JE, Willenbucher RF. Rapid development of severe copper deficiency in a patient with Crohn's disease receiving parenteral nutrition. JPEN J Parenter Enteral Nutr 1999; 23:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/68\">",
"      Galland L. Magnesium and inflammatory bowel disease. Magnesium 1988; 7:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/69\">",
"      Habtezion A, Silverberg MS, Parkes R, et al. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 2002; 8:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/70\">",
"      Park RH, Galloway A, Shenkin A, et al. Magnesium deficiency in patients on home enteral nutrition. Clin Nutr 1990; 9:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/71\">",
"      Oliva MM, Lake AM. Nutritional considerations and management of the child with inflammatory bowel disease. Nutrition 1996; 12:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/6/43113/abstract/72\">",
"      Hyams JS, Treem WR, Carey DE, et al. Comparison of collagen propeptides as growth markers in children with inflammatory bowel disease. Gastroenterology 1991; 100:971.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5887 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-812927D4EA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43113=[""].join("\n");
var outline_f42_6_43113=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      WATER-SOLUBLE VITAMINS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Folic acid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Vitamin B12",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Niacin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      FAT-SOLUBLE VITAMINS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Vitamin A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Vitamin D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Vitamin E",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Vitamin K",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ANTIOXIDANT VITAMINS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      MINERALS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Iron",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Other causes of anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Supplementation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Zinc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Calcium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Phosphate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Selenium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Copper",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Magnesium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      LABORATORY MEASURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/5887\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/5887|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/0/22540\" title=\"table 1\">",
"      Nutritional deficiency IBD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/7/41083\" title=\"table 2\">",
"      Clinical manifestations of zinc deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/33/541\" title=\"table 3\">",
"      Nutrition labs IBD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/13/9434?source=related_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/25/15767?source=related_link\">",
"      Causes of hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/37/18007?source=related_link\">",
"      Chronic complications of the short bowel syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/45/29400?source=related_link\">",
"      Chronic complications of the short bowel syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/0/20490?source=related_link\">",
"      Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/0/5130?source=related_link\">",
"      Diagnosis and treatment of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9562?source=related_link\">",
"      Drugs that affect bone metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44023?source=related_link\">",
"      Eating disorders: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/25/24984?source=related_link\">",
"      Etiology of hypocalcemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/46/2794?source=related_link\">",
"      Growth failure and poor weight gain in children with inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18808?source=related_link\">",
"      Indications for red blood cell transfusion in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/2/38949?source=related_link\">",
"      Iron deficiency in infants and young children: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/14/4329?source=related_link\">",
"      Iron requirements and iron deficiency in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30569?source=related_link\">",
"      Metabolic bone disease in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/7/44152?source=related_link\">",
"      Nutrition and dietary interventions in adults with inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39226?source=related_link\">",
"      Overview of dietary trace minerals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41722?source=related_link\">",
"      Overview of the management of Crohn's disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/54/19305?source=related_link\">",
"      Overview of the medical management of mild to moderate Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/14/21736?source=related_link\">",
"      Overview of vitamin A",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/3/39990?source=related_link\">",
"      Overview of vitamin D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/12/28871?source=related_link\">",
"      Overview of vitamin E",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/62/28650?source=related_link\">",
"      Overview of water-soluble vitamins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23685?source=related_link\">",
"      Relation between total and ionized serum calcium concentration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/55/20344?source=related_link\">",
"      Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/62/25578?source=related_link\">",
"      Treatment of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/21/3417?source=related_link\">",
"      Treatment of vitamin D deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=related_link\">",
"      Vitamin supplementation in disease prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?28/39/29301?source=related_link\">",
"      Zinc sulfate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_6_43114="Beau lines";
var content_f42_6_43114=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62607%7EDERM%2F85706%7EDERM%2F78502%7EDERM%2F85705%7EDERM%2F51899%7EDERM%2F85707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62607%7EDERM%2F85706%7EDERM%2F78502%7EDERM%2F85705%7EDERM%2F51899%7EDERM%2F85707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beau's lines",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transverse grooves representing Beau's lines are present on the nail plates.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Transverse grooves of the nail plate (Beau lines)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beau's line",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFFAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwC7LFj7p4qGSI9eprQmgIXjAPrUGxgvXivLvqfQ7mZImDhsdKrMmTlRzWnNGSeeTVSSMrk96Q7aGfcKSpx19qprCSx44rVkUkdOTzUJjIyTTGloU5YeOmKzbmEYPbNbzrkHms+4jHTvVbGbjdnN3VuCelZdxCMEY4rqpoeOBzWRcRZcjAxRclxRy91a57VnTWxHGK62S1B56ms64teM4q4ysYTpnNlXQ5BOAelTw3jIQD+tXZrbrkVRmteT2/CtVI5pQsaUF0smOcVMzbh9awRuiPGatRXTEc1ZBbdQeorPu4t1X1cOM5pkybhwaBM5W7i2tkdM1WrcvYAwasaVCjEYraMrowkrMZRRRTJCiiigAooopoBynmpE4qIVIrdjWkWTImFSL0qJTmpFyRx0qlqYtEgp45BzTVqReBWhmxacoyKRRk1IBg8UENjVHfvTgD6Uq+9O96ZIwrkYxSEe1SdDR2NMadhhzxxQRxmnt060H+lAmyMgYOaTnpUjDIHpSEYyaQ2xmPekIHYU4dQe1FILjQO/ege9KRmlGAM9xQO4wjjijBHWl9qQ0DGnrSEU40nBoAYVzwKAKfjmjbRYdxmKMfnTtpxQBzQO6PsC4gAHy8/Ss+VMZA71vXER2/8A1qz5YQuRjrXiyifVRkZBXd9RUE8WF4HOO9ajRbenT0qF4s+hFRaxrcw3jJ6ioWjIz/hW2lvvJBHGaZJahMkYo5QcjBZCDVaVeSK1rqPb15NUpEzxipHZMy2jycCs64hAbgc1uSR5bv8AhVd4CwyR+dFwsjCMHPI4qC4swwwK6A24LcAYFV5LZjnHWmjKSOTubXaSCKz7i3AHHWuvubM7SSBWVJaZc4FWnYxnFM5eW1LkECq0tvt6ZrqZbTaDxWfPa47VSmc8qfYw1Zo2xzVlJQwwalmtuDmqbxmNu+K1jIwcbDriIMpwPyrD1CEDJA5+lbaS54qrdx7lJrRMykrnO0VJcJtcgdKjrUyCiiigAooopoApy02lFWhMmU9amQ+lVweamU1aMpInU/Wpl61CvJFSjnFWjFkgwCPSnqeKjByM09TVEMfShaaDnk04dPeggUjg0mM5oY8gD8aMkd+tMYmMYo7Z4o68UEY96AD/AApp9KU8daaetIAPApP5UHtR+HFIAz6UhPoBmjNM3elA0hd1B5NNB5pfegoTPNLjik7+1KTkUAJnnFOpvQml6gUAFH40gzRntQB9uSRhwQM5HaqUoCn5hzWu3DYPX+lVZ4QTkHIrzGj6SLsY8kWTwox/Kq0sHGBWtt2Eg8momUY9c1HLc057GY0G3sKjuIwRn1rQeMjJA496gKg/1xS5UtB81zEuICQeKzZIsHpzXSyw557elZ9zDgkADnvWbiaxkYZi9aTywBg1ptARUMkRPUHip5SrmaIRnpT1gXvzx6VeEXy4waj28kUWIkzJu7fcSFFUTY4/hxXTRwBjkgGmXEOQQBzTszJtHI3Fh8p45rJuLXCnIrsZ4D0bkVnXNqcEgUMVjjZrbg1n3FryeBXUz2xUn5RVCe14JAqo3uZSicdNE0bcdKrs/JBziugvbbnpWNdW5GSBW0ZHNOBiX6Z5qjWlcg4OazWGDW8Xc5WrBRRRVCCiiigAooop3Acp5qZSKrjIqZCARjmtIsmSLCN6VOhyM1WXkYNSKcCtIs55Im5OPU09TjNRK2SKevTrVENEwYdD0pwbtUGcZp26mS0S5OaXrUYbkU7PWgmw6kPApu/mkZsEc0BYUnjmmAjrSMc0maCuUcWGPekzx05pKSkCF5oozQTwcUDE6Ckz69qdnOKYetAxaOlIKGNIBSeKFPHNNBpTjjFMYuRnHalA79c00U4H+VAWPuIby2WB9MU9k/d5Hbrk1JG27njI9sVFcybc84+lefbQ925Qdstlhg56U2VOy8ipQysrFsZFRKx79PrS5S7siIwOfzqKWMBMqPyq5PsfG373tVeNgf3bgip5dQUupT29jVOZMtwKuXQ8siokXdyTU26GiZRMByc4qCSIL1HStKUgA9fSqpx6HHvUSiUpFEx455x2qB4txwBWlKoI+noaijjOP8ahou5BEhUYpJE421aZGHToaidSecUXaM2zNnhHUVRkhB5YdK2WQ9xxVaeEY4zkd6LMEznbq23cKP0rMktSoORk100qEDpmqM6Ag8c042E9Tkru0BU4rn721wTxXc3cGR8o4rEu7XrxVmUonB31vwePxrBuIjG5zXb6ha4bOOK56/tgRwK1hKxy1IGJRTnQqxB4ptbnMFFFFABRRRQAU9T3plKMVaE0Toe5qRTVdWOalVuK0TM3EnU1KDVcGpFOOtUmZNEwPel71GDSg881VyLDx1zTg+O1Rg8+1KfqKYrC560H60m4Yz6UzOD60gtceTim570buhphPepGkS5zSZz3qPPPNGRTHYkJ5o7daZuNNzzRcLD880ZqOlB4ouOw/PFJ1P0ppOeaKQWHEjPSkLdeKBjBFNHWgLEgNL6VGelLn1p3A+0LXUkC43VMuorJkHBNeOQ+NbLALSSKPXFaVt4z05lIW8AYc85Fed7Q+h5Eejzzpn5WINEVyoba55NcFF4jtZT+7vIm/wCBVZg1YNysgbHcGjnHy6WO2a5CscEVDcXCMAynkVyQ1gKWwwIpkOpsJNzN8ppOVxKB0klyJWyTnHWo1nVZRzxj1rCa8Xlu2KibUFYdc+9K6SL5bnR3DAkNn9ahLqRisWDU1dSjNzTTd4bGevrSvcaizZXBYjqKnVT+NZVvcckk9uKtC4JH3s0WEy1tOT0GOKY6iohNuOTxQXGCAM9+aLEsjfG7vVVgT6fnU0gyOuKhyF69evFTYaZXdVxyOPUVnXMYEhxitFxnJzxVOVeaTQXM+ZMis27t8qcCtzYr/eA9Kp3SqgOelVYzkclfWmQRjmuY1G125GK725TO707VganbrtOKLENXPPL+3IJOOneszHWus1G3xnFc1dR7HreEr6HHUjYgooorQyCiiiiwBQKKKsBR1p6njio6eKaZLJ0NSZ5qupNPVuMkVdzNxJs0oJHNRqcjpRnPFO5NiYHnrS59TUXAp1Mlofnjimmg9qTkdaBC/nQDSUUDFHSkzzSH9KTP5UDHZo6mm54pQOcUBYD0zSqaTvx+tJ6+tADhzmg000tArCjpQKQkZpc96AsGeaKRh0ozxx1oA7d7VQR5e7b2yOlRSW7e3rkjmui8hQHGTyMfKOtRm3byipyozuxnAryj3+U55LcBDtJyfSnRxyRs22ZlxwfmIrbFpkZ2jdn0pPsgOcjGD2oJ5WYxa6RTGZ5CvX5Hz+dPTU7+BFVbmQheBk54rTFsQysABjtmlkhDSMzRoTnOStMLMoRa9qsahRcMynn5hmpV8TaiigP5bfhStbkkfKfT0FMltt8e0xgbT94dfzoD3lsXovFjKy+ZbsuB8zA9fpWxbeKrGcAGYxv33CuOltCAoII981VkthyTgseQe4pFKrNHq9vq0bjKOGUjgg1oQ6iCOTzXiWbi0yYZZEI9DxV+y8T6hanMx82Lp83BpoPap7ns4vVYdeT709b4KRk+3WvM9P8AF0M7DzIpEA6t2H41uPqsOSFuI2I6FW4ou0WnF9TuUukbJB4qvLKGJwcY9K5GPU/SQH6Gp/7T44b9ablcXLY3GuFzgHpVeacA56Dr1rIF7nJJPtVaa8A6Hn0zRcDTluQDkHGKrPcKwxn86x573JPI5qqL35+D+dTzaktGvcvwaxr1s59ac92GHDZNZ1zccnnJqmzMzdQUHPABrm9QhDZxXQ3Uu7PHNZVwobk007GU0mc267WIpKu3kJBz2qka6Iu5yyVmFFFFaEhRUkUTysFRWYn0Ga0rbQrqcBiAi989RSbsNK5kjmnCustPCnmEb3c9+Bwa37HwdApRjECO+annRXspHnMUUkhwiMx9hmrkWl3b4/dFR6txXrdtouniARi1KMOd6NnP4U8aSnK7Rj6U3U7DVHueUjRrvnpj2pf7JuV6ivVjpS4xtP5Ux9JDD7v4YqXUkivYRPKTp9wOq1C0Eqn5lIr0m70pVzx9RWXcaWgJwvSp9u0J4VdDhyGU8gj8KDXVTaXz8q8VRn00gksvNaLEJ7mUsM1sYdHNaD6c+CF61Unt5IeXUj3rSFSMupi6co7oiFNNOPFNJ4rQgQ80Zoo61NxhnJ5opMUZouOwoOTRkdqaTijNFxWFJ9OlG6mE9aTNK5SQ8tzTsjNRjjmnkjvTCx7O8ZBIC8EUzyGWTDg4AxyO9aDxEuO47CpVt0KdWJz+FeRzM+icLIx/K2nL9M9qlEYPQggccYzWmbRmAUkFcYz6VWe1MMhOOntSTYuW5UMKk4AJpjQhuADtHO3oM1pxJvXfk8HHA/rTzEu3BIyfzquYXKjEe2xltpFRlAAflyPQjNb65gkDKB5g4yRn9KrvASQQDgEnntRfqgcTBkgCg/Kp/DNUbuBZDujXDH+H0roZICXO3PNULqEcFTyKTkLk7HOzIu3BXNZkds1xhOO/GcV0V3Ar2zbFyy5waht7FmRecEDgH+lCk0SqdzHjtfKTyn4GeaBaMU4+7W+bLI+bBOaie22jC5x6GlzMPZ9DBMcqcLI4I96swX1/EQVlOB681opbBpMkZAxlfUVBIgUs8QKrnKjOcVonfVmbi0TWmrXxDmQK0aDLMAQB+NPn1sZVJFOWGcqc1aa8nbQZC1m8cbyhldPuyE8EH2yM1Dctp1vo8t15WLmUiJY27HHJrojSi1uYOrJMia8Vvut9Ki+0bjwc1ixuZHVWBbHoKuR2czviMFfTNZ+zS2ZXtm+hbNyR0NVpbnORmtKx8P3d0mY0lk9di9BVpfDrqVMkRAPZiAaORjUrnNvKDkVWkJNdkdFhWPCpufuCAePaon8OxHlU4P1yKLWE4tnD3KZUk1mywsXAUd+1emL4ch3LiIEdGyKs2/huNOREntVp2IdJs840/QLu7nCECNepZj2rrdP8CpEQ90WuIc/fj6V1FrpKpJGOEOQQcdK2oo59Mnmt4WAXuVOQQa0U7rUh0exl2PhO1+yb/LSNgmUUEfNj19Kr2+mqGYGMbTkV6FpmnrPauZkbJAB3nBJP938ayp9Me3naJ8ZVj0Of1qaiS1RpSXQzLayEa4wAT2HWtNLIbNpyVz+tWoLUKq/KAenA61pw25C4UBQDjFZpmrXcxhZgn5VOfSnizIGQv4d62vs5JB8smmm2JJ+QrnsapK4WMdrUYxjBqBoduenrW+LcdNwx3z2qjPEAcd8elDuhqKehz97AGHY/hWVJZrg7j9OK6W4hQqRlvoKzZ7Lbj5s57Z5rCcrGqgc3LagE8fpVO4ti3LDNdNLa+g4qpPbHHsajmYOCOVe0w3Q9ac2nLLFtZcjpgit0253c4H4VYhtG2H7rU4zMakEjzDWbNrK7KFcKQCpx1rOavRPF+mefp7SIp8yH5s47dxXnb16NGpzxPKqw5JCdqBSHpTc9++au5I8nA5phYZ470Hk0w9KbBIUtu6U3djApvPakJNK5dhxfjFIGpv1pGpczGkPD0obvmo80oNFwsfRrRKQD2FSJBg4HfvmrESBm6gcE88VKijILruA5wTXlH0jjoQwRkSc5H0PSnywoxzGuMDqe/vUxUBt2MCjA3dCeM9aL6WMmtbmcqCNiV4AOfrTHRVcMHB3eg6Vau4Az4UcYqnKhLcj8BxU3NYwvqDjZIQpAGOeM5qrchgMk596tMpKAZGB096CvmDA4I9eadxcljKZASSmRjotV5cbV3jr3xxV94mBOARz1xVWdCUxnOOn0oBxMm8iCEqQD9KntoA3Ue+R3pxXLbDllOPlIweKuIgzjbtH1qU9R8uhCYlPRcfWozbqeoGe2auKnbIPvSPFkE1SYuRlG2igKTB4hvUZTPT0Oax3jzJtOMdK6uytoJFna4nCMi5VNuTIemM9sDmsFoylwSmN4zj3NUm3YylC9yeCwa+hS3uZJUgUhFKjgEd2xzip9R0SFMiaRbpHcjzMEAgccf416ppNtp9v4Qt76JPtMoj5ZZNuD3yO9chqVjGUQh2aQ84UcA9TXoJKMUeelzSOaOh2trZJIAuW6Ac7R706ysAGBRFx/tVuW9irt8/PU5NW47UZ4AA9KzauaqNkU7eOWNAkcjop52pxipo9P3yDzASSQDvPataK28znb2xn6VdFud6ljyQME0mhpIwzp8SFMoRgnIHf0px08A8DIIGfSuhksQmcMnHofzqSazi2KIixPfPGaGrjVjnl0z5cggN2qL7FhyG5284rpPsBT7ykcZwajnscruCjd61DVgSuZKWCuu9mQcfdbPNWF05C7Ex4xwFA5q/DGEYh1OMdBWhA0LKxk80Z6qMVcbEtNMpWcU6wqyQyeVHIGzngUy/Cy3LSFVDnkgDGDXRWzzi1MKkRwMw6L1PuT0rEuYAs7hSWAORx1qp6RHSXvalOFME5A9ea0bfG3G08HtVaOEk8nn0rShCxpznPtWCOmUNLkQ38g59OtDFxySTjj8Kk+8T0JoZSWC/zquZi5Cqy7Tljn2PQ1DMtuYiHyp6jA/rmr7WzEEnp7nAqrLCi53AH/AIFwfypOTQKKZlTWqq4G/cmMkj6dKotCnoTnqCa1mgwT0JAx61WeHAPp9KxbuaqBlm3XBLZzmqksBYf/AF62mjyeR+lVZbbd6A1k2VyowpbcnuDj1FWLO2Of9WevUd6vvakjGV5PWtCzsXWLMkWSeBzTjuY1rWOX12zLaZeBf+eLfyrxy5tyELL1HUYr6H1q1WLTLt2T5RCx569DXjstgwALYwwz61vCo4O5xSpKaON/Wg8cVd1K2+zS/KCFNUuOe9d6kpK6PMlFxdmNPWmEe2aeabQCIqO4pxAzigLmgob3oxTgp9aXb9aLBcRYZXClI3YO2xcKTub0Hv7VLexxRShIfO4UBxKu1g+PmGPTNdGRDqmlaXHDq1tYtZoVeCdimH3E+YpA5JGPfis3xVdw3uqiSCU3ASJI3uCu0zOq4L/jSGfQ5XABxgdKehGB1+h7U8ESjCYOelTMIx5aqm11B3HrmvLPqnErOrMvXH0oVeOpLdqsEdAE5HNSeSAM/pRYjlsUpFJU8YqtNHxhBz61pSRgP8oJ7VFKu75Dj3NJjt2MzYcYAPPtTXiym0EdfTNaLxBDkc0rQdFHQe1JJgzHMWDwcY5JBqndLwxXG30Fb00GN2Rmsu5iYE4A68+1NitcwXH75doJBq5GoP3htHuKmtod0jlcnHerUcP8RHP6VKVzR7WKYTPCnP501cklSAf8Ks3ELIMRj5u1RKp/jADdxQFiNo0abgYU/pVF4B9p+UYAbqavqpWZc9Dx0qFwwlGScc0GU46noEdvaQ6Na29rcMxXLBS3yhu+exrOlgyS2Q2Txg1o+HbsS6J9jeFWH3xIBymT1qbylU5AAXPUivTi+ZI4LOLdzNjtMJkcAjjipIYQinuav4OAB37elPSHA+VRuz1ptdEDV1qQLCdkZUYzyasiEFVHJI/AfhU6W5Xlx+ZqwUOMkdKhgkMktl2lkQ7eCuD0qyI1NsGwAynHXn8aA0krAA4+XAUcAinqv7vIBxTDlIRC8uFAz7elV2hOSrHGDnJrRjXnPJA7UydMklRkGoa7DSMqOHEw2kDnqa14NLd0DpiQ55WIg4+oNMtIDJOq/KjMQMnpWyLJbG5gRXX5vvOW4/SlHQio+iM+SVvtYhaIIp4YMASffms7U4gtywQkgHGema6/UoDcWZmKhnA4OMkCuYmiIYlwSxPNOd7Dw9pO5n2tszSEH5V9TV0LbqnAaRu/pToxg88U4qQMKAAe4FZp2Oxq+hCEH8CAZp20AZLr9FqTYxXOT+FNMYCZxTJ02Kk3l73BYlfQ9qil8ojGzA9ianePngZzTJYvmAUE8dqhs0UUVHEfBVPzqJgQPu8Ve8tpMrjGaHtGUYBH51GvQbsjJdWbkj6VAwI42jH0rVnt2Qnp06Yqq8Z6sOKzZSKSK7uqbQeemK2YA/lAED04qnBAzyZXqT+VbCWzCLucenanFnLWtsYXivZ/wjt8z5BKbQfUkjivL7m0HlIUj2gDGcda9K8Z4FjDbj70r7yPZf8A69cfd2p2hM4UgGlJlU6fu3OB1exyuCpzjvXKXdu0LZHKHvXpGpW4wM5Nctqdop3/AC8Hp7VtRrcrt0OTFYbmVzl25puBUsyNE5RxyKiPHFegeRawjUg6mlNFAwooqazmSC5jllgS4RTkxSE7WHocUCOytF1VdC0xtDNjFGYj5yu0Idn3H5ju5wRjFcx4h+2nUnOqNE1ztXJjKEYxx93irv8Ablh/0Lum/wDfUn+NZWo3EV1cmWG0itIyAPKiJKj35Pemij6e2HANG32OcVYVN7Y6Gk8pjz0wa8c+uegxMcZyOOacQQcBsmphHwSOg609VUAsRznmqIZA1uNgAOAffNRLEqt8ykp3q22QAM/Q1AuV4YkkHmgEnYiZF8wnbgZyM807O3AGGHrjvU3ytuxgAc0KAF+6MUCkirIm9SCAQTWVfw4LAjHuO1bEgIBKnGfWqNyu5W/vY6+tDBKxjW8e1iORjkcVeSEMoB6+mKS2iAnJ3/MAMCrDAqflyc9zSjsaNXZUVNhwBntUDICW7c9a140AQO23P0qhOuSdg47kU7WAoSoQScYwOtV3UeYdwz9KvzqNvPTOKgmgYIrAEHtis3uJxN7w65FsmVPIx+Fb6qHVn24GfyrC0BHkhRTgYHSulii3Ic5AHGK76Xwo4aqsyIKNvH/16sQxnb93bipIo8gYBA9xVqKL5/mG49AOxrZGTGRJuIJyc9zzSTIo4J7cCryRPIvTAH4VHMibsHGR6UmhR1diODCsjIucD+KpVQlsHvxipFXpnin7RuDD0yMUi7akSR8cdRRIpIOF/Ore3BJXBqJ1OcZFTIlFe3hYyqQPzrUsrf7Y+JgDj7vzbc+1U4lIbjtWnp0aZJljLBOhB6c1mRV2uTzkQwogkaMA7TkZOP61z90EMpIzs55PWuj1VMCQK52jovU/TNc9JFnGQc4+lVJ32DDK+pTWLcw9DVnyCDgknB6VNGhDfKo/GriREvnaORgiojE6pStsZ5QY6cVHNgkAD8K0XhCqelV/LGeTxTaJi7lCROgxx9aiKkDIIGa0HjGeOcVE0YQ8jnFRJGtymsRbdgkYHOKhkRj6gVopFuRi3GOeB+lEUDBvMYDaPbvU2uhOVnqY8kTckgnPc1VljfOGzW9cFjDGigbc5zjrVVImmuAp5GTkL0NZyjqNT0uxdIgVFyBkdietXnTaOQBVy2iWOIAniqWpTfZrC5uDjKDC/wC8eBVI49ZyOB1xzfavM4zsQ7E47Dv+dZs8QJ6flW4kSrACWBZhmqV1EFUn2rOTPUUUly9jjdVhwW4rnLyAsD6r7V2OqRE5JPzdhWDPbnJRhyT68Gs07PUirDQ4TV7Vs/KnzDisTPGK7fU4QVcgZUHFcXcR+TIVPHoK9PD1OZWZ8/i6XJK6IycdaM8U1qSug5bDsijNMJxSHk0DsWIYZZ3RIYpHdztRVUksfQetWNQS1iCxRQ3cVwmBKJyPvY54wCOfWuj07VbePRIpYJpluba0a1SJYmIid2+abcOPun65rD8UXcV5qgMEjzCKGOFpnUq0rKMFiDzz780Byn1CyEsccfSrMY+U8ce1IV5IGalRMAjH5V5Fux9e9iF1wf8AZNQqck8/L044q3IMKOM1AISSSAcE8imJWYjRtktnim+XubAwTVgAbcCkiBU9eaYMgMW2QgLzSFcKST83YVdYAsTjn3qCYKG2kgE0yNzPcEH5hVS5jJBwD/KtGVOSSSff0qs5PPAIpFpGZFEVBLAg+1W0Tdt44p0iEnIPOKWJsHGcgDmktNCnqSbBtxxjrVaaJSoAPPXGKu5DAZweMVCV+U+vrVEmXJETuXAOelRFG2DI49a0mj3KB6U90zEBsXI7ik0EnYXRyIZlVBl26V2UFuEjQOvzHkt1rjYWH2iMOcAEdPrXqOn2dvaWAvbj95u4hQnP4murD66djhxMuWxmtb70iLjbxhvep7S3UOOc89T296mdHlYudsYbooqS3QKdqjJ710s5L6C7MqcAADvWdKFMh28knnNaly4RCelZqAM3THr71LLp9xwXKjOBgckVNHGGgynY4JoRcgDHAGM1ahRdrjuw4x60im7EaxFowTjjjioWiIPzED8KvR5XjoKXG9uRxSaCMiC0gEjZbPHp3q7CuYpdq4B6A+tSJF+6ygwo5zmnFD5Y2KCOuT2qGrGM5XM+YtM22QDODg/yqCRAVGEwwJ+hq+6nGMc00R/KNwFCibQdinGpxljgVPsGOOc/pVlYQMk04RDJ7ZqkrDcindRYhRhk57D1qo8bEYAGOtafG1kfvyPY1WlBAwTj0PpUtdRxdijMhjAPTIzUG3c+Dkep9qvXKhkEmefu4qtFGCTuBIA5xWUvI0i9C4kcMsA2FSBwCc8mmSw+VEfNJIbqVxxmkd1ijMe3MbdM1VklASRSMZxyTnihzSRm4y6EV6sMDfMWbI4DdcVTs9vmgK7Y7VHdSPMApOADnP8ASrNjCgQMevSsW+ZmjXLGzNPcAgzj0rl/FN158iWMQ/1bbnPqccD8K6DULiOw043M3zO/ywqP4m9fpXIxR9ZZWLuxySe59ac+w8JTu/aPoQTw+SqLvV+MnbziqNymUzknFassRDcj6fSqNwpGeAVrK3U7Uc7exAjPf6VhXNuUBY7gT0ArrLqJS2AMD+tY97CVUMR16HFQ0TLXQ5G6jIDMACQu4g964XXYdkwZe5PGOlekXsKKxDf6s8nnriuO1+0E0cjRllZTuweB1rqw8rM8zGU7o5MjHH6U00MxLkseT1pCc16J4wGk70GkzQNHe6QxvfDxtrG7t44vsLRSQPKsZ8/zAdxz1yvQ9sYrnfFtxFPqwaOZJ5FhjSadPuyyhcMw9ee/etiPzINE0lrDQLPUPMjJlnNuZCX3EbDjoQMdfWpfFNnatp9/INOt7J7XyMNCNuJHHzxN2JHX1FIqx9KqgEnzDKkUiAEkelSFScnNRsCDwK8lH1trilVAHoaRjt4GASKd0X+vpSoAQOc+5qiOVlcLhjnqamRcIp6GnxIG5IOTUhBx0z70IG7lVlYy5A4xUdxGyjkcds1adsAjoahkO4DnP1pgjNnBzkniqzAE4rSlUFSeM+lUXUBj2FSapXItrYPGaZCpO7oMCnSsFBBJHHanQr8o469aaWo7aE0artXd97FRgA5z1z0q1tO3jgfypgjGe+apogpumCNoyR1FDowGcZPWpT/rCOpFLIMtx6dKVmJq5SkkEIOUDZxnI5Fd9psksul2qIxljC7l4+6DXDXERkiYY9/xrqvh9fTSWT2wBPknZgehrWg7SscuJh7vMuh0cALlc5wKswBV+6cN6Cla0ZJ/LlYIQm5eOvtSwcZxzXYec3cr3yZQ7uMVXjQsvy9auSqZH5wFx60ka4YALgDtRYuMrIEgIVe2e1TKgX049qkVPkyMHBp6puzkY71LVieYRVQ5GDuHP1pBHyOwHPWrNvavjdtyMZ4/nSpGzNtHTqfYUiVJdCS2i3KgfhT6U+6RVjKpHtAPXPWpIUjGfOJ2jpilvEQRCWF8pjGD1zQZ7yM/yxt5HJ6Gkx/DwSeRUuN6HkBhyMfrTI4wGJwTg4yKDoQgHB3fkKbIVVfQ1OFCk5PHuKHHQkcfSi4XuUHIZ1LDgHnFF3IJMhYwtEx54wBTMnZtC+4NZt9DVJblJ4Tzkn6UFMjIJz61d2ZzuznsKY0DDp0PIqGWpdyhKjYBbgHoT3qrJGzrwOcd+M1oyRHO1m69B6Gn2+n7jmToelYyQOairsox6cTEu4dRkj3qaytFDkzMscSKWYn0rbMOSsacv0wK5jxpd+RJ/ZNuQZThrg/3f9mh2guZmdJSrT5F/SMTVb3+19SaRMi1j+WIY4A9fxqKRMHjlRwKdBHhTGo4PWpyoC8fN+FZxberPUcYwSitkVZMll3dOmapXOCNhH4VelBcc/dqrIq7cngfSqv0DltqZVzH5SfOKxryMt94k5H4VvTrwTk/1rNmXzBjcoCAkZHB9qhol6anKajlomzsUrwO1clriJ5rqoJCrt59e9dzqUYZGBwqA5yc4B9c1x2sQFYyR8wB5I5GTVR0Zy10mjzqdSkrDGADxUWavauALo7RgYFUa9OMrq54ElZ2CiijvVXEd1okNhZadGGS/e4lsWvWaG5MSsAxGwAegBOa5/xTHDBfIlkkkdlLElxEjyFidy53HP8AF/hWpaz22l6fpUl3qOoiUo08KW6IyRBiVI+brnHI6VheILyO/wBSe4imuJlZQN06qrcDpheAPTFJMZ9hMm9gc49KVlO0k8jvUrpzkdBSbSYx69TXmWPrCuSQoyMe1CAMeOSKkA+n9aaoI5HFFhirk5H8qkVsA55qI89cjFNTjIz+VFyXElkAC9KqyfL0HNWWG5RgfjVK5mVZFTBJI60N2GokcrcHjH0qrLknnkVakU7TgZzUJTCcjBoNIooxKBJluPWpASJcjkelSFefmyR6AVIAF5I/CjqUxUfeABkn0FNCs0n3vmFKB5TBgM88Cn43SFuRmqT0IaIWjIkIODjuKfMFCYHXFPbIbLdD3prLuIC8+lUhWIADyP5VJpd7Lo+pLPECYZMCRRTnQLkk4I96gmUchT165p7aozlFSVmejyXi3XllJAcfxA9RV2OEx5LAZC5+tcN4U1iGN1tLmEMVYEBu/wCPpXd3EaeSs0JHlkE4BziuuElJXR49WDpPlKS5MhOKmiU7znnHtTY1IcYGQeRg1owwqTyy7un0qyG7CCPEZIHXmp7a3MzY5AXqasSRJFhVkDg9TTTJsXZFnJ6mpZk5dDft5IzAsKIM8DGOtZ2sWXlTCSFdqkYIFVraVoJQzNwRkE+tTT3E9wixF8ls/MRj8qRkoOErogs7aS4ZkJB579qjvoTDL5ZdWKjPHSrVvI0L7YyWCjnjqaqXe0/NuGe/tSNYNuXkVOAcMcE9ajEuAwU8D170t5IqYCjDEdarbi5wuck/nUtnZBXVyczcYY8njFReaBkLkUKA0bZX5u5zxRHGo/eb14Pes7sq0UiMqx5ZeOntUiAphh+PFWHuYpcK/wC7bPJHQ1HJGYyTkMPrxVITl0JYZIZsJMuyQ9GXgU650+SNS0X71BySvb61WljwoYcE1E5nI2rLJsbryTSbsRyvoxsYV3JYBeeMVp2yhsBRnJGABz71FZWbMu0YxjqeKh1vUrfRrRsMfNPAPc1m3bViac5csdyLxPrEGg2TRWzK+pyfcI6J7muAiV5ZXklZpZ5DueRupJrSs7WTUp3vb8bJHG5Sx4x7Cn3AijYlWGf7uMVzzTn7zPToU40I8q1fV/oVokSNcn8qjfAJ2ZOetKZV4J5Poaj35YjGaa0Rvy3EkjLjK5+gqrNGxj5PfpVpSVBHfrUcvzjJ4ApbktsyrlPl61k3IAypxgnv2rbulBJIPygVj3cLeUZCpBI+UdjSY+mpjayEkEcMKqqKeSe7e5rjdUiDMVH3jkMB14rtL3P2do1zvQlyAeAfaucvtNa7e4LYiKqGGRkE0Ru3ZHNUslZ7HmfiKJkkRjux23Dmsaur8RQtFH5MwPyNjjoPQj865Q9a9Kk7xPArL32FA60VNZSxwXUck8C3ESnLRMSAw9MjmrMjtbOW+/sDTE0m80q3jEZMsU7xFy+45Y7geoxx7Vy/iE3R1JjfS20s+1cvblCmO33OM1dOs6V/0Llr/wCBEn+NZWozwXV0ZLW0S0jwB5SMWAPrk81SA+0ldSTkgYprEf3eakYDOBjPemMpztVeD3ryz62xEozkgZx19qafu89e1XlgCRD1NM8vKkkU7WHcqqpPWkC84HrU5jZemKjG7djr6UDEdAUwOKgWJSvQ8dzVkqwHA4qOTI5HSgLFLYQW6kZqMowJz+tXMZA206SMbc4ye9Iq9ikI+nTikMffAq35YBwB170FR6c0xXKRUlt2OlRklXyavlN3bvTJIAQSwp2YXKzAMoz1qNU2ykk9auRIp46dqk+zjcT2q47A2kUzFwWY1SdRvI7/AKYrYdRtIxmqUka7wcjI7UTiC1M50ZXV4uHHINdr4f8AEIurJbK4AVuiFRjn3rmJRjB2ioxviZWAzt6dqdOTg7owrUVVVmj06BWNtuPABxnHer2nxmUN3K4GB/OuE0rX5oonSXPI6muu8PaxbtDIVfMhbBx2rrjUjLY8qtRnFbG8UUTIr44IJI7VGsQa8ZQfkz6VI+0qGcgEjsOlVlmVZcs+0qfzoZyq5fubV4gZNm5FIBHrUU/mNKJAAqqMYFaMdw9yq5ChO5Pp7VWvsWsIaIbi/UGkRd7PcqBHgLSHjPIOapzPyzuA2R0PepZJ/MQb9w9vSq0ko6ORjGcYzUnRTVmVpmVuQw9MVFtIG7BwOOKgnkjLkfMCeBimx380KGNDlSfmBFZOSW51qLtoaUESuu13ZQegH+elV5MJlUYHtjPX3pl3eiS1Tyo1Q4wxFZsl5BlkZgrhcjHU1LlFDhTk9S6zhAwuBtA9Oacs2wBtxdQcjd3+tYV7qsUaqjSgY64NU211WcsgkIH3Vx96s/bJaG6w8mr2OskuJJZVQ27qHGRx2qSS4FmuCV3Y5rmNR8SapeqgiiEMagAFe1Ysovb2f99I5Y8GpliOkVcqGDbtzNI6e78UFJG8t03EYyBniufudSe4YPIpmbOcMeKnj01IwNx5qcWsYIJXJ/nWT9pLc2hClT+FFSK7uflOxSvZccCpGUSIWlUb8dRVzyFEYbI9lqJlDKcDHPQVai0tSuZPZFYWq8bnUDjnHNSXNusOwxuZFIyTjFSCF2XgAKD3PWo5chlUjIA7HOKegrtvcrqvykjBJ45qOVe6suOnNWGOVUJjcPQUx408v94CGPbPFAmyrFb+ey5GEzgisO/l2xyhTt2k7AB610Bl+9IuMAFcD6da5+9jdlG9VKgcEnp70paIlavU5++QxoOP3uCXP4dKpK0zSmSYnyxGQxz2PYD8RVzU1Gw7C0jHq3rVWdi2hXsMX+u8tWAB5+9j86ik/eM6/wAGhwfjW1eKx+0OGHzNEuOnA6/0rz016P43ukks7eOKZ5Y2jzJ2G8cd685Ir1KZ4NfcSprNoUuY2uomlgB+dFfaWH17VDijFamJ2un6Rbaharc2fhm/kgbO1/twAOOO61geIrQWWpNALN7PCqTDJMJWU47kfy7Vs6fqMEtvp8c32pFktZNOk2xllBJ3Ky+pyRlevFZfimaKbVcQmVjFEkMkkqFGkdVwWIPI/HmkhM+x41wcCrG0AcfXNNCd+mKf/CVUcn2rzD65h99OAfrShQRzimMxQkHgUbsdQQaafcSQ10AGeM1W8vc3H5+lSNLxxyT69qeq7B0/CkXaxAwKsByRTJE3DnoatFR1/nUTLkck8UDK2Nqnpk0gDHjGRUqhRyMn2NKo4BPSmkMjRRx0ppALc9KsMM8DNMClSOc+1Nolq5GIvmLYxnvTJ1byzkcVbHTIwM1BOMnHOKCVuVUQbgQOasYYrz3p5TA4HNSqmFrSI2+pVaLoOearTwFuFBA9a1xCu3qTTRFxg/hTtcSnYyEtj91uQe1RywrGcPn1xWpOpydvX2qFYfMfaxAz3xUuw+a5TEYUBsHn1qxbM1urSQyFXB4GetTpbYk2HlfWpZIDvA+UgVLT3MZWZfi168RVkuMFVH3fWnTa/HfRkAeVKOckYzVAwjkYLGkks4pIl+Uhx1p88kYexhfY63TNYSdIo/MU7VCkIcVpya5CdsWIjt4yeoP1rziCDypC8WUk9QarX1pdXM25ZDk9T0oeIklsZ/UoSlvoeoJqVrs8xpI3duWBwMVlate263CyK6AP2FcHdWkohjRncOByc8Gq62tz5ap5zHHrUSxL7F08DFa8x0MmpxNKWyuOmWNOuNYs48ImJJMbuvFYUmlKYhgszfkKSDS2TPqfesXUn0R1qjT7klzqckxJhLKO6mq8dlJczeZJu3N3zitGC02Y+UZ96s+U2cE544oUHLVlqSjpFEMFhagt50WW6cGrX2eAoi4A288fyqSKPCfMcH0FPcR5Gc1qoLqZybY1W2oyIoKnnntUSgFx2I5zUhAJyDn8aSRDuHr3ANWhJJbEZbL8jJNSZCgHdg9/ah/YZP8AKnDYInV1y5HBosVbQrsSSSBSoMseg4pdjDIA5xU+nWs1xEx+QcnlvWhLWyFJqKuyrICqlf1oVVHzP8wA5A71JK28BcYaIkMexqOOPCnPQ+tS9we1iow3MeqA/wCetRySgHbkt2qc7pZhHCCO2SKr+UYLhDIhyc5B6Z9M0vQHZaMkeON1eALs5+c/hniuVvXUJfxFgztjaT9RXQ3YELCWd2GWAcDn61zeqM0kysiqEYlcDgHnrUz1Jpq78jlrh3y6gYJGDWfHNJbzIYjliSmMZ3Z4xWncoIyQ7bhuIJHtWBdSFb+LyyR8wO4dQO/6VFKNmFdpxOf8TWDxI0s0my3yyIc5JI7D/GuCOdx4r2W/jtta06/06eYRCPdNE+QQhwWxn3HFeNdxXq00lsfOV5NuzCjb6DmjHftU1pcy2lyk9u+yVDlWwDj860MDoM22q6XpkY1aGxezjKNDMGA3bifMUgHJOR78VR8T3cV7qYkgkadUijiM7rgzMq4Lke/vW/YXT6fo+nef4iksxNGWSBbISFF3EZznoTmqvirTHbzr7+1BqEkSxGUmHyzscfIy9iO1NAz6+Ydc9M0RqcA9R6GnBtzYUU4JleK8q1z696bjHxjtmq5ibvzjoauPGRwefaoyV2sN3TjGe9NIIsp4+fPSnHpgZPNTKFUHpSHGQRjmmolu7Ii+0cjNM3bievNKf9YQ2cGiThuw7UrFWK7MATkkD1qVc9PwxSjGMr+lAO3kUluAjAKMngVE0ijjApWJbkngVGww3senNXe4lHuSK2SByBQVJfpxSIp2A5qRSw6mhC5eoIp3YZeMdc1YVATgdKYigng9KmTLcYwe1aIykOdFwMHnFMWPDetTFeBxz605skABcUyCnMc/w5pqx5XJHNXlAx2IFV5E+cbWwPajlC/QrqrM2SMcVJtXcpzg96lYKBjqaGh7jjNKw7CiNicpzQpChl27nNOjEiDI/KmxyDzCTigmxVfjOQdw5prqxwc/L1rSKKzHOAD3qG4tgWwmfzqHAcWiplAoMhLegNOilTghR+IqVrbGNwz7etSQwoqnIAPUcVDi0VZETOzAkqMfSou4OD19KtlecA59qkEZIycfSq5bi2KhQ4BbNKEbPA561amUjb8uQahYsGA5BotYa12GBCZApGPepVgXbzk1KATGDUyQqW5biqSE2VvkUYUDPrUJDMxORtz1FW2iRcZGQe9LMRHETERj0oaGn2M/aQ2FNIUwSSPm9+1TKG+YhOo4ppUNt3Lz3NSa31Io3YMQ2SuKYXkRNoJCk9PWpHwvAFV2zySeAetD0B2fQfBcpCJEaBXLcbielFwMNgMSq8gntUIaNZVY8qDzx+tRSymRTggoD0qU9BON3cSWRjA6wjMjcDHUCqH2gRn+IFegb1HYVZyRFIyvtKn5cVWt4g0sssqGZQCuB1yaiTehDilchGqR3D7LkOBtJBHPP/66wL+dGRUkdQgbhscDPXPtV7UrZ7VgWbG7IwRjFc5qB25B7DGfWovLZlwpx3iZEpG+Z952j7q+571msN8jhR+8MT5O7B4Gat6g3lwiLjOeSOao2UYuYbiPaCwBCsffirpK8tDDEySicpqV00Ec+CyMPmUY6Hp/I1yJ/wDr10HiMtDJPDvZtjEZPf61zw5r0KKsj57Eu8gB55zS96KcBmtjmOw0tY20ayOuLpXlhSLQ3TyLIU3Hrs/hznGfeqXiHUL6Jryxu4rZXnMbGSHlTEoHlqnbZ39aZHf6XdWVpFq1tdma2TykltnUb0ySAwYdRk8ioPEjyS38TPALeL7PEIIg+7bFt+XJ7nFNIGz7RhBBwB8w/SrWCqe/amwRDZljg+tLG4L7TnGeua8uJ9e7sYxxyTyahlRQNxIFT3IXsfm61W2lwc/jVaDjYiVSxwKEOE5QjqeakUMzbkGBTWJY7cAd6Eap3IsBnyTimSqCe5FTNFsAJ5pFAHXkmnbTUdyByFPsKUgHAxx9KlkQFsEcCgJgHjNSlZj3VyMhMYI69RioZEHGetTSAFxjrTHyzEGm9NRJBACOp4qTZgZzzTYlOcKOan2HaS3TvmmtRPzGR5C7h0HWnI/zA9Pem8KuB0NOXcxwQPqRVXsS0WEDNzjNKrHJDEilTfGARxxSSOCw9aoy5bjpFVMMDnPWoyqk5A+uKY7EDGcH0zUgYBMcGhMOSwCNJeFIzQu5SQQDg0A5PB2j1qYKFiLZJx6cmqJasMYnnCnOOlBRCgLqM09SVcDHyEfjSOQxOF/DNArEbgMBkEipY9v+FM25HQ05EwAMn0FAx5jBPfNMkhViQc59qkCknHcd81MsQYEluT7Ubi2KgiXGKkVSB04qUwgDPHNPTG0YGcUmrBciQAggAYNMEahwxGDU74yAg5FNlQ456elKwkQhvmwKJNyv0PFSxooYEtTZHG4jrxii1ikxuQyHOC3aoBtwR1NKEIHXikkwozxn2qWi7diJjngd6YVIBHQY7UvmbuMYNCtmVVdvlPXNSU1YhcKucHP41VbksCMLVq7AjkZUOcc59apyk7cq3OOaGVHUjGFIGevU+lV5WVz8owo7+tORgqkDJbNUZ3L5424OcVm2Wo3ElkyVVchc80+3lazkluQ7RnkjbznPaqpLSA7QQRx0qI3IhCxopBJ2s3fn0qL6kzV1YqaxK0yCSRxnhQmcnNYVwrSTLGv3iMH0rf1RXtljYxrI20q+4Z2FumffFc7EczbuW28kD0zS5bysZp8sboz762e1MpZdzqCHGOPrVae6itbGeFHwrpsZ+PmGQc/nVvxBdsRPHEXaSTrzwFzkD8ea5TVZj9i2kMrEHqMAnPQewrpg0tjza0nJXZxniaYT3k7x8xlsA4xWIKvarIWkAzwD0FURXVTWh5FZ3kO68VbsFt2uoxePIluT87RqCwHsDVZemKs6fbS3t3DbW67ppWCKM4GfrWyMGbn2fwzj/j/1b/wHT/GqviO7tbu/iaxMrQRW8cKtKoVjtXGSKnOk6YjFJPEFt5o4OyCRkB/3sfris/UrGXT7wwTFHyodJIzlXUjIYH0NMln3Esm9iIx8vUnFD4zgcH1qeLagPGRSSICSSQD6V5biz67m1K8rDI9fSmbNo4HBqf7MzfM2abgnI28iml3LUuwi8KVCg1CInkkJGAR1zV0IBHlepquQyE9yetVYUZEMkRJwcU0xjeB0I5AqwzMBznP0poOQST+tMpNleRVLjOaV1wT2HbFSQgFi1OfDN82BSHcqvGRgY/pimFQH6cmrMhO1ipBqDDOQxH5UNXNE7gqENwvPanEMQc5x+lPiDLwTx70joQ/UHtxQlYL3GCMDAJH1FOKnb7+tEkW08nB9qkQHqaaBihiFU5GO4IpZVWRcqcH0pF45IzSg5BIGT7VRNupD5TINzAmp49u35+ppC3ADAn2PINSLswCwxRsKWo1owWHPB7U4KY3xg49fSnFfQigBs7jg0XIJVAI5FMMQA3BSfarCFXTAxxTHGAFB/GmZrchZcAgcU5BznHT1pFXD8sTn8qsbdp9vpRcb0REVJ+6ealVs8YO7tSNnqMZ96f5oI5HNMTTYzIIII6e1RBirHGeKkJGDjrTd2STt9qQ7BnEoOMCkuAX5GBilDbeSo61E5PJJxQxco1Tngk46U8suzcvUcU1CGAz3pgIXKj1oLaGOxIJHT3qvI20dc0+YsFYrgVVb5ozuOcc1EjSAry4UkdumajDFlLNxS7gIuhPNM2sWOWAHpmo8i5LS4NIpPyHJx61RmfnJ+X1FWGcIT/Q1UcmZXyMHPFJsFpsRuQgLKcHsKqXEm4fLnPqfWppUCqx5IHc1SmbPyZyAO3epZrZdyvvminLbwI8DAHc1PYSNJesYtque5Gcc9hVWV8ybAeAOlVrKTGowMBt+frnr61EVqZ1Vo7F7WJPIuFiwZYCd5d+A7nqTXLXXlxXSm1nU5yz9gtbuq7Z7tDLckwxce+PpXJ6nGVwQAEJbaTwAoraRxK1jJ1RpJJZLiQ+SMYiH97HrXOavc7opXfO3G1FPbI61r6pIpgyN2wZAb1PtXI6xKpXaucBe/rVROKuznLo5kPvUYHANDnc5pydq7Yo8abu7ioRk5q5ptzLY30F1b482Jgy5GQfbFVgvU1PZ3E1rcRXFtI0c8bbkdeoNWjNs2jfaO53voEok6lUunCZ+mMgfjVDVb19QuvOljSIKixxxIMLGijAUZrp7zU/Fd5KLq1h1WCF0BZUQld2OSoxwD1xXLahdXV5dNNfyyS3GArNJ94Y7GqSEz7tgjBOQMYp3lF5ScfLUixkAFen061YhhJj3DgHnBrgUT6ZzK7uo+UDk9eKpSR/MWywzzx2rSkQE/LyR681FIpZscE0uVjjOxURGI6Z+tPktT1x+A61eWJYogBjAxg5pZW+Q9QcVSQ/asy3U+WcA/WqjEhCB29q05EPlEjOMdKz8Fsn+lQb03chiJKNtHtxSYZwNw5HU1PChJ5HHrSSZWUDAx/Ec0G11cbCjYZTk56cVFEpSTBBxnvWxaqvl4ypJ7UsloSS+Bx3FOxm6qTsVlhRkyo9jxUJGCVxyK0LZeCOlVyp8w7gMnp2ptEqdynIA+AOD9KjCFWxIeKnuodj5BJB5qON1lID8Y96DeLuiS3aPblicdeRTiI2b09xStEE+6QeeBintET0zQQ31ImizwDx0zUHlMJOSeP1qWVWUdPxpvmsFBPX6UAvIUOUGOKVJst81RrOrA5GWpwKMuBwfWgfLcsB13YU8etOcdCpzkVSKhc+ntUsW5euSMd6CXAkRCpB7egqVJcDoaj8wEHgiojKMggEdOvagnlbNCORHGWA9MUSoiq2P51TzheDk9cU/JwGHIFO4uTsSBRgdPU+9NlKqRnpSxDgnse1Mb7w/r2pXFaxG75XAzkdKao3IxPanvgDOPwFAcEY5GaCr2Gq4WLJAz06VCHBO1uM0rSfwgH3zUUj8E7QDQNakMrklgT04qF38tMgZyKSR2JII5JpJcgbTn1qLM1SsMWT5MdMnNMdMsSz4qIMQ+CeKVmXnJyM/nUN6jlpoRyDzJSeBx271DuKB12DngHPSkkl+8BgN6UkXzKyuQhAyKncSRBJHJNhUywAyQKypJmzuROnrWq1y4Aijz5hyOO9ZF3GYo15GSemeRSl5FxdtGVDK3mDd90nJzTJk2ok3mFZ8koPQU2U43EZLnGc9B9Ko3TkORnB9SaUfMU3fYhu5kjjKOxkmLZJz8oHr71l3l+TMjXCrNHH8qKe4z3xVi/uEeOKIAr/ebpz/AIVhX0zFcEgkDgg1omcNV9WjJ1m8Lu5IVATkIvQegFcjrNwXRNzFnxgn+VbOoy7znJxjjjmuX1B9zDkYzWtJXZ5eKnZaFOpVAyMVEKkXrxwa7InmskB4rS0K6istYs7m5QvFFIGYAZOPXHfHWs3sM1p+HRbPrlkL4IbbzRv38L+PtnGa0WpkbEls81w1wPFdswJ3eY8sqv8A984zn2qj4lvIb7UxLBI0wWJI2nZdpmZRguR71qT3BvbqfS/EUdta3QOIbmNFQQt2VtvBQ+vaqvjGA2+q28LBFdLSBW2kEZCcnI6/WhCk9D7ptipiORx702INIxQcD9KdDF+6O0fpUSh4mKrkE98dK4lsfSuz2JlgMR6jNRkAsQO9TM5Qc8/WoXIC7hnd2oFFDNpLd296V48tt6VYt4gELnFOYruzgYFAX1sZl0ShMYUnPeqhh25461oTFXn3AkccelNlAJGetKx0QlyoppHhBge1V7mIqQRkk1qsoFscLzVCXPlkt270rI0hK5JYLtbGevY1qkAg47dcd6xbUkHduHHrV7ziOh71UXoRUi3K4quFYqRimzJv+5gD2qKXIO4E4NPimXJBznt70By21RA7fJsbrVcWquT0FTTEktlTjsaS2cjIcA0NWN1dLQhNsyqHjYkioi86MAwOfXFXGd4+UXcvXntSmZHGGUZHelbsHO+qK5m+UFxk46YphkjJ5x14zUzrGV2qOW/zikNsNhOOnbFKwXSIDCjlimM4OariEg8HCinEyQv069TmgSDIU80GquMMrIwAxipknwQCOD+lISFbcQMY/KnIiMuTQN2J2ZB8qnqO9VUGXwTwTTLj5SAOTmkUnbnPzUCUdC2AVYjrS79rYAwPSq8TvzubJ7VIsmWwRx3oJaJ4nCAAgEjpmlJyxBxz0GKqtKpkAGMAVMzgvlW4WgzlGxMWKDBGPeoJHx9D6UFyw5PPWoHYY5OKCUhJWAcYJxULvu4PJz1FNmcFdpNQbiFx1xSbNYkhGZCq0ydXBbAPPY0sEuZMjt2pk05Z+D0o3HdplcqxbDnBA71EQGAU8Y75p0spDjA49TTIkaeTaoJY8Vly62G31ZAxVZCqLz1PvVSWTcQM4GORVu6jktJ9rhQQKoTA8bWBLDJqXdFJp6jblo4XLQbuPuljz71nSnK/MMgHJ+tLM78Dd8+eR6VWlncRkKQRnOKm92NrQZLMA5b5RjgCsm7dSz5CjPI69ParE0+1ZTgHI64zt96zLiTcN4LMT8vXtQncxkUL9SqckMgGRWJezribzFyrDGV6ir1/MHDhjwBxXOX85LEDCcYwM1SOCtIyL9mIZUycj9K52Vi757DpWtqc5DynbtJ+UrjGDWNXZSjZXPHryuwFOFNp68it0c7JR05qWNGZlRFJdjgKByT6VGvQVreHZY4dZtZJXCAMQHPRGIIVj9CQa1RkycaMUfyZr6xiu+hgeQ5B9C2NoP1NUZoZba4eG4RkljO1kbqPauoSIRazaSSTRx+TEsMliYmMrYGGQLjDbjk7s981la+AL6OPIMsMEcUpBz84HIz3xwM+1NEM+7o3z8uMVCZybiSPGDGFOfXNFFcB9MhrMXkAJp0o+UD0FFFBY5ZDtx2pA5RTn5vrRRQS9yD/AJaZ9efpT9vyBjyTRRQaC8mLPrVD7w2t0JoopS2NKYyX91KAO9TZzEG7kUUUQNZbEo+ZOaot/ruvSiimKG5YU5ULgADFKYVLfQ0UVoPqQLlbkgksPQ/WnTorXBQDG0daKKze4nuQyLs6GlMzRrgdKKKnqVIjeQEE7Rmq7DdItFFVIuA5huc56DtUZYjgdM0UUuhaK0zkMec4qaA5XcQMg0UVKKew9X3mRQNu04yKYQCyqee4NFFUyUM27D1J5701pW6DjmiikKRP5hIBPXFRsdx5+lFFMzRDJgOOKY5w4/Kiip6miIXYxrleucVDI+0YA69aKKY+pWDE3HzcgDOKjEj7t6sVYntRRXOxshmZpctI7Mfc1nSMQuF4wc5ooqpqzQ1sUL6XaTtXBPfNUJCwj+Zic9aKKyY+hSe4KK67QVPLD19qzp23xyP90YztHFFFXE5qvU5q/kxlgoznGO1YFxKyytL1ZRuGeeaKKqO551fZnP6ozM+WOSxJJ9TVCiiu2Ox48/iCnxnpRRWkSHsWE5qTrxRRW3QwZpW+rahHB9njvbhYcY2CQ4A9KiTkHNFFUjJ7n//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transverse groove on the nail plate is a Beau's line.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Nail plate detachment from the matrix area (onychomadesis)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor with nail dystrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nail dystrophy caused by a subungual glomus tumor. The red subungual patch indicates the location of the tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Median nail dystrophy, also called median canaliform dystrophy of Heller",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43114=[""].join("\n");
var outline_f42_6_43114=null;
var title_f42_6_43115="Range of motion elbow";
var content_f42_6_43115=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Range of motion of the elbow and wrist",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Joint action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Position for examination",
"       </td>",
"       <td class=\"subtitle1\">",
"        Normal range of motion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Elbow",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Extension",
"       </td>",
"       <td>",
"        Shoulder at 90&deg; abduction",
"       </td>",
"       <td rowspan=\"2\">",
"        0&deg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Palm facing up",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Flexion",
"       </td>",
"       <td>",
"        Shoulder at 90&deg; abduction",
"       </td>",
"       <td rowspan=\"2\">",
"        150&deg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wrist supinated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Supination",
"       </td>",
"       <td>",
"        Elbow flexed at 90&deg; touching the iliac crest",
"       </td>",
"       <td rowspan=\"2\">",
"        90&deg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hand in neutral, perpendicular to ground",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Pronation",
"       </td>",
"       <td>",
"        Elbow flexed at 90&deg; touching the iliac crest",
"       </td>",
"       <td rowspan=\"2\">",
"        90&deg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hand in neutral, perpendicular to ground",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Wrist",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Flexion",
"       </td>",
"       <td>",
"        Elbow at 0&deg;",
"       </td>",
"       <td rowspan=\"2\">",
"        90&deg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hand fully pronated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Extension",
"       </td>",
"       <td>",
"        Elbow at 0&deg;",
"       </td>",
"       <td rowspan=\"2\">",
"        70&deg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hand fully pronated",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43115=[""].join("\n");
var outline_f42_6_43115=null;
var title_f42_6_43116="Acute porphyrias drug interactions";
var content_f42_6_43116=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F57422&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F57422&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Examples of drugs known to be unsafe or safe in the acute porphyrias",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"3\">",
"        Safe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Acetaminophen",
"        </p>",
"        <p>",
"         Aminoglycosides",
"        </p>",
"        <p>",
"         Aspirin",
"        </p>",
"        <p>",
"         Atropine",
"        </p>",
"        <p>",
"         Erythropoietin*",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Gabapentin",
"        </p>",
"        <p>",
"         Glucocorticoids",
"        </p>",
"        <p>",
"         Histamine",
"         <sub>",
"          2",
"         </sub>",
"         receptor antagonists (eg, cimetidine, famotidine, ranitidine*)",
"        </p>",
"        <p>",
"         Insulin",
"        </p>",
"        <p>",
"         Opioid analgesics",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Penicillin and derivatives",
"        </p>",
"        <p>",
"         Phenothiazines (eg, chlorpromazine, prochlorperazine, promethazine)",
"        </p>",
"        <p>",
"         Proton pump inhibitors (eg, lansoprazole, omeprazole, pantoprazole)",
"        </p>",
"        Vigabatrin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"3\">",
"        Unsafe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Alcohol",
"        </p>",
"        <p>",
"         Antipyrine (phenazone)",
"        </p>",
"        <p>",
"         Barbiturates*",
"        </p>",
"        <p>",
"         Carbamazepine*",
"        </p>",
"        <p>",
"         Carisoprodol*",
"        </p>",
"        <p>",
"         Clonazepam (high doses)",
"        </p>",
"        <p>",
"         Danazol*",
"        </p>",
"        <p>",
"         Diclofenac* and possibly other NSAIDs",
"        </p>",
"        <p>",
"         Ergot derivatives (including dihydroergotamine)",
"        </p>",
"        <p>",
"         Estrogens*",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Ethosuximide and methsuximide",
"        </p>",
"        <p>",
"         Glutethimide*",
"        </p>",
"        <p>",
"         Griseofulvin*",
"        </p>",
"        <p>",
"         Hydralazine",
"        </p>",
"        <p>",
"         Hydroxyzine",
"        </p>",
"        <p>",
"         Meprobamate*",
"        </p>",
"        <p>",
"         Metoclopramide*",
"        </p>",
"        <p>",
"         Nifedipine",
"        </p>",
"        <p>",
"         Nitrofurantoin",
"        </p>",
"        <p>",
"         Phenytoin*",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Primidone*",
"        </p>",
"        <p>",
"         Progesterone and synthetic progestins*",
"        </p>",
"        <p>",
"         Pyrazinamide*",
"        </p>",
"        <p>",
"         Rifampin*",
"        </p>",
"        <p>",
"         Spironolactone",
"        </p>",
"        <p>",
"         Sulfasalazine",
"        </p>",
"        <p>",
"         Sulfonamide antibiotics* (including trimethoprim-sulfamethoxazole [cotrimoxazole])",
"        </p>",
"        <p>",
"         Tamoxifen",
"        </p>",
"        <p>",
"         Valproic acid*",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    This table includes examples of commonly used drugs known to be safe or unsafe in the acute porphyrias (ie, porphyrias associated with acute neurovisceral attacks).",
"    <br>",
"     NOTE:&nbsp;",
"     <strong>",
"      This list is incomplete.",
"     </strong>",
"     &nbsp;It is strongly recommended that clinicians consult the websites of the American Porphyria Foundation (www.porphyriafoundation.com) and the European Porphyria Network (EPNET: www.porphyria-europe.com), which are frequently updated; list many other drugs, including those that are not classified with certainty; and provide evidence for these classifications. Refer to the UpToDate topics on individual porphyrias for more information on clinical manifestations.",
"     <div class=\"footnotes\">",
"      * In US labeling for these drugs, porphyria is listed as a contraindication, warning, precaution, or adverse effect. Erythropoietin and ranitidine are regarded as safe by other sources. Estrogens are unsafe for porphyria cutanea tarda, but can be used with caution in the acute porphyrias, especially in low doses or by the transdermal route.",
"     </div>",
"     <div class=\"reference\">",
"      Adapted from: Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005; 142:439.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43116=[""].join("\n");
var outline_f42_6_43116=null;
var title_f42_6_43117="Tubular sodium entry";
var content_f42_6_43117=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F62197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F62197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sodium entry into different tubule segments",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 187px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Major mechanisms of passive Na+ entry into the cells across the luminal (apical) membrane in the different nephron segments. With the exception of the selective Na+ channels in the collecting tubules, Na+ reabsorption in the more proximal segments is linked to the reabsorption or secretion of other solutes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Rose, BD, Kidney Int 1991; 39:336.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43117=[""].join("\n");
var outline_f42_6_43117=null;
var title_f42_6_43118="FDA label ex pharmacogen";
var content_f42_6_43118=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F65875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F65875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Various genomic biomarkers in the context of US Food and Drug Administration (FDA)-approved drug labels",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Biomarker",
"       </td>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Synopsis of drug label information",
"       </td>",
"       <td class=\"subtitle1\">",
"        Label recommends testing prior to instituting therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ALK (anaplastic lymphoma kinase) gene rearrangements",
"       </td>",
"       <td>",
"        Crizotinib",
"       </td>",
"       <td>",
"        Crizotinib selectively inhibits ALK tyrosine kinase. ALK gene rearrangements, which include the echinoderm microtubule-associated protein-like 4-AKL (EML4-ALK) fusion oncogene, may result in expression of oncogenic fusion proteins and increased tumor growth. Detection of ALK-positive NSCLC is necessary for selection of patients for treatment with crizotinib.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        BRAF",
"        <sup>",
"         V600",
"        </sup>",
"        , BRAF",
"        <sup>",
"         V600E",
"        </sup>",
"        mutations",
"       </td>",
"       <td>",
"        Vemurafenib",
"       </td>",
"       <td>",
"        Vemurafenib inhibits BRAF kinase, which inhibits tumor growth in melanomas that have specific types of mutated BRAF at the V600 site. Confirmation of a V600 BRAF mutation is required for selection of patients for treatment of melanoma with vemurafenib.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        c-KIT expression",
"       </td>",
"       <td>",
"        Imatinib",
"       </td>",
"       <td>",
"        Imatinib inhibits proliferation and induces apoptosis in gastrointestinal stromal tumors (GIST) cells that express an activating c-KIT mutation.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        CCR5 (Chemokine C-C motif receptor 5)",
"       </td>",
"       <td>",
"        Maraviroc",
"       </td>",
"       <td>",
"        Maraviroc is indicated for treatment-experienced adult patients infected with only CCR5-tropic strains of HIV-1 that are resistant to multiple antiretroviral agents.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Cystic fibrosis transmembrane conductance regulator (CFTR) gene, G551D mutation",
"       </td>",
"       <td>",
"        Ivacaftor",
"       </td>",
"       <td>",
"        Ivacaftor is indicated for treatment of patients with cystic fibrosis who harbor a G551D mutation in at least one of their CFTR genes.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Cytochrome P450 (CYP) 2C19 variants",
"       </td>",
"       <td>",
"        Clopidogrel",
"       </td>",
"       <td>",
"        Patients with genetically reduced CYP2C19 function have lower systemic exposure to the active metabolite of clopidogrel, diminished antiplatelet response, and higher cardiovascular event rates following myocardial infarction than do patients with normal CYP2C19 function.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Voriconazole",
"       </td>",
"       <td>",
"        CYP2C19 is significantly involved in the metabolism of voriconazole; poor metabolizers have on average four-fold higher voriconazole exposure than their homozygous counterparts.",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Citalopram",
"       </td>",
"       <td>",
"        Maximum recommended daily dose of 20 mg (rather than 40 mg) for CYP2C19 poor metabolizers.&nbsp;&nbsp;",
"       </td>",
"       <td>",
"        &nbsp;No",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        CYP2C9 variants",
"       </td>",
"       <td>",
"        <p>",
"         Warfarin",
"        </p>",
"        <p>",
"         For additional information on warfarin see below",
"        </p>",
"       </td>",
"       <td>",
"        Increased bleeding risk for patients carrying either the CYP2C9*2 or CYP2C9*3 allele.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Celecoxib",
"       </td>",
"       <td>",
"        CYP2C9 poor metabolizers may have abnormally high plasma levels due to reduced metabolic clearance.",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        CYP2D6 variants",
"       </td>",
"       <td>",
"        Atomoxetine",
"       </td>",
"       <td>",
"        Patients with reduced activity in this pathway (poor metabolizers) have higher plasma concentrations of atomoxetine compared to people with normal activity (extensive metabolizers).",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluoxetine",
"       </td>",
"       <td>",
"        CYP2D polymorphisms of the poor metabolizer phenotype do not affect the metabolism of fluoxetine because of compensatory mechanisms. However, fluoxetine inhibits the activity of the 2D6 isoenzyme and it may affect the metabolism of other drugs that are metabolized with this enzyme, potentially making normal metabolizers resemble poor metabolizers. Drugs that are predominantly metabolized by CYP2D6 that have a relatively narrow therapeutic index (example tricyclic antidepressants) should be initiated at the low end of the dose range if concomitant fluoxetine is being used.",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Codeine",
"       </td>",
"       <td>",
"        Some individuals may be ultra-rapid metabolizers due to a specific CYP2D6* genotype; these individuals convert codeine into its active metabolite, morphine, more rapidly and completely than other people. This rapid conversion results in higher than expected serum morphine levels.",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tetrabenazine",
"       </td>",
"       <td>",
"        Patients without expression of CYP2D6 drug metabolizing enzyme likely to have increased exposure.",
"       </td>",
"       <td>",
"        Yes, if daily doses &gt;50 mg",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Deletion of chromosome 5q(del(5q))",
"       </td>",
"       <td>",
"        Lenalidomide",
"       </td>",
"       <td>",
"        Indicated for the treatment of myelodysplastic syndrome in patients with deletion 5q cytogenetic abnormality with transfusion dependent anemia.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Dihydropyrimidine dehydrogenase (DPD) deficiency",
"       </td>",
"       <td>",
"        Fluorouracil, capecitabine",
"       </td>",
"       <td>",
"        Unexpected, severe toxicity (eg, stomatitis, diarrhea, neutropenia, and neurotoxicity) associated with these drugs has been attributed to a deficiency of DPD activity.",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Familial hypercholesterolemia",
"       </td>",
"       <td>",
"        Atorvastatin",
"       </td>",
"       <td>",
"        Dose adjustment is needed in pediatric patients (age 10 to 17) with homozygous familial hypercholesterolemia.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Glucose-6-phosphate dehydrogenase (G6PD) deficiency",
"       </td>",
"       <td>",
"        Rasburicase, dapsone, primaquine, chloroquine",
"       </td>",
"       <td>",
"        These drugs administered to patients with glucose-phosphate dehydrogenase (G6PD) deficiency can cause severe hemolysis.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        HER2 overexpression",
"       </td>",
"       <td>",
"        Trastuzumab, lapatinib",
"       </td>",
"       <td>",
"        Over-expression of HER2/neu necessary for selection of patients who are appropriate for use of these agents.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        HLA-B*1502 allele presence",
"       </td>",
"       <td>",
"        Carbamazepine",
"       </td>",
"       <td>",
"        Serious dermatologic reactions can result in individuals with the HLA-B*1502 allele.",
"       </td>",
"       <td>",
"        Yes (in patients of Asian descent)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        HLA-B*5701 allele presence",
"       </td>",
"       <td>",
"        Abacavir",
"       </td>",
"       <td>",
"        Hypersensitivity reactions, lactic acidosis, and severe hepatomegaly can occur in patients who carry the HLA-B*5701 allele at high risk for such reactions to abacavir; screening for this allele is recommended prior to initiating treatment with abacavir.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        KRAS mutation",
"       </td>",
"       <td>",
"        Panitumumab, cetuximab",
"       </td>",
"       <td>",
"        Use of these drugs is not recommended for the treatment of patients with colorectal cancer who have mutated KRAS in their tumors.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Arylamine N-acetyltransferase (NAT) variants",
"       </td>",
"       <td>",
"        Rifampin, isoniazid, pyrazinamide, isosorbide dinitrate, hydralazine hydrocloride",
"       </td>",
"       <td>",
"        Slow acetylation may lead to higher blood levels of these drugs and thus, an increase in toxic reactions.",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Philadelphia chromosome positivity",
"       </td>",
"       <td>",
"        Busulfan",
"       </td>",
"       <td>",
"        This drug is clearly less effective in patients with chronic myelogenous leukemia (CML) who lack the Philadelphia (Ph1) chromosome.",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dasatinib",
"       </td>",
"       <td>",
"        Indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) with resistance or intolerance to prior therapy.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        PML/RAR alpha gene expression (retinoic acid receptor) expression",
"       </td>",
"       <td>",
"        Tretinoin, arsenic trioxide",
"       </td>",
"       <td>",
"        Indicated for treatment of acute promyelocytic leukemia (APL) characterized by a t(15,17) translocation and/or the presence of PML/RAR alpha gene. The response rate of other APML subtypes has not been demonstrated and therefore, patients who lack this genetic marker should be considered for alternative treatment.",
"       </td>",
"       <td>",
"        Yes, if no t(15,17)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Protein C deficiency (hereditary or acquired)",
"       </td>",
"       <td>",
"        <p>",
"         Warfarin",
"        </p>",
"        <p>",
"         For additional information on warfarin see above and below",
"        </p>",
"       </td>",
"       <td>",
"        Hereditary or acquired deficiencies of protein C or its cofactor protein S have been associated with tissue necrosis following drug administration.",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Thiopurine methyltransferase (TPMT) variants",
"       </td>",
"       <td>",
"        Azathioprine, 6-mercaptopurine, thioguanine",
"       </td>",
"       <td>",
"        Individuals with TPMT deficiency or lower activity due to mutation are at increased risk for myelotoxicity.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Uridine diphospho- glucuronosyltransferase 1A1 (UGT 1A1) variants",
"       </td>",
"       <td>",
"        Irinotecan",
"       </td>",
"       <td>",
"        Patients exposed to this drug who have the UGT1A1*28 allele may be more susceptible to toxicity.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nilotinib",
"       </td>",
"       <td>",
"        Can increase bilirubin levels; the (TA)7/(TA)7 genotype (UGT1A1*28 allele) is associated with a statistically significant increase in the risk of hyperbilirubinemia.",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Urea cycle disorder (UCD) deficiency",
"       </td>",
"       <td>",
"        Valproic acid",
"       </td>",
"       <td>",
"        Use is contraindicated in individuals with urea cycle disorder. Evaluation for UCD prior to therapy should be considered for patients in certain high risk groups including those with family history of UCD.",
"       </td>",
"       <td>",
"        Yes for patients with history of unexplained encephalopathy or coma, unexplained mental retardation, cyclical vomiting and lethargy, history of elevated ammonia or glutamine, family history of UCD, or unexplained infant deaths.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Vitamin K epoxide reductase (VKORC1) variants",
"       </td>",
"       <td>",
"        <p>",
"         Warfarin",
"        </p>",
"        <p>",
"         For additional information on warfarin see above",
"        </p>",
"       </td>",
"       <td>",
"        Certain single nucleotide polymorphisms in the VKORC1 gene (especially the -1639G&gt;A allele) have been associated with lower dose requirements for warfarin.",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43118=[""].join("\n");
var outline_f42_6_43118=null;
var title_f42_6_43119="Endovascular repair of AAA with common iliac aneurysm";
var content_f42_6_43119=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F56169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F56169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endovascular repair of AAA with common iliac aneurysm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 232px; height: 354px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Abdominal aortic aneurysm and left common iliac artery aneurysm treated with internal iliac artery coiling and endograft extension into the external iliac artery.",
"    <div class=\"footnotes\">",
"     AAA: abdominal aortic aneurysm.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_6_43119=[""].join("\n");
var outline_f42_6_43119=null;
